DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	IRGM; MEFV; PSTPIP1; IL18RAP; VNN1; LY86; FOS; CALCA; ANXA1; ITGB2; S100A8; S100A9; CSF1R; HCK; PLA2G4B; ADORA3; CYBA; CCL5; TNFRSF1B; ITGAL; CXCR2; PTAFR; ADORA2A; CD40LG; CCR7; CNR2; ADM; CHI3L1; MAP2K3; SLC11A1; CXCR3; AIF1; GSDMD; NLRP6; LYZ; RAC1; ADAM8; S100A12; HYAL1; NAIP; TCIRG1; IL18; THEMIS2; NLRP9; NFAM1; IL17RE; PLD4; KLRG1; CD180; P2RX7; MGLL; MYD88; SIGLEC1; IL22; MMP25; IL23A; IL1RAP; NLRC4; ADGRE2; PYCARD; LY96; CD14; CCR3; PTGDR; PPBP; TLR10; C3AR1; TLR6; PTGIR; TLR4; CCL4; IL36RN; FPR1; TLR1; CCR5; IL1RN; TUSC2; IL36B; PTGER2; CCR1; C5AR2; CCR2; FPR2; IL2RA;	GO:0006954~inflammatory response	84	381	22.0472440944882	0	0	0	0	0	0	0
up	SIRPB1; DOK2; LILRA1; LILRB3; ADAP1; IGSF6; EGFR; IFNG; IL2RA; CD4; CD3D; ASGR2; GP1BA; ADRB2; CD3E; CD14; CD3G; SAG; IFITM1; LAG3; CXCR2; FPR2; CD27; CCR1; CXCR3; CCR5; IRF9; KLRD1; ADGRE1; ADGRF1; ADGRG6; DTX1; ADGRG3; ADGRF4; ADGRG5; ADGRF2; LILRB2; NFAM1; KLRG1; IL17RA; P2RX7; DOK1; MYD88; BAG1; ADGRE3; KLRF1; MARCO; ADGRE2; SIGLEC9; LY96; TRBV24-1; TRBV19; TRBV6-6; TRBV5-1; CD80; TRBV6-1; TRBV7-1; TRBV27; TRBV7-3; CD8A; TRBV5-5; TRBV3-1; TRBV2; TRBV28; TRBV25-1; TRBV7-2; TRBV4-1; TRBV7-6; TRBV29-1; TRBV7-7; TRBV14; TRBV15; TRBV5-7; TRBV30; TRBV6-7; TRBV4-2; TRBV20-1; TRBV7-4; TRBV12-5; TRBV6-5; TRBV12-4; TRBV5-6; TRBV16; TRBV23-1; TRBV5-4; CD86; TRBV9; ANXA1; TRBV12-3; TRBV18; TRBV7-9; TRBV11-2; TRBV10-3;	GO:0007166~cell surface receptor signaling pathway	93	268	34.7014925373134	0	0	0	0	0	0	0
up	FOS; MYC; POMC; IL2RA; CD4; IGHE; MMP1; ANXA1; ITGB2; CSF1R; MMP3; HCK; ALOX5; UBB; ITGAM; PIM1; CCL4; CCL5; OSM; MMP9; IL2RB; MUC1; CD36; IL1RN; TNFRSF1B; ITGAX; FPR1; PTPRZ1; IL32; PRTN3; PTAFR; PTPN6; CASP1; IL2RG; CCR1; CSF2RB; CD80; FLT3; CCR2; CD86; STAT5A; IL12RB1; CEBPA; CEBPD; CCR5; JAK3; UBA52; GRB2; YWHAZ; LCN2; BCL2L1; IL10RA; IL16; IL18; IL13RA2; IRF4; IL20RB; CSF3R; IL22; IL23A; IL1RAP; IL26; IL20; IL36B; IL36RN; IFNGR1;	GO:0019221~cytokine-mediated signaling pathway	66	278	23.7410071942446	0	0	0	0	0	0	0
up	TRAV19; SH2D1B; TYROBP; SH2D1A; LILRA1; CRTAM; CD160; CD8A; TRBV12-3; TRAV8-4; IGKC; TRAC; TRBC1; HLA-B; HLA-H; CD3D; TRBV7-9; TRAV29DV5; HLA-A; ITGB2; CD3E; FCGR3A; CD3G; IGLC2; HLA-C; CD8B; FCGR1A; IFITM1; ICAM2; HLA-E; SELL; CD19; CD1D; HLA-G; LAG3; CD33; CD22; ITGAL; CD247; ITGB7; CD1C; CD40LG; HLA-F; SFTPD; KIR2DL1; KIR3DL2; B2M; CD300C; KLRD1; CD300E; TREML2; LAIR1; LAIR2; JAML; TREML1; OSCAR; LILRB2; LILRB1; RAET1E; TREM1; KLRF1; HCST; CD300A; PILRA; SIGLEC9; HHLA2;	GO:0050776~regulation of immune response	66	216	30.5555555555556	0	0	0	0	0	0	0
down	AGPAT2; KRT34; KRT14; PTHLH; KRT5; KRT15; SPRR1B; SPRR2E; SPRR1A; SPRR2A; ATP2C1; BNC1; COL7A1; PLOD1; LAMB3; LAMC2; KRT31; LAMA3; EDA2R; SPRR3; COL17A1; KLK5; KRTDAP;	GO:0008544~epidermis development	23	82	28.0487804878049	0	0	0	0	0	0	0
down	NRP1; TBX3; ONECUT2; HRAS; PDGFA; BMP2; ITGA2; FGFR2; STX2; LHX1; COMP; VEGFC; APLP1; EFNB2; FGD1; GAMT; PHLDA2; LHX4; PDGFC; HSPG2; LAMB1; LAMC2; LAMA1; NTN1; LAMC1; LAMB3; AGRN; EGFLAM; LAMA3; LAMA5; LAMB2; MEGF8;	GO:0009887~animal organ morphogenesis	32	111	28.8288288288288	0	0	0	0	0	0	0
down	SH3PXD2B; HGS; KDM6A; RAMP2; ALOX12B; TADA3; AGR2; PDGFB; LDLR; IL1B; LMNA; FN1; CSF2; APP; TFAP2A; GSN; INHBA; CSF1; HSPA1B; BMP2; BMP7; CDH3; TNC; ITGA3; CALR; CD34; AKT1; CDH5; PHB; WNT5A; SOX9; HMGA2; ACTA2; ACTG1; ACTG2; CAV1; CNTN1; GAS6; MAPK11; NTRK2; FOXD1; RBMS3; RNF207; PIK3R3; SMO; C1QTNF1; ADAM19; EPB41L4B; ATP13A2; ROBO1; IL36A;	GO:0010628~positive regulation of gene expression	51	374	13.6363636363636	0	0	0	0	0	0	0
down	DAPL1; TLL1; SOX15; INHBA; BMP1; MAL; MDK; AKT1; STX2; PGF; FOXL2; KRTDAP; HSPG2; BNC1; MECOM; SIM2; CCDC85B; NXN; CXCL17; TTLL7; EGFL6; ARHGEF28; SPATA20; TWIST2; EDARADD; PTPRU; EXT2; MMP19; TWSG1; RAI14; NDRG3; NDRG4; JAG2; TESMIN; DLX1; ELK1; DLX2; SOX12; NKX2-8; KIAA1522; NR2F2; FOXA2; FOXA1; SPINK6; ETV5; FSTL3; ETV1; ETV4; CAV1; SPDEF; FOXC2; SOX18; NKX3-2; FOXD1; POU2F2; FSTL1; SRC; FRK; SOX7; HES2; CAV2; FOXE1; ONECUT2;	GO:0030154~cell differentiation	63	572	11.013986013986	0	0	0	0	0	0	0
down	FN1; PDGFA; ERBB2; SPARC; TPM1; GLI3; ALOX15; SDC1; FGFR2; CDH3; TNC; LOX; WNT5A; TGFB2; PTK7; SCRIB; ARHGEF19; DCBLD2; WNT5B; EPB41L4B; CELSR1; SPRR3; VANGL2; PLEC;	GO:0042060~wound healing	24	82	29.2682926829268	0	0	0	0	0	0	0
down	FOXE1; TBX3; RBFOX2; PDGFB; CSF2; TFAP2A; ENO1; GLI3; BMP2; SRC; HMGA1; BMP7; NR2F2; YWHAQ; CALR; SHC1; PHB; MSX2; SOX18; WNT5A; SOX9; LHX1; DAP; SMARCA4; HMGA2; FOXL2; PITX1; CDK5; MAP3K10; MECOM; GAS6; PTPRK; CCDC85B; FOXD1; DAB2IP; TSHZ3; ERN2; SFRP1; TWIST2; GATA6; CREB3L1; NACC2; SCMH1; SFRP2; NACC1; SOX7; LGR4; GLIS2; TP63; ZNF703; ZNF219; DKK3; ZNF282; SIX4; YEATS2; TSC22D4; LOXL2; MAGED1; C11orf95; SIX5; SIX1;	GO:0045892~negative regulation of transcription, DNA-templated	61	530	11.5094339622642	0	0	0	0	0	0	0
down	HAS3; TAF4; FOXE1; DVL1; CEP290; TGFB1I1; LRP5; TADA3; PDGFB; IL1B; TF; TFAP2A; INHBA; GLI3; SPP1; EGR2; BMP2; SRC; HMGA1; ERCC2; BMP7; ELK1; MDK; NR2F2; SMARCA1; SHC1; NOS1; AKT1; PHB; SOX18; MAP2K2; WNT5A; SOX9; LHX1; SMARCA4; HMGA2; FOXL2; PCBD1; ACTA2; MECOM; ACVR1; YWHAH; FHL2; FZD2; ATXN7L3; SIX1; TEAD2; CREB3L2; SFRP1; AFAP1L2; GATA6; FOXC2; SOX7; LGR4; GLIS2; TP63; RNF14; SIX4; USP22; FOXA2; MAGED1; SERTAD3; ZFHX4;	GO:0045893~positive regulation of transcription, DNA-templated	63	570	11.0526315789474	0	0	0	0	0	0	0
down	AKR1B15; PLOD2; MGST3; KDM6A; AKR1B10; PLOD3; UGDH; ALOX12B; CBR3; CYP7B1; MICAL2; FADS2; CH25H; CYB5R3; CYP1A1; CYP11A1; CYP2E1; P4HB; TXN; G6PD; BMP2; CYP4B1; P4HA1; NQO1; CBR1; VCAM1; MAOA; GPX3; NOS1; PDIA3; ALDH3A1; UQCRC1; PRDX2; SPR; ALDH1A3; ALDH9A1; ALDH7A1; PGD; ALDH18A1; PCBD1; SORD; PLOD1; AOX1; CYP24A1; CRYZ; LOXL1; PRDX4; DHRS2; PDIA5; PTGR1; PDIA6; NSDHL; MSMO1; P3H1; CYP27C1; TP53I3; PHYHD1; NXN; HEPHL1; RETSAT; DEGS2; MOXD1; FA2H; MICAL3; LDHD; P3H3; MSRB3; GPX8; PXDN; VAT1; HEPH; TXNDC17; CYP4F12; DUOX2; PNPO; CYP39A1; STEAP1; FADS3; CYP2J2; CYP2S1; STEAP2;	GO:0055114~oxidation-reduction process	81	526	15.3992395437262	0	0	0	0	0	0	0
down	PIGR; IGHA1; TF; KRT1; CDH3; ACTG1; POC1B; ZG16B;	GO:0001895~retina homeostasis	8	40	20	0.00010037914018057	0.00140424855207757	0.494367265389323	0.532210201237399	0.294016384017732	0.494266886249142	0.0128532967256504
down	ADCY6; ADCY3; ADCY9; EDNRA; ADORA2B; CAP2; CAP1; LGR4;	GO:0007190~activation of adenylate cyclase activity	8	40	20	0.00010037914018057	0.00140424855207757	0.494367265389323	0.532210201237399	0.294016384017732	0.494266886249142	0.0128532967256504
up	PES1; NOP56; RRP9; DKC1; NPM3; RPL26; RPP38; TBL3; NOLC1; WDR74; ISG20; IMP4; RPP25; DDX47; ISG20L2; UTP3; DDX21; IMP3; LYAR; MRM2; NOB1; WDR3; UTP18; EBNA1BP2; MRTO4; ESF1; PIH1D2;	GO:0006364~rRNA processing	27	139	19.4244604316547	0.0001033067796945	0.0116785854759402	0.486265012022016	0.49050058998949	0.478517003544928	0.486265012022016	0.105607109523593
down	AGR2; ITGB1; ATP2B4; ITGA3; EPHA2; AKT1; LRP1; ARHGEF16; PPP1R9B;	GO:1903078~positive regulation of protein localization to plasma membrane	9	53	16.9811320754717	0.00011393226398281	0.00157720329931307	0.560546738795469	0.604068863636906	0.313997319536649	0.560546738795469	0.0144363773583766
down	SYNGR1; HRAS; APP; DLG4; GRIK2; SYNPO;	GO:0048169~regulation of long-term neuronal synaptic plasticity	6	20	30	0.00011464927803217	0.00157888434318595	0.563959798640269	0.607870472126592	0.315056216032417	0.563845149362237	0.0144517642040137
down	COL4A1; NR2F2; LOX; EFNB2; CDH2; LAMA1;	GO:0048514~blood vessel morphogenesis	6	20	30	0.00011464927803217	0.00157888434318595	0.563959798640269	0.607870472126592	0.315056216032417	0.563845149362237	0.0144517642040137
down	APP; ICAM1; NGFR; PARP1; VCAM1; CDK5; LRP1; LGMN;	GO:1904646~cellular response to amyloid-beta	8	41	19.5121951219512	0.00011674296476194	0.00160355232945027	0.574025157734459	0.618971199167806	0.318124578976287	0.574025157734459	0.0146775539665244
down	SLC39A13; ATP13A2; MT1H; SLC39A7; MT1E; MT1G; MT2A;	GO:0006882~cellular zinc ion homeostasis	7	30	23.3333333333333	0.00011887625803663	0.00162026200542481	0.584276808250074	0.630281920110253	0.320970954140137	0.584157931992037	0.0148305001263566
down	ICAM1; AKT1; HRH1; CAV1; TRPM4; ADRA1B; ADRA1D;	GO:0045907~positive regulation of vasoconstriction	7	30	23.3333333333333	0.00011887625803663	0.00162026200542481	0.584276808250074	0.630281920110253	0.320970954140137	0.584157931992037	0.0148305001263566
down	NRP1; PLXNA2; PLXNB2; PLXNB1; PLXNA1;	GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance	5	12	41.6666666666667	0.00012507632553837	0.00170039661026787	0.61449998737004	0.663154678004468	0.327574896585006	0.61449998737004	0.0155639841328145
up	TLR4; ZG16; IL18RAP; EOMES; SPN; AVPR2; LILRB1;	GO:0032609~interferon-gamma production	7	10	70	0.00012638212138771	0.013334718052197	0.594501499007805	0.600062312348864	0.568719546244711	0.594501499007805	0.120583184727791
down	MMP14; SORD; FHL2; STEAP2; MMP19; FOXC2; TIMP3; NOS1;	GO:0009725~response to hormone	8	42	19.047619047619	0.00013524816851195	0.00181540706189976	0.66420375556223	0.717085789450406	0.33825207885943	0.663798011056694	0.0166166919737368
down	RAMP2; ITGB1; CXCL8; CD9; CXCR1; CD81; CAV1; LRP1;	GO:0031623~receptor internalization	8	42	19.047619047619	0.00013524816851195	0.00181540706189976	0.66420375556223	0.717085789450406	0.33825207885943	0.663798011056694	0.0166166919737368
down	RAMP2; FOSL1; PTN; GJB2; TSPO; TGFB2; CAV1; DSG2;	GO:0032570~response to progesterone	8	42	19.047619047619	0.00013524816851195	0.00181540706189976	0.66420375556223	0.717085789450406	0.33825207885943	0.663798011056694	0.0166166919737368
down	CYP1A1; FBN1; FBN2; EFEMP1; SHROOM2; FOXC2; TWSG1; LAMA1;	GO:0043010~camera-type eye development	8	42	19.047619047619	0.00013524816851195	0.00181540706189976	0.66420375556223	0.717085789450406	0.33825207885943	0.663798011056694	0.0166166919737368
up	S1PR4; OXT; CALCA; CD36; GJA1; CD24; CD52; CCR1; ADM; BCAP31; TRPC5; FPR2; PTGDR; CXCR2; CXCR3; CCR7; PTGER2; CCR6; CCR5; FPR1; CXCR5; PTGIR; CCR2; CCR3; C3AR1; C5AR2; ACKR3; CX3CR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	28	150	18.6666666666667	0.00014035267264289	0.0144868367327928	0.66007861943954	0.666394489708471	0.603937550382382	0.66007861943954	0.131001563215196
down	NRP1; S100A2; PRSS3; CDH13; STARD13; LOXL2; TGFB1I1;	GO:0043542~endothelial cell migration	7	31	22.5806451612903	0.00014186012449768	0.00188980497509226	0.696107630910133	0.752142380086718	0.345145682902864	0.695823910661138	0.017297667184726
down	CCNK; PDGFB; SRC; CCNB1; CCND1; AKT1; PKD1;	GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity	7	31	22.5806451612903	0.00014186012449768	0.00188980497509226	0.696107630910133	0.752142380086718	0.345145682902864	0.695823910661138	0.017297667184726
down	ERCC1; ERCC2; FGFR2; GDNF; WNT7B; PDGFC; TEAD2;	GO:0048568~embryonic organ development	7	31	22.5806451612903	0.00014186012449768	0.00188980497509226	0.696107630910133	0.752142380086718	0.345145682902864	0.695823910661138	0.017297667184726
down	ADAM10; F12; GLI3; F3; ECE1; COMP; MMP14; MMP16; CPE;	GO:0016485~protein processing	9	55	16.3636363636364	0.00014639106855651	0.00194041361371664	0.717901800201161	0.776165445486655	0.349874653850076	0.717755409132604	0.017760895612598
down	TBX3; HOXC11; LRP4; LRP5; GLI3; WNT5A; ECE1; LMBR1; SFRP2;	GO:0042733~embryonic digit morphogenesis	9	55	16.3636363636364	0.00014639106855651	0.00194041361371664	0.717901800201161	0.776165445486655	0.349874653850076	0.717755409132604	0.017760895612598
up	EGFR; EGF; LCK; FES; CSF1R; LYN; HCK; FGR; ERBB3; FGFR3; PTPN6; LTK; FLT4; FLT3; ZAP70; SYK; MAP2K3; BLK; BMX; JAK3; EPHB3; EPHB1; BTK; TWF1; ABI3;	GO:0018108~peptidyl-tyrosine phosphorylation	25	127	19.6850393700787	0.00015257742026486	0.0154135657748422	0.717419030085398	0.724437591417582	0.628604634577795	0.717419030085398	0.139381788341263
down	MYO1C; SYNGR1; YWHAQ; AKAP12; LTBP2; HOMER3; TRAK1; AP1M2;	GO:0006605~protein targeting	8	43	18.6046511627907	0.00015610543897637	0.00205888317774311	0.765228861862179	0.827671037452728	0.360054496227013	0.765072756423203	0.018845265225896
down	MMP2; MMP7; PEPD; MMP12; MMP14; MRC2; MMP19; MMP16;	GO:0030574~collagen catabolic process	8	43	18.6046511627907	0.00015610543897637	0.00205888317774311	0.765228861862179	0.827671037452728	0.360054496227013	0.765072756423203	0.018845265225896
down	TRIO; PTPRF; PTN; PTPRU;	GO:0007185~transmembrane receptor protein tyrosine phosphatase signaling pathway	4	6	66.6666666666667	0.00016222666068777	0.00211333109328392	0.794910637370072	0.860125754966556	0.366470026493672	0.794261730727321	0.0193436351287909
down	APOD; TNC; TSPO; MAP1B;	GO:0014012~peripheral nervous system axon regeneration	4	6	66.6666666666667	0.00016222666068777	0.00211333109328392	0.794910637370072	0.860125754966556	0.366470026493672	0.794261730727321	0.0193436351287909
down	PFN2; MYH10; WASF1; WASF3;	GO:0098885~modification of postsynaptic actin cytoskeleton	4	6	66.6666666666667	0.00016222666068777	0.00211333109328392	0.794910637370072	0.860125754966556	0.366470026493672	0.794261730727321	0.0193436351287909
down	MYO1C; CCBE1; SMOC2; ROBO1;	GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway	4	6	66.6666666666667	0.00016222666068777	0.00211333109328392	0.794910637370072	0.860125754966556	0.366470026493672	0.794261730727321	0.0193436351287909
down	SNAI2; FBLN1; KDF1; FERMT1;	GO:2000647~negative regulation of stem cell proliferation	4	6	66.6666666666667	0.00016222666068777	0.00211333109328392	0.794910637370072	0.860125754966556	0.366470026493672	0.794261730727321	0.0193436351287909
down	PRKACA; BMP7; NF2; ACVR1; WLS; EXT2; TWSG1;	GO:0001707~mesoderm formation	7	32	21.875	0.00016831551814811	0.00216165226172559	0.823904461334998	0.892408877221279	0.372818872698064	0.823567830298702	0.0197859260004404
down	HOXA3; TGM2; AXL; JAG1; BAK1; FOXC2; SEMA3C;	GO:0001974~blood vessel remodeling	7	32	21.875	0.00016831551814811	0.00216165226172559	0.823904461334998	0.892408877221279	0.372818872698064	0.823567830298702	0.0197859260004404
down	TFAP2A; FGFR2; MMP14; MMP16; DLX2; SIX1; SIX4;	GO:0048701~embryonic cranial skeleton morphogenesis	7	32	21.875	0.00016831551814811	0.00216165226172559	0.823904461334998	0.892408877221279	0.372818872698064	0.823567830298702	0.0197859260004404
down	ISL1; TGFB2; JAG1; PPP1R13L; SEMA3C;	GO:0003215~cardiac right ventricle morphogenesis	5	13	38.4615384615385	0.00016878989746405	0.00216165226172559	0.825720178394133	0.894924036354393	0.373363253190479	0.825213808701741	0.0197859260004404
down	FN1; APP; FBLN1; MAPK12; CAV1;	GO:0010952~positive regulation of peptidase activity	5	13	38.4615384615385	0.00016878989746405	0.00216165226172559	0.825720178394133	0.894924036354393	0.373363253190479	0.825213808701741	0.0197859260004404
down	SERPINE1; IGFBP5; LRP1; SEMA6D; NDRG4;	GO:0014912~negative regulation of smooth muscle cell migration	5	13	38.4615384615385	0.00016878989746405	0.00216165226172559	0.825720178394133	0.894924036354393	0.373363253190479	0.825213808701741	0.0197859260004404
down	MAL; SHROOM2; DLG5; CELSR1; VANGL2;	GO:0045176~apical protein localization	5	13	38.4615384615385	0.00016878989746405	0.00216165226172559	0.825720178394133	0.894924036354393	0.373363253190479	0.825213808701741	0.0197859260004404
down	BMP7; FGFR2; LHX1; EFNB1; SIM2; SATB2;	GO:0009880~embryonic pattern specification	6	22	27.2727272727273	0.00017797759091764	0.00225211739151634	0.869776486814526	0.943637187045348	0.381738563929432	0.869242554041773	0.0206139668446376
down	MYH10; NDST1; AP2B1; LOXL1; TAB1; ROBO1;	GO:0035904~aorta development	6	22	27.2727272727273	0.00017797759091764	0.00225211739151634	0.869776486814526	0.943637187045348	0.381738563929432	0.869242554041773	0.0206139668446376
down	FAT1; DLG5; VANGL2; MTCL1; PARD3; SCRIB;	GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity	6	22	27.2727272727273	0.00017797759091764	0.00225211739151634	0.869776486814526	0.943637187045348	0.381738563929432	0.869242554041773	0.0206139668446376
down	MGST3; GSTA4; GSTP1; GSTM1; GSTT2B; AKR1A1;	GO:1901687~glutathione derivative biosynthetic process	6	22	27.2727272727273	0.00017797759091764	0.00225211739151634	0.869776486814526	0.943637187045348	0.381738563929432	0.869242554041773	0.0206139668446376
down	IL33; KRT18; KRT8; INHBA; G0S2; TGFB2; FADD; TNFRSF12A;	GO:0097191~extrinsic apoptotic signaling pathway	8	44	18.1818181818182	0.00017953891966526	0.00226646512396488	0.876688544725501	0.951915352065248	0.383136054565681	0.876688544725501	0.0207452937826134
up	RAC2; ARHGAP25; CGNL1; POF1B; RND1; PACSIN1; RHOF; SH3BP1; SHROOM3; LMOD3; MYO1G; MYO5B; MYO6; RHOG; TMOD1; RND3; RAC1; CORO1A; MYO7B; CORO7; RHOV; RHOD; LMOD2; MYO1F;	GO:0007015~actin filament organization	24	121	19.8347107438017	0.00018524195522384	0.0183235167375589	0.870822431507305	0.879528803402826	0.693545880358084	0.870822431507305	0.16569589210503
down	PIP5K1C; LDLR; ITGB1; ANXA3; AXL; LRP1; GAS6; P2RY6; ELMO3;	GO:0006909~phagocytosis	9	57	15.7894736842105	0.00018622152741387	0.00233968374016202	0.909133496834546	0.987346538348375	0.388947940874506	0.908947275307132	0.0214154747120728
down	MEIS2; SRC; CCNB1; FOSL1; IGFBP2; TNC; MAP1B; MMP14; POSTN;	GO:0009612~response to mechanical stimulus	9	57	15.7894736842105	0.00018622152741387	0.00233968374016202	0.909133496834546	0.987346538348375	0.388947940874506	0.908947275307132	0.0214154747120728
up	PGLYRP1; HLA-B; HLA-DRB1; HLA-A; CD1D; PGLYRP3; NLRC4;	GO:0016045~detection of bacterium	7	11	63.6363636363636	0.00019349769963161	0.0187495322010392	0.909439188268601	0.918727077850919	0.705988823405674	0.909439188268601	0.169548264620793
down	PTPN1; CDH13; STON2; EHD4; SPHK1; PACSIN3; ARFGAP1;	GO:0030100~regulation of endocytosis	7	33	21.2121212121212	0.0001986210698085	0.00246625037968309	0.968873578525874	1	0.398253686221706	0.968476336386257	0.0225739580666939
down	WNT9A; TBX3; RECK; TFAP2A; MSX2; TP63; ZNF358;	GO:0035115~embryonic forelimb morphogenesis	7	33	21.2121212121212	0.0001986210698085	0.00246625037968309	0.968873578525874	1	0.398253686221706	0.968476336386257	0.0225739580666939
down	BAG3; IL1B; ITGAV; KITLG; FADD; BAK1; BOK;	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	7	33	21.2121212121212	0.0001986210698085	0.00246625037968309	0.968873578525874	1	0.398253686221706	0.968476336386257	0.0225739580666939
down	IL1B; PTX3; CALR; LRP1; MFGE8; LMAN2; ABR; GAS6;	GO:0050766~positive regulation of phagocytosis	8	45	17.7777777777778	0.00020578649790392	0.0025373953764805	1	1	0.402929962895887	0.999998861753158	0.0232251588480867
down	SERPINE2; PTN; PRKCZ; NFATC4; NTRK2; TSHZ3; SHANK2; SHANK3;	GO:0060291~long-term synaptic potentiation	8	45	17.7777777777778	0.00020578649790392	0.0025373953764805	1	1	0.402929962895887	0.999998861753158	0.0232251588480867
down	PAK4; IL1B; CYP1A1; LGALS1; BMP2; CCNB1; IGFBP5; AKT1;	GO:0071407~cellular response to organic cyclic compound	8	45	17.7777777777778	0.00020578649790392	0.0025373953764805	1	1	0.402929962895887	0.999998861753158	0.0232251588480867
down	LRP5; PDGFA; FGFR2; WNT5A; SOX9; SMO;	GO:0002053~positive regulation of mesenchymal cell proliferation	6	23	26.0869565217391	0.00021857642835487	0.00267025857865797	1	1	0.411201413985288	0.999998861753158	0.0244412755811113
down	DAPK3; VCL; SLC9A1; ACTG1; CAMSAP3; LIMCH1;	GO:0051893~regulation of focal adhesion assembly	6	23	26.0869565217391	0.00021857642835487	0.00267025857865797	1	1	0.411201413985288	0.999998861753158	0.0244412755811113
down	KDM6A; HOXA5; CCBE1; NDN; JAG2;	GO:0003016~respiratory system process	5	14	35.7142857142857	0.00022326629161673	0.00269648719396789	1	1	0.414227100291796	0.999998861753158	0.0246813500143608
down	SNAI2; FGFR2; EFNB2; PTPRK; KDF1;	GO:0010839~negative regulation of keratinocyte proliferation	5	14	35.7142857142857	0.00022326629161673	0.00269648719396789	1	1	0.414227100291796	0.999998861753158	0.0246813500143608
down	ACP5; ATP2B4; CD34; TSPO; CAV1;	GO:0045019~negative regulation of nitric oxide biosynthetic process	5	14	35.7142857142857	0.00022326629161673	0.00269648719396789	1	1	0.414227100291796	0.999998861753158	0.0246813500143608
down	CDH2; IGFBP5; AKT1; BVES; POPDC3;	GO:0051146~striated muscle cell differentiation	5	14	35.7142857142857	0.00022326629161673	0.00269648719396789	1	1	0.414227100291796	0.999998861753158	0.0246813500143608
down	GJB3; PDGFA; COL5A2; ITGA3; COMP; PKD1; DACT2;	GO:0043588~skin development	7	34	20.5882352941176	0.00023318000480898	0.0027971049445639	1	1	0.420656728675411	0.999998861753158	0.025602319313111
down	HS6ST1; PDGFA; HOXA5; FGFR2; IGFBP5; TNS3; SLC7A11;	GO:0048286~lung alveolus development	7	34	20.5882352941176	0.00023318000480898	0.0027971049445639	1	1	0.420656728675411	0.999998861753158	0.025602319313111
down	DVL1; RBFOX2; DSCAM; LRP4; ITGB1; CDK5; TRAK1;	GO:0048813~dendrite morphogenesis	7	34	20.5882352941176	0.00023318000480898	0.0027971049445639	1	1	0.420656728675411	0.999998861753158	0.025602319313111
down	FUOM; APP; GLI3; BMP7; CALR; ISL1; JAG1; DIXDC1; EIF2AK4;	GO:0045665~negative regulation of neuron differentiation	9	59	15.2542372881356	0.0002346776656168	0.00280743365566596	1	1	0.421599685217938	0.999998861753158	0.0256968595484504
down	APP; BMP7; PPP1R9B; AGRN; LAMC2; EGFLAM; MAP1B; NTN1;	GO:0016358~dendrite development	8	46	17.3913043478261	0.00023510006471438	0.00280743365566596	1	1	0.421862859878087	0.999998861753158	0.0256968595484504
up	TLR4; TYROBP; IFNG; HSPB1; SPN; TNFRSF8; CCR2; SYK; TLR1;	GO:0042535~positive regulation of tumor necrosis factor biosynthetic process	9	21	42.8571428571429	0.00023737738211848	0.0216743809672803	1	1	0.770289604974489	0.999996350881189	0.195997086238165
down	PLOD2; PLOD3; PLOD1; P3H3;	GO:0017185~peptidyl-lysine hydroxylation	4	7	57.1428571428571	0.00024869942885574	0.00293023193731816	1	1	0.42962317353662	0.999998861753158	0.0268208505606829
down	HAS3; ABCC5; IL1B; HAS2;	GO:0030213~hyaluronan biosynthetic process	4	7	57.1428571428571	0.00024869942885574	0.00293023193731816	1	1	0.42962317353662	0.999998861753158	0.0268208505606829
down	NRP1; DSCAM; SEMA5A; MEGF8;	GO:0048842~positive regulation of axon extension involved in axon guidance	4	7	57.1428571428571	0.00024869942885574	0.00293023193731816	1	1	0.42962317353662	0.999998861753158	0.0268208505606829
down	CFH; CD59; IL11; TGFB2;	GO:1903659~regulation of complement-dependent cytotoxicity	4	7	57.1428571428571	0.00024869942885574	0.00293023193731816	1	1	0.42962317353662	0.999998861753158	0.0268208505606829
down	AGR2; PTPN1; BAK1; DAB2IP;	GO:1903896~positive regulation of IRE1-mediated unfolded protein response	4	7	57.1428571428571	0.00024869942885574	0.00293023193731816	1	1	0.42962317353662	0.999998861753158	0.0268208505606829
down	CTSV; SPARC; ANXA3; IGFBP2; SDC1; MDK; ALDH3A1; WNT7B; PTPRU;	GO:0051384~response to glucocorticoid	9	60	15	0.00026257006262664	0.0030867992728303	1	1	0.437365282854174	0.999998861753158	0.0282539347663989
up	EGFR; EGF; LCK; OSM; HCLS1; RAC2; CD19; ERBB3; FGFR3; CCR7; CD80; BTC; CHI3L1; CD86; CX3CR1; AKR1C2; GRB2; RAC1; ADAM8; RHOG; GAB1; IL18; TNFAIP8L3; TRAT1; EPGN; PIK3AP1; PIK3R5; IL26; ICOS;	GO:0051897~positive regulation of protein kinase B signaling	29	165	17.5757575757576	0.00026478468796442	0.0237207112916055	1	1	0.801253482387151	0.999996350881189	0.214501641531071
down	EFNA1; FOXA1; DAB2IP; SFRP1; SFRP2; FOXA2;	GO:0010719~negative regulation of epithelial to mesenchymal transition	6	24	25	0.00026612666555103	0.00311479819150462	1	1	0.439370209288137	0.999998861753158	0.0285102130507425
down	AP2A2; AP2A1; LDLR; AP2B1; NCEH1; PCSK9;	GO:0034383~low-density lipoprotein particle clearance	6	24	25	0.00026612666555103	0.00311479819150462	1	1	0.439370209288137	0.999998861753158	0.0285102130507425
down	PDPN; SLC6A15; SLC6A14; SLC7A5; SLC7A11; SLC38A7; SLC38A5;	GO:0003333~amino acid transmembrane transport	7	35	20	0.00027242036856112	0.003174445701343	1	1	0.442836787734137	0.999998861753158	0.0290561756168171
down	TERT; PDGFB; NGFR; BMP2; SMARCA4; TGFB2; APLN;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	7	35	20	0.00027242036856112	0.003174445701343	1	1	0.442836787734137	0.999998861753158	0.0290561756168171
up	PRKCB; LYN; MS4A1; CD79A; CD19; CTLA4; PLCG2; PTPN6; MNDA; SYK; BLK; NCKAP1L; BTK; LAT2; IGHM; IGHV3-35; TRBC2; LCK; TRBC1; TRDC; IGHE; IGHD; IGLC2; IGKC;	GO:0050853~B cell receptor signaling pathway	24	125	19.2	0.00028226263935915	0.0243062730855562	1	1	0.82110201789578	0.999996350881189	0.219796759560046
up	IL2RA; LYN; CTLA4; HLA-G; PDCD1; FCRLB; SPINK5;	GO:0050777~negative regulation of immune response	7	12	58.3333333333333	0.00028667887379763	0.0243062730855562	1	1	0.82604493476673	0.999996350881189	0.219796759560046
down	CCL21; TGFB2; SFRP2; FOXC2; FERMT1;	GO:0033630~positive regulation of cell adhesion mediated by integrin	5	15	33.3333333333333	0.00029014964879825	0.00334429008245293	1	1	0.452657839259839	0.999998861753158	0.0306107866038539
down	WFS1; MECOM; KANK2; AMIGO2; TM7SF3;	GO:0043069~negative regulation of programmed cell death	5	15	33.3333333333333	0.00029014964879825	0.00334429008245293	1	1	0.452657839259839	0.999998861753158	0.0306107866038539
down	CA2; SPP1; LOX; PPP1R9B; PAQR8;	GO:0048545~response to steroid hormone	5	15	33.3333333333333	0.00029014964879825	0.00334429008245293	1	1	0.452657839259839	0.999998861753158	0.0306107866038539
down	SRC; WNT5A; LHX1; FOXL2; TGFB2;	GO:0060065~uterus development	5	15	33.3333333333333	0.00029014964879825	0.00334429008245293	1	1	0.452657839259839	0.999998861753158	0.0306107866038539
down	DLGAP1; UNC13B; SYT1; GJC1; CDK5; GRIK2; GPR176; SNCB; SYPL1; CEP89; NRXN1; GABRP; CEL; SLC12A7; CACNB3; NLGN4Y; HRH1; SLC12A4; DLG4; GABRR2;	GO:0007268~chemical synaptic transmission	20	249	8.03212851405623	0.00029146033495797	0.00335210996951663	1	1	0.453466240282476	0.999998861753158	0.0306823631980702
down	TERT; BMP2; FGFR2; SMARCA4; DIXDC1; WLS; SFRP1;	GO:0030177~positive regulation of Wnt signaling pathway	7	36	19.4444444444444	0.00031679517319438	0.00362774947791928	1	1	0.467589675634911	0.999998861753158	0.0332053327860181
down	WNT9A; NF2; GDNF; DLX1; ISL1; DLX2; PPP1R13L;	GO:0045597~positive regulation of cell differentiation	7	36	19.4444444444444	0.00031679517319438	0.00362774947791928	1	1	0.467589675634911	0.999998861753158	0.0332053327860181
down	CTSV; SPP1; PTN; GJB2; STC1; TPPP3;	GO:0046697~decidualization	6	25	24	0.00032143442281629	0.00365717877633471	1	1	0.470128937917261	0.999998861753158	0.0334747035497634
down	TPM1; FGFR2; ISL1; FKBP1A; FOXC2; PKP2;	GO:0055010~ventricular cardiac muscle tissue morphogenesis	6	25	24	0.00032143442281629	0.00365717877633471	1	1	0.470128937917261	0.999998861753158	0.0334747035497634
down	PTPRF; SPARCL1; FLRT3; NRXN1; GPC4; LRFN4;	GO:0099560~synaptic membrane adhesion	6	25	24	0.00032143442281629	0.00365717877633471	1	1	0.470128937917261	0.999998861753158	0.0334747035497634
up	CCDC88B; HLA-DPB1; LCK; HLA-DPA1; CCR2; SIRPG; PYCARD; SIRPB1;	GO:0050870~positive regulation of T cell activation	8	17	47.0588235294118	0.00032216670850615	0.0261715029634151	1	1	0.85744487772768	0.999996350881189	0.236663659785552
up	LST1; ATP10A; ZMPSTE24; FMNL1; ANXA1; S100B; ITGB2; FES; CSF1R; HCK; VIL1; FGR; EPB42; CORO1A; CDC42EP1; FGD3; FGD2; SHROOM3; SEMA4A; PALMD; RHOV; RAC1; RND3; RHOG; RAC2; RND1; RHOF; RHOD;	GO:0008360~regulation of cell shape	28	159	17.6100628930818	0.00032521454819745	0.0261715029634151	1	1	0.860184327571056	0.999996350881189	0.236663659785552
down	IGFBP2; SHC1; TKT; HMGA2; GAS6; DAB2IP; KCTD11; NDN; RUVBL2;	GO:0040008~regulation of growth	9	62	14.5161290322581	0.00032662125153271	0.00370031170005648	1	1	0.472947572219365	0.999998861753158	0.0338695056426126
down	MYO1C; YIF1B; MICALL1; PARD3; VPS37D; ZDHHC1; ZDHHC2; ZDHHC12;	GO:0006612~protein targeting to membrane	8	49	16.3265306122449	0.00034417031079814	0.00388253401670585	1	1	0.482823237419398	0.999998861753158	0.0355374137223216
down	GSTP1; ACP5; CD34; AXL; TSPO; CX3CL1; HSF1; GAS6;	GO:0032720~negative regulation of tumor necrosis factor production	8	49	16.3265306122449	0.00034417031079814	0.00388253401670585	1	1	0.482823237419398	0.999998861753158	0.0355374137223216
up	TYROBP; ITGB3; ITGB2; ISG15; ITGA2B; PLEK; HCK; FGR; ITGAM; ITGAL; ITGAX; ITGB7; CD40LG; FCER1G; SYK; ADAM15; FERMT3; TSPAN32; ITGB8; PRAM1;	GO:0007229~integrin-mediated signaling pathway	20	96	20.8333333333333	0.00035487240677212	0.0276218719238366	1	1	0.878087800156003	0.999996350881189	0.249779055821177
down	ADAM10; CSF1; MT1G; HYAL2;	GO:0042117~monocyte activation	4	8	50	0.00036394494168734	0.00403689556658221	1	1	0.493845062962127	0.999998861753158	0.0369503080426731
down	MAOA; COMT; MAOB; MOXD1;	GO:0042420~dopamine catabolic process	4	8	50	0.00036394494168734	0.00403689556658221	1	1	0.493845062962127	0.999998861753158	0.0369503080426731
down	IGFBP2; IGFBP4; IGFBP6; IGFBP5;	GO:0043567~regulation of insulin-like growth factor receptor signaling pathway	4	8	50	0.00036394494168734	0.00403689556658221	1	1	0.493845062962127	0.999998861753158	0.0369503080426731
down	TERT; PTN; TSPO; IDH2;	GO:0060253~negative regulation of glial cell proliferation	4	8	50	0.00036394494168734	0.00403689556658221	1	1	0.493845062962127	0.999998861753158	0.0369503080426731
down	MMP2; MSX2; FBN2; SFRP1;	GO:0060346~bone trabecula formation	4	8	50	0.00036394494168734	0.00403689556658221	1	1	0.493845062962127	0.999998861753158	0.0369503080426731
down	SH3PXD2B; FOXE1; TGFB2; TP63;	GO:1904888~cranial skeletal system development	4	8	50	0.00036394494168734	0.00403689556658221	1	1	0.493845062962127	0.999998861753158	0.0369503080426731
down	ITGA2; MSX2; HSF1; SFRP1; PPP1R9B; ZNF703; RUVBL2;	GO:0071392~cellular response to estradiol stimulus	7	37	18.9189189189189	0.00036678246467003	0.00405987604943742	1	1	0.495376844433349	0.999998861753158	0.0371606518344468
down	C3; PHB; WNT5A; FZD2; KLK5;	GO:0045745~positive regulation of G protein-coupled receptor signaling pathway	5	16	31.25	0.00037118513201561	0.00407458296055238	1	1	0.497759262032942	0.999998861753158	0.0372952663884007
down	SAA1; KRT20; P3H1; RHBDF1; LLGL1;	GO:0050708~regulation of protein secretion	5	16	31.25	0.00037118513201561	0.00407458296055238	1	1	0.497759262032942	0.999998861753158	0.0372952663884007
down	SLC9A1; SLC9A3; TRPM4; HCN2; SLC9A7;	GO:0098719~sodium ion import across plasma membrane	5	16	31.25	0.00037118513201561	0.00407458296055238	1	1	0.497759262032942	0.999998861753158	0.0372952663884007
down	MYH10; ACTG1; WASF2; CTTN; DBN1;	GO:0098974~postsynaptic actin cytoskeleton organization	5	16	31.25	0.00037118513201561	0.00407458296055238	1	1	0.497759262032942	0.999998861753158	0.0372952663884007
down	GSN; GSTP1; CD9; LPAR1; HDAC11; WASF3;	GO:0014003~oligodendrocyte development	6	26	23.0769230769231	0.0003853528806097	0.00420399377158979	1	1	0.503214349239033	0.999998861753158	0.038479782869696
down	UGDH; CSPG4; CHST3; XYLT1; CHPF; CHPF2;	GO:0030206~chondroitin sulfate biosynthetic process	6	26	23.0769230769231	0.0003853528806097	0.00420399377158979	1	1	0.503214349239033	0.999998861753158	0.038479782869696
down	PIGR; SRC; SHC1; AKT1; SOX9; BCAR1; EFEMP1; FAM83A;	GO:0007173~epidermal growth factor receptor signaling pathway	8	50	16	0.00038855428360684	0.00421291372532412	1	1	0.504282344337594	0.999998861753158	0.0385614285384465
down	MYO1D; PPP1R26; SPOCD1; SPRED1; SH3RF2; CSRNP3; LMTK3; CAMSAP3;	GO:0010923~negative regulation of phosphatase activity	8	50	16	0.00038855428360684	0.00421291372532412	1	1	0.504282344337594	0.999998861753158	0.0385614285384465
down	PTPN1; CCND1; VCP; CREB3L2; CREB3L1; ERN2; CALR; WFS1;	GO:0030968~endoplasmic reticulum unfolded protein response	8	50	16	0.00038855428360684	0.00421291372532412	1	1	0.504282344337594	0.999998861753158	0.0385614285384465
up	CD74; CD19; CD27; TCIRG1; IL13RA2; TLR8; FCER1G;	GO:0016064~immunoglobulin mediated immune response	7	13	53.8461538461538	0.00041273137775532	0.0306195090872233	1	1	0.901285395021361	0.999996350881189	0.276886088336198
up	CRTAM; HLA-DOA; CCR2; SLC46A2; SPINK5; TBX21; PRELID1;	GO:0045580~regulation of T cell differentiation	7	13	53.8461538461538	0.00041273137775532	0.0306195090872233	1	1	0.901285395021361	0.999996350881189	0.276886088336198
down	TAF4; ICAM1; INHBA; KITLG; MMP14; FOXL2; MMP19;	GO:0001541~ovarian follicle development	7	38	18.4210526315789	0.00042288530992717	0.00456647232837862	1	1	0.515706034573556	0.999998861753158	0.0417976032371796
down	ACTN4; RAMP2; CDH5; RAB13; MICALL2; PARD3; F11R;	GO:0070830~bicellular tight junction assembly	7	38	18.4210526315789	0.00042288530992717	0.00456647232837862	1	1	0.515706034573556	0.999998861753158	0.0417976032371796
down	RHOC; STMN1; CFL1; MYH10; PLK1; CUL7; SNX33; RTKN;	GO:0000281~mitotic cytokinesis	8	51	15.6862745098039	0.00043748079828176	0.00471447803351608	1	1	0.520455857119457	0.999998861753158	0.0431523215613726
down	NRP1; RAMP2; MT1G; AKT1; DAB2IP; SPHK1;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	6	27	22.2222222222222	0.00045878129934495	0.00490415009904629	1	1	0.526607346319883	0.999998861753158	0.0448884183052289
down	SERPINE2; GLI3; GPC3; VCP; MEGF8; GLIS2;	GO:0045879~negative regulation of smoothened signaling pathway	6	27	22.2222222222222	0.00045878129934495	0.00490415009904629	1	1	0.526607346319883	0.999998861753158	0.0448884183052289
down	ITGB4; CD34; EPHA2; MMP14; CTTN; FSCN1;	GO:0048870~cell motility	6	27	22.2222222222222	0.00045878129934495	0.00490415009904629	1	1	0.526607346319883	0.999998861753158	0.0448884183052289
down	AP2A2; AP2A1; AP1S1; AP2B1; AP1B1; AP1M2;	GO:0050690~regulation of defense response to virus by virus	6	27	22.2222222222222	0.00045878129934495	0.00490415009904629	1	1	0.526607346319883	0.999998861753158	0.0448884183052289
down	UGDH; LHX1; ACVR1; TENM4; LRP5;	GO:0001702~gastrulation with mouth forming second	5	17	29.4117647058824	0.00046821211516112	0.00496492126916858	1	1	0.529271497463739	0.999998861753158	0.0454446659017039
down	CA2; KRT16; VCL; RIPK4; SOX9;	GO:0002009~morphogenesis of an epithelium	5	17	29.4117647058824	0.00046821211516112	0.00496492126916858	1	1	0.529271497463739	0.999998861753158	0.0454446659017039
down	BMP2; BMP1; MDK; WNT5A; SOX9;	GO:0061036~positive regulation of cartilage development	5	17	29.4117647058824	0.00046821211516112	0.00496492126916858	1	1	0.529271497463739	0.999998861753158	0.0454446659017039
down	SNAI2; ITGB1; SRC; CAV1; NTRK2;	GO:2000811~negative regulation of anoikis	5	17	29.4117647058824	0.00046821211516112	0.00496492126916858	1	1	0.529271497463739	0.999998861753158	0.0454446659017039
down	PINLYP; SCG5; ANXA5; ANXA4; ANXA3; NQO1; SNCB; UGT1A7;	GO:0043086~negative regulation of catalytic activity	8	52	15.3846153846154	0.00049128956230326	0.00518887900265321	1	1	0.535216033131591	0.999998861753158	0.0474945844850083
down	TFAP2A; NQO1; GRN; TGFB2; CDK5; GRIK2; PCSK9; CTSZ;	GO:0043525~positive regulation of neuron apoptotic process	8	52	15.3846153846154	0.00049128956230326	0.00518887900265321	1	1	0.535216033131591	0.999998861753158	0.0474945844850083
down	G6PD; TP53I3; FMO2; IDH2;	GO:0006739~NADP metabolic process	4	9	44.4444444444444	0.00051288259477	0.00536351778593798	1	1	0.540578254887583	0.999998861753158	0.049093079351209
down	SIX1; NET1; SMO; SIX4;	GO:0051451~myoblast migration	4	9	44.4444444444444	0.00051288259477	0.00536351778593798	1	1	0.540578254887583	0.999998861753158	0.049093079351209
down	ACTN1; FLNA; DPYSL3; BAIAP2L1;	GO:0051764~actin crosslink formation	4	9	44.4444444444444	0.00051288259477	0.00536351778593798	1	1	0.540578254887583	0.999998861753158	0.049093079351209
down	ADAM10; HRAS; PRKCZ; GPC4;	GO:0098696~regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	4	9	44.4444444444444	0.00051288259477	0.00536351778593798	1	1	0.540578254887583	0.999998861753158	0.049093079351209
down	PCSK9; NEDD4L; STK39; HECW2;	GO:2000650~negative regulation of sodium ion transmembrane transporter activity	4	9	44.4444444444444	0.00051288259477	0.00536351778593798	1	1	0.540578254887583	0.999998861753158	0.049093079351209
down	ADAM10; CTSV; GJB3; FSTL3; SLC4A2; ERCC1; CCNB1; TSPAN8; ATP2B4; CALR; AXL; SOX9; HSF1; B4GALNT1; BNC1; PRDX4; GAMT; WFDC2; DZIP1; SPATA20; SCMH1; LGR4; TP63; RAI14; NDRG3; JAG2; TESMIN;	GO:0007283~spermatogenesis	27	407	6.63390663390663	0.00051793898629248	0.00540573327819443	1	1	0.541839002703454	0.999998861753158	0.0494794840568352
down	SNAI2; SLIT3; EFNA1; SOX9; JAG1; ROBO1;	GO:0003180~aortic valve morphogenesis	6	28	21.4285714285714	0.00054266383262424	0.00554489437207277	1	1	0.548090470950489	0.999998861753158	0.0507532463332057
down	ANO6; ATP13A5; ANO1; PIEZO1; ANO10; PANX2;	GO:0006812~cation transport	6	28	21.4285714285714	0.00054266383262424	0.00554489437207277	1	1	0.548090470950489	0.999998861753158	0.0507532463332057
down	C3; IL1B; ADORA2B; ISL1; CXCL17; CCBE1;	GO:0010575~positive regulation of vascular endothelial growth factor production	6	28	21.4285714285714	0.00054266383262424	0.00554489437207277	1	1	0.548090470950489	0.999998861753158	0.0507532463332057
down	GPX3; PRDX3; PRDX2; PXDN; DUOX2; PRDX4;	GO:0042744~hydrogen peroxide catabolic process	6	28	21.4285714285714	0.00054266383262424	0.00554489437207277	1	1	0.548090470950489	0.999998861753158	0.0507532463332057
down	APP; TUBB; MAP1B;	GO:0009987~cellular process	3	3	100	0.00054382215644621	0.00554489437207277	1	1	0.54831647271399	0.999998861753158	0.0507532463332057
down	CTSV; ICAM1; ITGA3;	GO:0034698~response to gonadotropin	3	3	100	0.00054382215644621	0.00554489437207277	1	1	0.54831647271399	0.999998861753158	0.0507532463332057
down	FBN1; MFAP2; EFEMP1;	GO:0048050~post-embryonic eye morphogenesis	3	3	100	0.00054382215644621	0.00554489437207277	1	1	0.54831647271399	0.999998861753158	0.0507532463332057
down	NECTIN2; FEZ1; MARK1;	GO:0051654~establishment of mitochondrion localization	3	3	100	0.00054382215644621	0.00554489437207277	1	1	0.54831647271399	0.999998861753158	0.0507532463332057
down	SPDEF; AGR2; HOXA5;	GO:0060480~lung goblet cell differentiation	3	3	100	0.00054382215644621	0.00554489437207277	1	1	0.54831647271399	0.999998861753158	0.0507532463332057
down	FGFR2; GDNF; PGF;	GO:0060688~regulation of morphogenesis of a branching structure	3	3	100	0.00054382215644621	0.00554489437207277	1	1	0.54831647271399	0.999998861753158	0.0507532463332057
down	EMP2; PDPN; PARVA;	GO:0070252~actin-mediated cell contraction	3	3	100	0.00054382215644621	0.00554489437207277	1	1	0.54831647271399	0.999998861753158	0.0507532463332057
down	HYAL2; AQP3; HAS2;	GO:0070295~renal water absorption	3	3	100	0.00054382215644621	0.00554489437207277	1	1	0.54831647271399	0.999998861753158	0.0507532463332057
down	HSPA1B; TSPO; AKT1; CDK5; CAV1; NXN; SH3RF2; IVNS1ABP;	GO:0031397~negative regulation of protein ubiquitination	8	53	15.0943396226415	0.00055033525821424	0.00560053270451421	1	1	0.549882712824756	0.999998861753158	0.0512625122997842
down	CYB5R3; G6PD; LSS; ACLY; HMGCS2; NSDHL; MSMO1;	GO:0006695~cholesterol biosynthetic process	7	40	17.5	0.0005555744008463	0.00562147991085325	1	1	0.551114450101483	0.999998861753158	0.0514542452079298
down	ITGA2; FLNA; MCC; PLK1; VCP; DLG4; DZIP1;	GO:0045184~establishment of protein localization	7	40	17.5	0.0005555744008463	0.00562147991085325	1	1	0.551114450101483	0.999998861753158	0.0514542452079298
down	GAPDH; APP; NGFR; CDK5; GRIK2; TP63; BOK;	GO:0051402~neuron apoptotic process	7	40	17.5	0.0005555744008463	0.00562147991085325	1	1	0.551114450101483	0.999998861753158	0.0514542452079298
down	BMP2; SOX9; ISL1; TGFB2; ACVR1;	GO:0003203~endocardial cushion morphogenesis	5	18	27.7777777777778	0.00058315693715516	0.00576846656865049	1	1	0.556987286765285	0.999998861753158	0.0527996360396201
down	CTSV; ERCC1; COMP; HYAL2; TP63;	GO:0010259~multicellular organism aging	5	18	27.7777777777778	0.00058315693715516	0.00576846656865049	1	1	0.556987286765285	0.999998861753158	0.0527996360396201
down	TMPRSS2; F12; PARP1; CTSE; PCSK9;	GO:0016540~protein autoprocessing	5	18	27.7777777777778	0.00058315693715516	0.00576846656865049	1	1	0.556987286765285	0.999998861753158	0.0527996360396201
down	ADCY6; ADCY3; ADCY9; PRKACA; PRKAR1B;	GO:0034199~activation of protein kinase A activity	5	18	27.7777777777778	0.00058315693715516	0.00576846656865049	1	1	0.556987286765285	0.999998861753158	0.0527996360396201
down	FLNA; VASP; ACTG1; FBLIM1; FERMT2;	GO:0034329~cell junction assembly	5	18	27.7777777777778	0.00058315693715516	0.00576846656865049	1	1	0.556987286765285	0.999998861753158	0.0527996360396201
down	SNAI2; IL1B; NOS1; ISL1; RUVBL2;	GO:0035066~positive regulation of histone acetylation	5	18	27.7777777777778	0.00058315693715516	0.00576846656865049	1	1	0.556987286765285	0.999998861753158	0.0527996360396201
down	ALOX12B; FADS2; GSTP1; ALOX15; CYP2J2;	GO:0043651~linoleic acid metabolic process	5	18	27.7777777777778	0.00058315693715516	0.00576846656865049	1	1	0.556987286765285	0.999998861753158	0.0527996360396201
down	FGD1; FGD5; FGD6; PPP1R9B; RAB17;	GO:0046847~filopodium assembly	5	18	27.7777777777778	0.00058315693715516	0.00576846656865049	1	1	0.556987286765285	0.999998861753158	0.0527996360396201
down	GLI3; COL8A1; SHROOM2; FAT1; TENM3;	GO:0048593~camera-type eye morphogenesis	5	18	27.7777777777778	0.00058315693715516	0.00576846656865049	1	1	0.556987286765285	0.999998861753158	0.0527996360396201
down	SYT1; DLG4; GRIK2; NMU; CLSTN1;	GO:0050806~positive regulation of synaptic transmission	5	18	27.7777777777778	0.00058315693715516	0.00576846656865049	1	1	0.556987286765285	0.999998861753158	0.0527996360396201
down	APOD; SRC; MMP14; LRP1; DLC1;	GO:0051895~negative regulation of focal adhesion assembly	5	18	27.7777777777778	0.00058315693715516	0.00576846656865049	1	1	0.556987286765285	0.999998861753158	0.0527996360396201
down	RHOC; CDH5; VCP; BIK; BAK1; DAB2IP; AJUBA; BMF;	GO:0031334~positive regulation of protein-containing complex assembly	8	54	14.8148148148148	0.00061498755382472	0.00607200001932712	1	1	0.563943586857268	0.999998861753158	0.0555779230472408
down	HOXC11; GLI3; BMP7; FBN1; GDNF; FOXC2;	GO:0001656~metanephros development	6	29	20.6896551724138	0.00063798814700688	0.00624098368160609	1	1	0.568569513678099	0.999998861753158	0.0571246557462672
down	SEC24D; SEC31A; CALR; PDIA3; SEC24C; SEC13;	GO:0002474~antigen processing and presentation of peptide antigen via MHC class I	6	29	20.6896551724138	0.00063798814700688	0.00624098368160609	1	1	0.568569513678099	0.999998861753158	0.0571246557462672
down	AKT1; NCS1; SFRP1; SFRP2; ACAP3; MARK1;	GO:0010975~regulation of neuron projection development	6	29	20.6896551724138	0.00063798814700688	0.00624098368160609	1	1	0.568569513678099	0.999998861753158	0.0571246557462672
down	ERBB2; GLI3; CDK5; NTRK2; BOK; SOX9;	GO:0048709~oligodendrocyte differentiation	6	29	20.6896551724138	0.00063798814700688	0.00624098368160609	1	1	0.568569513678099	0.999998861753158	0.0571246557462672
down	TF; MELTF; STEAP2; STEAP1; HEPH; HEPHL1;	GO:0055072~iron ion homeostasis	6	29	20.6896551724138	0.00063798814700688	0.00624098368160609	1	1	0.568569513678099	0.999998861753158	0.0571246557462672
up	FCHO1; ARPC3; EGFR; EGF; CD4; APOB; CD3D; ADRB2; CLTB; CD3G; UBB; AVPR2; BTC; ARRB1; AP2S1; UBA52; GRB2; VAMP2; YWHAZ; FCHO2; DHCR24; KIAA0319; EPGN; NECAP1;	GO:0061024~membrane organization	24	134	17.910447761194	0.00067755971976646	0.0480157246186741	1	1	0.964702430414712	0.999996350881189	0.434196581350168
up	GNA14; ITGB3; PRKCB; LCK; GP1BA; LYN; PLCG2; PTPN6; CD40LG; FCER1G; GP5; SYK; ARRB1; P2RX1; GNG2; YWHAZ; TRPC3; TREML1; PIK3R5; ENTPD2;	GO:0030168~platelet activation	20	102	19.6078431372549	0.00069330206485052	0.0484087971163275	1	1	0.967474563835444	0.999996350881189	0.437751057223631
down	AGPAT2; AXL; GAS6; AGPAT1;	GO:0001961~positive regulation of cytokine-mediated signaling pathway	4	10	40	0.00070055023045467	0.00672883572802663	1	1	0.580428323234162	0.999998861753158	0.0615900383892343
down	FGFR2; TGFB2; FZD2; VANGL2;	GO:0003149~membranous septum morphogenesis	4	10	40	0.00070055023045467	0.00672883572802663	1	1	0.580428323234162	0.999998861753158	0.0615900383892343
down	NRP1; NTN1; MYH10; CTTN;	GO:0006930~substrate-dependent cell migration, cell extension	4	10	40	0.00070055023045467	0.00672883572802663	1	1	0.580428323234162	0.999998861753158	0.0615900383892343
down	ITGA3; TWSG1; FSTL3; FSTL1;	GO:0030510~regulation of BMP signaling pathway	4	10	40	0.00070055023045467	0.00672883572802663	1	1	0.580428323234162	0.999998861753158	0.0615900383892343
down	MDK; GLG1; SCIN; PTHLH;	GO:0032330~regulation of chondrocyte differentiation	4	10	40	0.00070055023045467	0.00672883572802663	1	1	0.580428323234162	0.999998861753158	0.0615900383892343
down	AP2A2; AP2A1; AP2B1; PCSK9;	GO:0032802~low-density lipoprotein particle receptor catabolic process	4	10	40	0.00070055023045467	0.00672883572802663	1	1	0.580428323234162	0.999998861753158	0.0615900383892343
down	CEACAM1; CDH13; RHBDF1; MVB12A;	GO:0042058~regulation of epidermal growth factor receptor signaling pathway	4	10	40	0.00070055023045467	0.00672883572802663	1	1	0.580428323234162	0.999998861753158	0.0615900383892343
down	LMNA; CCNB1; MYH10; FHL2;	GO:0055015~ventricular cardiac muscle cell development	4	10	40	0.00070055023045467	0.00672883572802663	1	1	0.580428323234162	0.999998861753158	0.0615900383892343
down	AXL; WNT5A; LHX1; BAK1;	GO:0060068~vagina development	4	10	40	0.00070055023045467	0.00672883572802663	1	1	0.580428323234162	0.999998861753158	0.0615900383892343
down	LRP4; NRXN1; NLGN4Y; CEL;	GO:0097104~postsynaptic membrane assembly	4	10	40	0.00070055023045467	0.00672883572802663	1	1	0.580428323234162	0.999998861753158	0.0615900383892343
down	MSX2; CLEC5A; SATB2; PTHLH; LRP5;	GO:0002076~osteoblast development	5	19	26.3157894736842	0.00071802531545661	0.00683477598303587	1	1	0.583754581466229	0.999998861753158	0.06255972536581
down	PRKACA; NOS1; ADRA1B; RNF207; EHD3;	GO:0055117~regulation of cardiac muscle contraction	5	19	26.3157894736842	0.00071802531545661	0.00683477598303587	1	1	0.583754581466229	0.999998861753158	0.06255972536581
down	ADAM10; CFL1; CDK5; PDLIM5; SHANK3;	GO:0061001~regulation of dendritic spine morphogenesis	5	19	26.3157894736842	0.00071802531545661	0.00683477598303587	1	1	0.583754581466229	0.999998861753158	0.06255972536581
down	NRP1; HRAS; CSF3; CDK5; BAIAP2L1;	GO:2000251~positive regulation of actin cytoskeleton reorganization	5	19	26.3157894736842	0.00071802531545661	0.00683477598303587	1	1	0.583754581466229	0.999998861753158	0.06255972536581
down	TGFB1I1; NOS1; AKT1; IGFBP7; MICB; CRNN; DNAJB4;	GO:0009408~response to heat	7	42	16.6666666666667	0.00071938194848653	0.00683541772558349	1	1	0.584039233907161	0.999998861753158	0.0625655993311943
up	LYN; FGR; CD24; FPR2; BTLA;	GO:0002768~immune response-regulating cell surface receptor signaling pathway	5	6	83.3333333333333	0.0007223788815518	0.0497080424580861	1	1	0.972625499097695	0.999996350881189	0.449499872642055
down	PLXNB2; CTIF; ERBB2; HNRNPL; ITGA2; KRT17; ELAVL1; RBMS3; LARP6;	GO:0045727~positive regulation of translation	9	70	12.8571428571429	0.00072501315471595	0.00687660061950629	1	1	0.585085615855779	0.999998861753158	0.0629425525100512
down	NRP1; PDGFB; PDGFA; BCAR1; CSPG4; PDGFC;	GO:0048008~platelet-derived growth factor receptor signaling pathway	6	30	20	0.00074578386098944	0.0070483886469983	1	1	0.589015413047399	0.999998861753158	0.0645149539827123
down	DIAPH2; ERCC1; SRC; PTN; MDK; PAQR8;	GO:0048477~oogenesis	6	30	20	0.00074578386098944	0.0070483886469983	1	1	0.589015413047399	0.999998861753158	0.0645149539827123
up	NEFH; NCKAP1L; RHOV; PARVG; RHOG; CYFIP2; RAC2; RAC1;	GO:0030031~cell projection assembly	8	20	40	0.00075679433755337	0.0505148049696137	1	1	0.975876380521179	0.999996350881189	0.456795264458979
down	SNAI2; ERBB2; GSTP1; AKT1; SOX9; DAB2IP; PPP1R9B;	GO:0071364~cellular response to epidermal growth factor stimulus	7	43	16.2790697674419	0.00081447349394092	0.0076838762720192	1	1	0.601895912022344	0.999998861753158	0.0703316671263989
down	NTN1; TFAP2A; FGFR2; ALDH1A3; ABR; SIX1; CELSR1; SIX4;	GO:0042472~inner ear morphogenesis	8	57	14.0350877192982	0.00084650476348091	0.0079296258939502	1	1	0.607892885766967	0.999998861753158	0.072581050119333
down	PDGFB; ITGA2; FGFR2; TGM2; AKT1; IRAK1; CDH13; CX3CL1;	GO:0048661~positive regulation of smooth muscle cell proliferation	8	57	14.0350877192982	0.00084650476348091	0.0079296258939502	1	1	0.607892885766967	0.999998861753158	0.072581050119333
down	HOXC6; WNT5A; DLX1; NKX3-2; KIAA1217; XYLT1;	GO:0048706~embryonic skeletal system development	6	31	19.3548387096774	0.00086712081628559	0.0080288744410795	1	1	0.611472145724318	0.999998861753158	0.0734894868942581
down	PLXNB1; CAPN2; SYDE1; F11R; CAPN6; STMN1;	GO:0051493~regulation of cytoskeleton organization	6	31	19.3548387096774	0.00086712081628559	0.0080288744410795	1	1	0.611472145724318	0.999998861753158	0.0734894868942581
down	MYO1C; HRAS; ERBB2; CACNB3; CDK5; MTCL1;	GO:0090314~positive regulation of protein targeting to membrane	6	31	19.3548387096774	0.00086712081628559	0.0080288744410795	1	1	0.611472145724318	0.999998861753158	0.0734894868942581
down	DVL1; GSTP1; CEACAM1; AKT1; NF2; GMFB; SPRED1; AKT1S1; CAMK2N2;	GO:0006469~negative regulation of protein kinase activity	9	72	12.5	0.00087013047095096	0.0080288744410795	1	1	0.61201933162158	0.999998861753158	0.0734894868942581
down	CTSV; KRT20; GAS6; CLEC16A; CADPS2; SFRP1; MFSD2A; PCSK9; GAS2L1;	GO:0009267~cellular response to starvation	9	72	12.5	0.00087013047095096	0.0080288744410795	1	1	0.61201933162158	0.999998861753158	0.0734894868942581
down	WNT9A; NGFR; SRC; CD44; PRDX3; AKT1; GAS6; SH3RF1; SFRP2;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	9	72	12.5	0.00087013047095096	0.0080288744410795	1	1	0.61201933162158	0.999998861753158	0.0734894868942581
down	F12; PLAU; KLKB1; KRT1; SERPINE1;	GO:0042730~fibrinolysis	5	20	25	0.00087489450382638	0.0080288744410795	1	1	0.61284782455437	0.999998861753158	0.0734894868942581
down	GSTP1; EFNA1; NF2; CAV1; SPRED1;	GO:0043409~negative regulation of MAPK cascade	5	20	25	0.00087489450382638	0.0080288744410795	1	1	0.61284782455437	0.999998861753158	0.0734894868942581
down	SYNGR1; MYH9; RAB11B; STEAP2; RAB11FIP5;	GO:0045055~regulated exocytosis	5	20	25	0.00087489450382638	0.0080288744410795	1	1	0.61284782455437	0.999998861753158	0.0734894868942581
down	RAPGEF3; BAG3; IL1B; PRKACA; GAS6;	GO:0046827~positive regulation of protein export from nucleus	5	20	25	0.00087489450382638	0.0080288744410795	1	1	0.61284782455437	0.999998861753158	0.0734894868942581
down	LRP5; IGFBP5; VEGFC; SFRP1; TRPM4; TWIST2; TWSG1;	GO:0045668~negative regulation of osteoblast differentiation	7	44	15.9090909090909	0.00091921386638882	0.00827767643913314	1	1	0.620439614208597	0.999998861753158	0.0757668087417237
down	RBFOX2; APP; MYH10; ALDH1A3; DLG4; ABR; NRXN1;	GO:0050885~neuromuscular process controlling balance	7	44	15.9090909090909	0.00091921386638882	0.00827767643913314	1	1	0.620439614208597	0.999998861753158	0.0757668087417237
down	SPARC; FOSL1; SDC1; ALDH3A1; CARM1; MMP19; DUOX2;	GO:0051591~response to cAMP	7	44	15.9090909090909	0.00091921386638882	0.00827767643913314	1	1	0.620439614208597	0.999998861753158	0.0757668087417237
down	APP; GRN; LRP1;	GO:0002265~astrocyte activation involved in immune response	3	4	75	0.00092984497180426	0.00827767643913314	1	1	0.622066286137051	0.999998861753158	0.0757668087417237
down	CSF1; STXBP1; PPP1R9B;	GO:0003006~developmental process involved in reproduction	3	4	75	0.00092984497180426	0.00827767643913314	1	1	0.622066286137051	0.999998861753158	0.0757668087417237
down	FN1; ITGB1; PKD1;	GO:0007161~calcium-independent cell-matrix adhesion	3	4	75	0.00092984497180426	0.00827767643913314	1	1	0.622066286137051	0.999998861753158	0.0757668087417237
down	GSTP1; SPARC; ITGA2;	GO:0033591~response to L-ascorbic acid	3	4	75	0.00092984497180426	0.00827767643913314	1	1	0.622066286137051	0.999998861753158	0.0757668087417237
down	HOXA5; JAG1; CSF3;	GO:0045639~positive regulation of myeloid cell differentiation	3	4	75	0.00092984497180426	0.00827767643913314	1	1	0.622066286137051	0.999998861753158	0.0757668087417237
down	IL1B; CD44; BMP7;	GO:0070487~monocyte aggregation	3	4	75	0.00092984497180426	0.00827767643913314	1	1	0.622066286137051	0.999998861753158	0.0757668087417237
down	GDNF; SIX1; SIX4;	GO:0072107~positive regulation of ureteric bud formation	3	4	75	0.00092984497180426	0.00827767643913314	1	1	0.622066286137051	0.999998861753158	0.0757668087417237
down	CEACAM1; PTPRG; TENM3;	GO:1903385~regulation of homophilic cell adhesion	3	4	75	0.00092984497180426	0.00827767643913314	1	1	0.622066286137051	0.999998861753158	0.0757668087417237
down	RAB11B; BVES; NDRG4;	GO:2001135~regulation of endocytic recycling	3	4	75	0.00092984497180426	0.00827767643913314	1	1	0.622066286137051	0.999998861753158	0.0757668087417237
down	SOX9; HMGA2; SND1; SFRP1;	GO:0010564~regulation of cell cycle process	4	11	36.3636363636364	0.00093205824861608	0.00827767643913314	1	1	0.622614910075545	0.999998861753158	0.0757668087417237
down	P4HB; PRDX4; P4HA2; P4HA1;	GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline	4	11	36.3636363636364	0.00093205824861608	0.00827767643913314	1	1	0.622614910075545	0.999998861753158	0.0757668087417237
down	PIP5K1C; RAMP2; VCL; ZNF703;	GO:0034333~adherens junction assembly	4	11	36.3636363636364	0.00093205824861608	0.00827767643913314	1	1	0.622614910075545	0.999998861753158	0.0757668087417237
down	SRC; CDH5; HRH1; ABR;	GO:0043114~regulation of vascular permeability	4	11	36.3636363636364	0.00093205824861608	0.00827767643913314	1	1	0.622614910075545	0.999998861753158	0.0757668087417237
down	GPI; G6PD; HK1; G6PC3;	GO:0051156~glucose 6-phosphate metabolic process	4	11	36.3636363636364	0.00093205824861608	0.00827767643913314	1	1	0.622614910075545	0.999998861753158	0.0757668087417237
down	ITGB5; VCL; BVES; CAMSAP3;	GO:0090136~epithelial cell-cell adhesion	4	11	36.3636363636364	0.00093205824861608	0.00827767643913314	1	1	0.622614910075545	0.999998861753158	0.0757668087417237
down	CAV1; DSG2; TRPM4; PKP2;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	4	11	36.3636363636364	0.00093205824861608	0.00827767643913314	1	1	0.622614910075545	0.999998861753158	0.0757668087417237
down	ITSN1; NTRK2; ERBB2; FGFR2; DDR1; EPHB4; EPHA2; MST1R; AXL;	GO:0033674~positive regulation of kinase activity	9	73	12.3287671232877	0.00095106337439132	0.00843233781107493	1	1	0.625799700349492	0.999998861753158	0.0771824473782193
down	SOX12; BAG3; ERCC2; PTN; AKT1; PKD1;	GO:0021510~spinal cord development	6	32	18.75	0.00100310719609398	0.00882002380379812	1	1	0.634500534967385	0.999998861753158	0.0807309951716118
down	TF; CSF1; EPHA2; GPC3; GLO1; OSTM1;	GO:0030316~osteoclast differentiation	6	32	18.75	0.00100310719609398	0.00882002380379812	1	1	0.634500534967385	0.999998861753158	0.0807309951716118
down	CAPN2; CLPP; LGMN; ADAMTS7; CTSV; CTSZ;	GO:0051603~proteolysis involved in cellular protein catabolic process	6	32	18.75	0.00100310719609398	0.00882002380379812	1	1	0.634500534967385	0.999998861753158	0.0807309951716118
down	LRP4; NR2F2; COMP; KREMEN2; KREMEN1; SLC7A11;	GO:0060173~limb development	6	32	18.75	0.00100310719609398	0.00882002380379812	1	1	0.634500534967385	0.999998861753158	0.0807309951716118
down	TERT; CYP1A1; AKT1; EIF4G1; ADAMTS1; CCND1;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	6	32	18.75	0.00100310719609398	0.00882002380379812	1	1	0.634500534967385	0.999998861753158	0.0807309951716118
up	ITGB2; S100A8; S100A9; ALOX5; CCR6; ADAM8;	GO:0002523~leukocyte migration involved in inflammatory response	6	11	54.5454545454545	0.00102804975841964	0.0598435725063077	1	1	0.991039967116529	0.999996350881189	0.54115344096909
up	IL2RA; IL2RB; IL2RG; STAT5A; SYK; JAK3;	GO:0038110~interleukin-2-mediated signaling pathway	6	11	54.5454545454545	0.00102804975841964	0.0598435725063077	1	1	0.991039967116529	0.999996350881189	0.54115344096909
up	CCT8; AFDN; GSDMD; PLEKHA7; TSPAN33; P2RX7;	GO:0046931~pore complex assembly	6	11	54.5454545454545	0.00102804975841964	0.0598435725063077	1	1	0.991039967116529	0.999996350881189	0.54115344096909
down	SPOCK1; FAT4; NAV3; NAV2; PCSK9; TRAK1; BTBD2;	GO:0022008~neurogenesis	7	45	15.5555555555556	0.00103427441371251	0.00907901149255584	1	1	0.639770776377716	0.999998861753158	0.0831015481673535
up	CSTA; ANXA1; DSP; FLG; TGM1; EVPL; TGM4; TGM5; EPB42;	GO:0018149~peptide cross-linking	9	27	33.3333333333333	0.00103911951844382	0.0598435725063077	1	1	0.991662603713682	0.999996350881189	0.54115344096909
up	DBI; PLA2G4B; PLA2G4A; PLA2G4F; PLB1; PLBD1; MBOAT2; TMEM86B; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	9	27	33.3333333333333	0.00103911951844382	0.0598435725063077	1	1	0.991662603713682	0.999996350881189	0.54115344096909
up	CD4; LCK; HCK; CD8B; CD247; AP2S1; AP1S2; B2M; RAC1;	GO:0050690~regulation of defense response to virus by virus	9	27	33.3333333333333	0.00103911951844382	0.0598435725063077	1	1	0.991662603713682	0.999996350881189	0.54115344096909
down	FMO1; FMO2; CYP2J2; CYP2E1; CYP2S1;	GO:0006082~organic acid metabolic process	5	21	23.8095238095238	0.00105590527187527	0.00914772835209587	1	1	0.643335487768961	0.999998861753158	0.0837305238457802
down	ITGA3; LOX; LTBP4; ZNF703; DKK3;	GO:0017015~regulation of transforming growth factor beta receptor signaling pathway	5	21	23.8095238095238	0.00105590527187527	0.00914772835209587	1	1	0.643335487768961	0.999998861753158	0.0837305238457802
down	CYP1A1; CYP2J2; CYP4F12; CYP2E1; CYP2S1;	GO:0019373~epoxygenase P450 pathway	5	21	23.8095238095238	0.00105590527187527	0.00914772835209587	1	1	0.643335487768961	0.999998861753158	0.0837305238457802
down	GPR143; DCTN2; RAB11B; MLPH; RAB17;	GO:0032402~melanosome transport	5	21	23.8095238095238	0.00105590527187527	0.00914772835209587	1	1	0.643335487768961	0.999998861753158	0.0837305238457802
down	TUBB; SPARC; ETV5; WNT5A; VCP;	GO:0050807~regulation of synapse organization	5	21	23.8095238095238	0.00105590527187527	0.00914772835209587	1	1	0.643335487768961	0.999998861753158	0.0837305238457802
down	ITGB1; BMP2; SLC9A1; CALR; GATA6;	GO:0055007~cardiac muscle cell differentiation	5	21	23.8095238095238	0.00105590527187527	0.00914772835209587	1	1	0.643335487768961	0.999998861753158	0.0837305238457802
down	HS6ST1; AKT1; NSDHL; PLCD3; FBXW8;	GO:0060716~labyrinthine layer blood vessel development	5	21	23.8095238095238	0.00105590527187527	0.00914772835209587	1	1	0.643335487768961	0.999998861753158	0.0837305238457802
down	SH3PXD2B; HGS; CPE; RAB38; FERMT2;	GO:0072657~protein localization to membrane	5	21	23.8095238095238	0.00105590527187527	0.00914772835209587	1	1	0.643335487768961	0.999998861753158	0.0837305238457802
up	TLR4; CD4; HLA-DRB1; CD74; S100B; PRKCB; CD36; GJA1; S100A4; CASP1; CCR7; S100A12; BST2; CARD16; LURAP1L; UNC5CL; SLC44A2; SECTM1; LITAF; MAP3K3; MYD88; SHARPIN; CARD9; DDX21; NDFIP2; TERF2IP; PIM2; TLR6; IL36B;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	29	183	15.8469945355191	0.00114229848791558	0.0638074496543904	1	1	0.994182569546921	0.999996350881189	0.576997988151456
down	SH3PXD2B; HOXD8; FGFR2; HOXC8; NKX3-2; HYAL2;	GO:0048705~skeletal system morphogenesis	6	33	18.1818181818182	0.00115488750122528	0.00995496537956893	1	1	0.660141819390212	0.999998861753158	0.0911192849213694
down	TERT; PDGFB; MMP2; IGFBP5; P2RY6; ADAMTS1;	GO:1904707~positive regulation of vascular smooth muscle cell proliferation	6	33	18.1818181818182	0.00115488750122528	0.00995496537956893	1	1	0.660141819390212	0.999998861753158	0.0911192849213694
down	DDOST; STT3A; DPAGT1; MGAT5B; B3GALT5; B3GALNT1; PMM1;	GO:0006487~protein N-linked glycosylation	7	46	15.2173913043478	0.0011603486617453	0.00995496537956893	1	1	0.661114596952225	0.999998861753158	0.0911192849213694
down	MYO1D; APP; SRC; NR2F2; NDST1; DLC1; TWSG1;	GO:0030900~forebrain development	7	46	15.2173913043478	0.0011603486617453	0.00995496537956893	1	1	0.661114596952225	0.999998861753158	0.0911192849213694
down	PLOD3; SLIT3; GHR; IGFBP2; PGF; IGFBP7; RAMP2;	GO:0032870~cellular response to hormone stimulus	7	46	15.2173913043478	0.0011603486617453	0.00995496537956893	1	1	0.661114596952225	0.999998861753158	0.0911192849213694
down	CXCL14; SPARC; BMP2; GJB2; TGFB2; SIX1; LRP10;	GO:0048839~inner ear development	7	46	15.2173913043478	0.0011603486617453	0.00995496537956893	1	1	0.661114596952225	0.999998861753158	0.0911192849213694
down	MYH9; MYH10; AHNAK2; ANXA6;	GO:0001778~plasma membrane repair	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	SOX18; CCBE1; PDPN; FOXC2;	GO:0001946~lymphangiogenesis	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	MT2A; SNCB; NEDD4L; TESMIN;	GO:0010038~response to metal ion	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	CYP1A1; CYP11A1; CYP24A1; LGMN;	GO:0042359~vitamin D metabolic process	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	SRC; LRP1; MFSD2A; RAB17;	GO:0045056~transcytosis	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	BMP2; PTN; WNT5A; TGFB2;	GO:0045778~positive regulation of ossification	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	NRP1; STMN1; BCAR1; MST1R;	GO:0048012~hepatocyte growth factor receptor signaling pathway	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	SPINT1; FOSL1; NR2F2; PKD1;	GO:0060674~placenta blood vessel development	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	CA2; SRC; TFPI2; HAS2;	GO:0071498~cellular response to fluid shear stress	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	CSF2; SRC; CAPG; FSCN1;	GO:0071803~positive regulation of podosome assembly	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	KDM6A; HSPG2; NXN; SPEG;	GO:0072358~cardiovascular system development	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	SERPINE2; CEACAM1; CD9; C1QTNF1;	GO:0090331~negative regulation of platelet aggregation	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	UBE2C; PLK1; CDC20; FZR1;	GO:1904668~positive regulation of ubiquitin protein ligase activity	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	TERT; TBX3; EPCAM; HMGA2;	GO:2000648~positive regulation of stem cell proliferation	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
down	RAMP2; RRAS; CEACAM1; CD34;	GO:2001214~positive regulation of vasculogenesis	4	12	33.3333333333333	0.0012125480881412	0.0101562874618083	1	1	0.667300935860244	0.999998861753158	0.0929620160081272
up	RGS14; ADAP1; RGPD1; PRTN3; RGS2; ARHGAP25; RANBP1; RAP1GAP; ARRB1; RGS6; ARHGDIB; NCKAP1L; AFDN; ARHGAP4; RGS1; NPRL3; ACAP1; MAPRE2; ARHGAP40; ALS2CL; RINL; ARHGAP27; RASGRP2; ARHGAP30; RASAL3; TAGAP; PREX1; GRHL3; NPRL2; SMAP2; RIN2; ARHGAP45; USP6NL; SIPA1; RGPD5; ARHGAP9; ARHGEF10L; ADAP2; RGS18; GMIP; ERRFI1; SH3BP1; CCL4; CCL5;	GO:0043547~positive regulation of GTPase activity	44	322	13.6645962732919	0.00123053571589105	0.0671561330925366	1	1	0.995585632975965	0.999996350881189	0.607279461823136
down	ITGB1; STMN1; ITGA3; RASIP1; DLC1;	GO:0035024~negative regulation of Rho protein signal transduction	5	22	22.7272727272727	0.0012632537755658	0.0105145549733907	1	1	0.673298352202999	0.999998861753158	0.0962412920499051
down	APOD; GSN; CCNB1; PTN; MDK;	GO:0042246~tissue regeneration	5	22	22.7272727272727	0.0012632537755658	0.0105145549733907	1	1	0.673298352202999	0.999998861753158	0.0962412920499051
down	CCL21; AP2A1; C3; TF; SERPINE1;	GO:0048260~positive regulation of receptor-mediated endocytosis	5	22	22.7272727272727	0.0012632537755658	0.0105145549733907	1	1	0.673298352202999	0.999998861753158	0.0962412920499051
down	SYT1; CAV2; BVES; NDRG4; STX2;	GO:0048278~vesicle docking	5	22	22.7272727272727	0.0012632537755658	0.0105145549733907	1	1	0.673298352202999	0.999998861753158	0.0962412920499051
up	S100A8; MPO; S100A9; GNLY; S100A12; HAMP; COTL1; IL17RA; RNASE7;	GO:0050832~defense response to fungus	9	28	32.1428571428571	0.00128324156392889	0.0692367152901635	1	1	0.996438424485206	0.999996350881189	0.626093749946495
down	HS6ST1; TGFB2; DPYSL3; CTF1; TENM4; TENM3; TENM2;	GO:0048666~neuron development	7	47	14.8936170212766	0.0012981516442373	0.0107712050355965	1	1	0.677224588727686	0.999998861753158	0.0985904484006861
down	ITGB1; SOX9; SMO; FOXA2; APC2; TBX3;	GO:0001708~cell fate specification	6	34	17.6470588235294	0.00132364040076427	0.0109484265286305	1	1	0.680216007032209	0.999998861753158	0.100212583194957
down	PLXNB1; BMP7; NBL1; WNT7B; CTTN; DAB2IP; MAP4K4; DBN1;	GO:0048812~neuron projection morphogenesis	8	62	12.9032258064516	0.00138329935699655	0.0114063035626683	1	1	0.686988789508975	0.999998861753158	0.104403600072731
down	GAPDH; CXCL6; FAM3A; CXCL9; CXCL1; CXCL10; CXCL11; CXCL8;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	8	62	12.9032258064516	0.00138329935699655	0.0114063035626683	1	1	0.686988789508975	0.999998861753158	0.104403600072731
up	CCL5; CXCR2; CCR1; CCR7; CCR2; CCR5; CCR6;	GO:0002407~dendritic cell chemotaxis	7	17	41.1764705882353	0.00141444559061543	0.0737998644422206	1	1	0.998549766977167	0.999996350881189	0.667357393841261
up	CD4; CD3E; CCL4; ZAP70; SYK; TRAT1; P2RX5;	GO:0050850~positive regulation of calcium-mediated signaling	7	17	41.1764705882353	0.00141444559061543	0.0737998644422206	1	1	0.998549766977167	0.999996350881189	0.667357393841261
up	TLR4; FCN1; FFAR2; CD14; TLR1; CD244; PYCARD;	GO:2000484~positive regulation of interleukin-8 secretion	7	17	41.1764705882353	0.00141444559061543	0.0737998644422206	1	1	0.998549766977167	0.999996350881189	0.667357393841261
down	SPARC; ACP5; FOSL1; DDOST; LIFR; CD274; TIMP3;	GO:0034097~response to cytokine	7	48	14.5833333333333	0.00144841917105187	0.011572518374619	1	1	0.694392461312343	0.999998861753158	0.105924989071168
down	COMP; RAP1GDS1; ACTA2;	GO:0014829~vascular smooth muscle contraction	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	CD9; CD81; PTGFRN;	GO:0014905~myoblast fusion involved in skeletal muscle regeneration	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	PLAU; PDGFA; PLXNA1;	GO:0014910~regulation of smooth muscle cell migration	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	LOX; LOXL2; LOXL1;	GO:0018057~peptidyl-lysine oxidation	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	SCRIB; DLG5; TP63;	GO:0030859~polarized epithelial cell differentiation	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	APOC1; TSPO; LRP1;	GO:0032374~regulation of cholesterol transport	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	CALR; CDC20; FZR1;	GO:0040020~regulation of meiotic nuclear division	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	CA2; STC1; RAB11B;	GO:0044070~regulation of anion transport	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	HMGB3; INHBA; SFRP1;	GO:0045578~negative regulation of B cell differentiation	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	KCNMA1; ANO6; SHANK3;	GO:0045794~negative regulation of cell volume	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	IL1B; APOC1; CCDC3;	GO:0045833~negative regulation of lipid metabolic process	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	ICAM1; CD81; GAS6;	GO:0046813~receptor-mediated virion attachment to host cell	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	HOXA3; NKX3-2; GATA6;	GO:0048645~animal organ formation	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	WNT5A; SFRP2; VANGL2;	GO:0060028~convergent extension involved in axis elongation	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	NRP1; SEMA3C; PLXNA1;	GO:0060666~dichotomous subdivision of terminal units involved in salivary gland branching	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	NRP1; SIX1; SIX4;	GO:0061551~trigeminal ganglion development	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	CAV2; EMP2; CAV1;	GO:0070836~caveola assembly	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	LMNA; PTN; WNT5A;	GO:0072201~negative regulation of mesenchymal cell proliferation	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	HK1; TSPO; AKT1;	GO:0072656~maintenance of protein location in mitochondrion	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	ICAM1; FLNA; RAB13;	GO:0097368~establishment of Sertoli cell barrier	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	RRAS; FUT1; TSTA3;	GO:1904906~positive regulation of endothelial cell-matrix adhesion via fibronectin	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	NMU; DLG4; NRXN1;	GO:2000821~regulation of grooming behavior	3	5	60	0.00145365847557455	0.011572518374619	1	1	0.694849507632461	0.999998861753158	0.105924989071168
down	GLI3; VEGFC; CX3CL1; DMRTA2; SMO;	GO:0002052~positive regulation of neuroblast proliferation	5	23	21.7391304347826	0.00149918338096988	0.0118460063873358	1	1	0.700118638912935	0.999998861753158	0.108428265697771
down	PROM1; DSCAM; TFAP2A; LHX1; FJX1;	GO:0010842~retina layer formation	5	23	21.7391304347826	0.00149918338096988	0.0118460063873358	1	1	0.700118638912935	0.999998861753158	0.108428265697771
down	SRC; PRKACA; PLK1; PCBD1; DZIP1;	GO:0043393~regulation of protein binding	5	23	21.7391304347826	0.00149918338096988	0.0118460063873358	1	1	0.700118638912935	0.999998861753158	0.108428265697771
down	ITSN1; DLG5; LPAR1; SHANK3; SHANK2;	GO:0060999~positive regulation of dendritic spine development	5	23	21.7391304347826	0.00149918338096988	0.0118460063873358	1	1	0.700118638912935	0.999998861753158	0.108428265697771
down	NGFR; NFATC4; DAB2IP; TRAF7; MAGED1;	GO:2001235~positive regulation of apoptotic signaling pathway	5	23	21.7391304347826	0.00149918338096988	0.0118460063873358	1	1	0.700118638912935	0.999998861753158	0.108428265697771
down	SRC; ITGA2; ITGA3; SOX9; TGFB2; DOCK1;	GO:0010634~positive regulation of epithelial cell migration	6	35	17.1428571428571	0.00151057646862185	0.011888427052773	1	1	0.701481690459886	0.999998861753158	0.108816548384164
down	TBX3; FOSL1; FGFR2; CCND1; CALR; TGFB2;	GO:0045787~positive regulation of cell cycle	6	35	17.1428571428571	0.00151057646862185	0.011888427052773	1	1	0.701481690459886	0.999998861753158	0.108816548384164
down	MICAL2; SOX18; WNT5A; CCDC40; SMO; VANGL2; NDRG4; TBX3;	GO:0001947~heart looping	8	63	12.6984126984127	0.00151748070374635	0.011888427052773	1	1	0.702270911312297	0.999998861753158	0.108816548384164
down	SLIT3; BMP2; TGFB2; ACVR1;	GO:0003181~atrioventricular valve morphogenesis	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	NQO1; NOS1; AKT1; SPR;	GO:0006809~nitric oxide biosynthetic process	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	MDK; CDH3; HAS2; TP63;	GO:0010838~positive regulation of keratinocyte proliferation	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	SLC16A2; SLC16A9; SLC16A3; SLC16A12;	GO:0015718~monocarboxylic acid transport	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	SERPINE1; SERPINE2; TSPAN8; CD34;	GO:0030195~negative regulation of blood coagulation	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	FLNA; PFN2; CX3CL1; SYNPO;	GO:0032233~positive regulation of actin filament bundle assembly	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	CAPN1; CDK5; LGMN; MVB12A;	GO:0032801~receptor catabolic process	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	RAMP2; DDAH1; CEACAM1; AKAP12;	GO:0043116~negative regulation of vascular permeability	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	EDNRA; LHX1; MMP14; FLRT3;	GO:0060322~head development	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	HOXA5; AKT1; SMO; ZNF703;	GO:0060644~mammary gland epithelial cell differentiation	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	CYP1A1; ITGA2; CPS1; E2F7;	GO:0070365~hepatocyte differentiation	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	SEC24D; SEC31A; SEC24C; SEC13;	GO:0090110~COPII-coated vesicle cargo loading	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	MICALL1; SNX33; EHD2; PACSIN3;	GO:0097320~plasma membrane tubulation	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	DVL1; WNT5A; EFNB2; NLGN4Y;	GO:0099054~presynapse assembly	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
down	ACTN4; MELTF; FBLN1; POSTN;	GO:1900025~negative regulation of substrate adhesion-dependent cell spreading	4	13	30.7692307692308	0.00154715478431033	0.011888427052773	1	1	0.705102241120324	0.999998861753158	0.108816548384164
up	IL2RA; CD24; IL12RB1; IL18; TMIGD2; IL23A; PYCARD; HHLA2;	GO:0042104~positive regulation of activated T cell proliferation	8	23	34.7826086956522	0.00157125362679977	0.0783400333034464	1	1	0.999996350881189	0.999996350881189	0.70841323156843
up	HLA-B; HLA-H; HLA-A; HLA-C; HLA-E; HLA-G; HLA-F; BCAP31; B2M;	GO:0002474~antigen processing and presentation of peptide antigen via MHC class I	9	29	31.0344827586207	0.00157153085510298	0.0783400333034464	1	1	0.999996350881189	0.999996350881189	0.70841323156843
down	DVL1; UNC13B; DGKI; SYT1; STXBP1; NRXN1; PDZD11;	GO:0007269~neurotransmitter secretion	7	49	14.2857142857143	0.0016119070377848	0.0123680623941172	1	1	0.711108588169721	0.999998861753158	0.11320672229838
down	ACTN4; IL1B; APP; CALR; IRAK1; TRIP6; EDARADD; SPHK1;	GO:1901224~positive regulation of NIK/NF-kappaB signaling	8	64	12.5	0.00166176795087847	0.0126772570871333	1	1	0.716180045379873	0.999998861753158	0.116036827502656
up	HLA-DRA; HLA-DRB1; HLA-DMA; HLA-DMB;	GO:0002503~peptide antigen assembly with MHC class II protein complex	4	4	100	0.00168716641943134	0.0817414914230613	1	1	0.999996350881189	0.999996350881189	0.739171936115152
up	CD247; FCER1G; SLC11A1; STOML2;	GO:0032623~interleukin-2 production	4	4	100	0.00168716641943134	0.0817414914230613	1	1	0.999996350881189	0.999996350881189	0.739171936115152
down	CEP290; TUBB; PRKACA; TUBG1; PLK1; DYNC1I2; DCTN2; DCTN1; DYNC1H1;	GO:0010389~regulation of G2/M transition of mitotic cell cycle	9	80	11.25	0.00170426439893734	0.0129455728412117	1	1	0.72008268467865	0.999998861753158	0.11849276167345
down	TERT; TADA3; LMNA; TF; NF2; DDOST; LSS; CD81; NEDD4L;	GO:0031647~regulation of protein stability	9	80	11.25	0.00170426439893734	0.0129455728412117	1	1	0.72008268467865	0.999998861753158	0.11849276167345
down	CAV2; SEC61A1; ATL3; ATL1; SEC31A; LMAN2;	GO:0007029~endoplasmic reticulum organization	6	36	16.6666666666667	0.00171693581871968	0.0130231669683144	1	1	0.721113043862265	0.999998861753158	0.119202992307723
down	MEIS2; WFS1; ISL1; NKX3-2; MSLN;	GO:0031016~pancreas development	5	24	20.8333333333333	0.00176597649609223	0.0133000104861946	1	1	0.725816339893905	0.999998861753158	0.121736982374241
down	ONECUT2; AKT1; SOX9; BAK1; FOXA2;	GO:0031018~endocrine pancreas development	5	24	20.8333333333333	0.00176597649609223	0.0133000104861946	1	1	0.725816339893905	0.999998861753158	0.121736982374241
down	PDGFB; PDGFA; SRC; VEGFC; PDGFC;	GO:0031954~positive regulation of protein autophosphorylation	5	24	20.8333333333333	0.00176597649609223	0.0133000104861946	1	1	0.725816339893905	0.999998861753158	0.121736982374241
down	TBX3; CXCL14; CXCL10; SOX9; SOSTDC1;	GO:0045662~negative regulation of myoblast differentiation	5	24	20.8333333333333	0.00176597649609223	0.0133000104861946	1	1	0.725816339893905	0.999998861753158	0.121736982374241
up	CD160; HLA-E; HLA-G; HLA-F; CLNK;	GO:0002729~positive regulation of natural killer cell cytokine production	5	8	62.5	0.00177339436324597	0.0842007643669188	1	1	0.999996350881189	0.999996350881189	0.761410648814171
up	MYO1G; ITGB7; ZAP70; GPR15; CCR6;	GO:0072678~T cell migration	5	8	62.5	0.00177339436324597	0.0842007643669188	1	1	0.999996350881189	0.999996350881189	0.761410648814171
down	STK25; FOSL1; CAPN2; SDC1; PRDX3; FKBP1B; BAK1;	GO:0042542~response to hydrogen peroxide	7	50	14	0.00178939017955171	0.0134381681756135	1	1	0.728281803077545	0.999998861753158	0.123001560339734
down	CCL21; FKBP1B; TPCN1; PLCB3; PLCD3; PLCB4; PLCH2;	GO:0051209~release of sequestered calcium ion into cytosol	7	50	14	0.00178939017955171	0.0134381681756135	1	1	0.728281803077545	0.999998861753158	0.123001560339734
down	GLI3; EVC; MAP3K10; NSDHL; DZIP1; DZIP1L; TCTN2; SMO;	GO:0007224~smoothened signaling pathway	8	65	12.3076923076923	0.00181668681152136	0.0136238663008292	1	1	0.730527151702633	0.999998861753158	0.124701283014372
up	IRGM; TLR4; ASS1; CD14; CD36; TNFRSF1B; CASP1; CX3CR1; CCR5; LCN2; HAMP; IRF8; CMPK2; CARD16; LILRB2; LILRB1; LITAF; MYD88; PYCARD; LY96; IL36B; CD80; CD86; IL36RN; CD180; PPBP;	GO:0071222~cellular response to lipopolysaccharide	26	163	15.9509202453988	0.00183803993585907	0.084982749061424	1	1	0.999996350881189	0.999996350881189	0.768481979794153
down	SH3PXD2B; APOC1; CXCL1; DDOST; MMP16; GMFB; CAV1; SH3PXD2A; SAE1;	GO:0043085~positive regulation of catalytic activity	9	81	11.1111111111111	0.00184274945621565	0.0137997988938636	1	1	0.732597235994288	0.999998861753158	0.126311620314445
down	SRC; SLC9A1; ASIC1; LGMN;	GO:0010447~response to acidic pH	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	CCL21; TPM1; CYFIP1; LIMA1;	GO:0031529~ruffle organization	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	CYP7B1; ISL1; KANK2; TP63;	GO:0033147~negative regulation of intracellular estrogen receptor signaling pathway	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	GSTP1; SFRP1; SFRP2; MAPK8IP1;	GO:0043508~negative regulation of JUN kinase activity	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	ICAM1; SORD; S100A13; LOXL2;	GO:0046688~response to copper ion	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	AGR2; SFRP1; SFRP2; VANGL2;	GO:0048546~digestive tract morphogenesis	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	CXCL8; VEGFC; ARTN; PGF;	GO:0050930~induction of positive chemotaxis	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	ICAM1; NOS1; STC1; PACSIN3;	GO:0051926~negative regulation of calcium ion transport	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	TGFB2; TENM4; FOXC2; NDRG4;	GO:0060038~cardiac muscle cell proliferation	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	CAV1; HYAL2; MVP; SH3BP5L;	GO:0061099~negative regulation of protein tyrosine kinase activity	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	MEIS2; ANXA3; EPHA2; GATA6;	GO:0070848~response to growth factor	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	CD34; WNT5A; MECOM; SFRP2;	GO:0071425~hematopoietic stem cell proliferation	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	BMP7; PTN; DAB2IP; CYFIP1;	GO:1900006~positive regulation of dendrite development	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	PTN; HMGA2; ELAVL1; SMO;	GO:2000036~regulation of stem cell population maintenance	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	MYO1C; SNAI2; PRKACA; F11R;	GO:2000810~regulation of bicellular tight junction assembly	4	14	28.5714285714286	0.00194097332341892	0.0142165681833089	1	1	0.739673160482127	0.999998861753158	0.130126371866408
down	BMP2; SOX9; HMGA2; TGFBI; CREB3L2; WNT5B;	GO:0002062~chondrocyte differentiation	6	37	16.2162162162162	0.0019439856531307	0.0142165681833089	1	1	0.740139894914957	0.999998861753158	0.130126371866408
down	CLDN7; SRC; ISL1; STXBP1; HSF1; PRKCZ;	GO:0031333~negative regulation of protein-containing complex assembly	6	37	16.2162162162162	0.0019439856531307	0.0142165681833089	1	1	0.740139894914957	0.999998861753158	0.130126371866408
up	PTGES; NUPR1; VNN1; S100A8; TREM1; HPR;	GO:0002526~acute inflammatory response	6	13	46.1538461538462	0.00198008590202203	0.0895375986933392	1	1	0.999996350881189	0.999996350881189	0.809670572790466
up	CD4; IL2RB; IL2RG; STAT5A; JAK3; GRB2;	GO:0035723~interleukin-15-mediated signaling pathway	6	13	46.1538461538462	0.00198008590202203	0.0895375986933392	1	1	0.999996350881189	0.999996350881189	0.809670572790466
down	COL4A1; COL5A2; MMP2; CAPN2; COL16A1; NTRK2; PDGFC;	GO:0071230~cellular response to amino acid stimulus	7	51	13.7254901960784	0.00198166177305437	0.0144404890153149	1	1	0.743005427246749	0.999998861753158	0.132175952684966
down	FSTL3; KRT75; INHBA; HYAL2; DACT2; SFRP1; BVES; STON2;	GO:0002244~hematopoietic progenitor cell differentiation	8	66	12.1212121212121	0.00198277555698778	0.0144404890153149	1	1	0.743005427246749	0.999998861753158	0.132175952684966
down	PRKACA; AKT1; CDK5; MAP3K10; ACVR1; STK39; CDC42BPB; CDC42BPA;	GO:0018107~peptidyl-threonine phosphorylation	8	66	12.1212121212121	0.00198277555698778	0.0144404890153149	1	1	0.743005427246749	0.999998861753158	0.132175952684966
down	GOT2; OAT; ALDH18A1; ASPG; GPT2;	GO:0008652~cellular amino acid biosynthetic process	5	25	20	0.00206594646216129	0.0149844707830085	1	1	0.747894872554923	0.999998861753158	0.137155099049878
down	CYP4B1; NOS1; CYP2J2; CYP2S1; CYP2E1;	GO:0042738~exogenous drug catabolic process	5	25	20	0.00206594646216129	0.0149844707830085	1	1	0.747894872554923	0.999998861753158	0.137155099049878
down	ACTG1; LAMA5; LAMA3;	GO:0001738~morphogenesis of a polarized epithelium	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	F12; ENO1; MELTF;	GO:0010756~positive regulation of plasminogen activation	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	SERPINE1; SERPINE2; CTSZ;	GO:0010757~negative regulation of plasminogen activation	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	PLA2G7; ALOX12B; ALOX15;	GO:0034440~lipid oxidation	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	CYP7B1; CH25H; GAS6;	GO:0035754~B cell chemotaxis	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	MMP14; SCRIB; APCDD1;	GO:0043615~astrocyte cell migration	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	SOX9; DLX1; DLX2;	GO:0046533~negative regulation of photoreceptor cell differentiation	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	TXN; CDK5; BARD1;	GO:0046826~negative regulation of protein export from nucleus	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	PTN; GRN; FKBP1B;	GO:0048680~positive regulation of axon regeneration	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	FLNA; DBN1; DZIP1;	GO:0051220~cytoplasmic sequestering of protein	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	CAPN1; IGFBP5; CAV1;	GO:0060056~mammary gland involution	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	LRP5; COL4A1; LAMA1;	GO:0061304~retinal blood vessel morphogenesis	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	SERPINE1; FAM20C; HTRA1;	GO:0097187~dentinogenesis	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	UNC13B; GRN; NLRP10;	GO:1900426~positive regulation of defense response to bacterium	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	ITSN1; CYFIP1; CTTNBP2;	GO:1905274~regulation of modification of postsynaptic actin cytoskeleton	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	GPC1; GPC3; GPC4;	GO:1905475~regulation of protein localization to membrane	3	6	50	0.00213059958247985	0.0151224082815371	1	1	0.750527864827535	0.999998861753158	0.138417661575265
down	SRC; NQO1; AXL; PCGF2; PPP5C; HSF1; NET1; SPHK1;	GO:0070301~cellular response to hydrogen peroxide	8	67	11.9402985074627	0.00216058461794544	0.0153147321448485	1	1	0.751883447045012	0.999998861753158	0.140178030620267
down	PARP1; CAPN2; ELK1; WNT5A; EFNB2; DDIT4;	GO:1901216~positive regulation of neuron death	6	38	15.7894736842105	0.00219301773544056	0.0155238718735726	1	1	0.753045663688221	0.999998861753158	0.142092317792887
up	EGFR; LYN; LCK; PTK6; FES; HCK; FGR; BLK; SLA;	GO:0038083~peptidyl-tyrosine autophosphorylation	9	31	29.0322580645161	0.00230309937065432	0.100322163411621	1	1	0.999996350881189	0.999996350881189	0.907193231653069
up	EGFR; EGF; ERBB3; BTC; GRB2; GAB1; PTK6; GRB7; PTPN18;	GO:0038128~ERBB2 signaling pathway	9	31	29.0322580645161	0.00230309937065432	0.100322163411621	1	1	0.999996350881189	0.999996350881189	0.907193231653069
up	TYROBP; EGFR; ITGB2; ITGAM; CYBA; FPR2; SYK;	GO:0032930~positive regulation of superoxide anion generation	7	19	36.8421052631579	0.00235653601909158	0.101258347317022	1	1	0.999996350881189	0.999996350881189	0.915658955214848
up	SH2D1A; POMC; LTA; WNT1; ITGB2; S100A9; CCL4; CCL5; GJA1; CD33; FGFR3; ADORA2A; CCR1; SSTR3; PTGIR; CX3CR1; CCR5; EFNA3; AFDN; GRB2; LTB; PCDH1; GRAP; IL18; GPNMB; LILRB2; FCRL2; TSPAN32; IL26; SIRPG; ADRB2; FGFBP1; FGFBP2;	GO:0007267~cell-cell signaling	33	230	14.3478260869565	0.00236724442969449	0.101258347317022	1	1	0.999996350881189	0.999996350881189	0.915658955214848
down	ALOX15; PCYT2; LPIN3; ETNK2;	GO:0006646~phosphatidylethanolamine biosynthetic process	4	15	26.6666666666667	0.00239902853189355	0.0168195237204843	1	1	0.761235051029652	0.999998861753158	0.15395161265693
down	FGF5; CDH2; DNER; METRN;	GO:0010001~glial cell differentiation	4	15	26.6666666666667	0.00239902853189355	0.0168195237204843	1	1	0.761235051029652	0.999998861753158	0.15395161265693
down	ACOX3; CRAT; EHHADH; DECR2;	GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase	4	15	26.6666666666667	0.00239902853189355	0.0168195237204843	1	1	0.761235051029652	0.999998861753158	0.15395161265693
down	SHISA9; UNC13B; SYNGR1; GRIK2;	GO:0048172~regulation of short-term neuronal synaptic plasticity	4	15	26.6666666666667	0.00239902853189355	0.0168195237204843	1	1	0.761235051029652	0.999998861753158	0.15395161265693
down	GSN; CAPG; TRIOBP; CAPZB;	GO:0051016~barbed-end actin filament capping	4	15	26.6666666666667	0.00239902853189355	0.0168195237204843	1	1	0.761235051029652	0.999998861753158	0.15395161265693
down	SRGAP2C; FLNA; MDK; DAB2IP;	GO:2001224~positive regulation of neuron migration	4	15	26.6666666666667	0.00239902853189355	0.0168195237204843	1	1	0.761235051029652	0.999998861753158	0.15395161265693
down	APP; ITGA3; TCF7L1; VANGL2; DACT2;	GO:0030111~regulation of Wnt signaling pathway	5	26	19.2307692307692	0.00240142954666289	0.0168195237204843	1	1	0.761253166292137	0.999998861753158	0.15395161265693
down	CSF1; GJB2; CX3CL1; CAV1; BVES; PANX2; HYOU1;	GO:0002931~response to ischemia	7	53	13.2075471698113	0.00241382849801686	0.0168396298637965	1	1	0.761928912164489	0.999998861753158	0.154135647189576
down	PDGFB; CD34; CRIP2; TGFB2; JAG1; TWSG1; MECOM;	GO:0030097~hemopoiesis	7	53	13.2075471698113	0.00241382849801686	0.0168396298637965	1	1	0.761928912164489	0.999998861753158	0.154135647189576
down	BAG3; CAPN1; PARP1; COX6A1; CALML3; PSMD2; RNF180;	GO:0050790~regulation of catalytic activity	7	53	13.2075471698113	0.00241382849801686	0.0168396298637965	1	1	0.761928912164489	0.999998861753158	0.154135647189576
up	TLR4; TUSC2; SASH3; CD40LG; FCER1G; TIGIT; IL20RB; IL23A;	GO:0032733~positive regulation of interleukin-10 production	8	25	32	0.00241973839939413	0.102579624288601	1	1	0.999996350881189	0.999996350881189	0.927606998249343
up	ITGB2; ITGAM; FCGR1A; CD36; FCER1G; ARHGAP25; AIF1; GULP1; BIN2; MARCO; SH3BP1; IGHE; IGLC2; TRDC; TRBC2; IGHV3-35; IGKC; IGHD; TRBC1; IGHM;	GO:0006911~phagocytosis, engulfment	20	115	17.3913043478261	0.00245601202716972	0.103195974380547	1	1	0.999996350881189	0.999996350881189	0.933180528690944
down	RAB13; MICALL2; RAB17; EHD4; EHD3; EHD2;	GO:0032456~endocytic recycling	6	39	15.3846153846154	0.00246534580101188	0.01713140686365	1	1	0.764072172114319	0.999998861753158	0.156806325646953
down	PDGFB; PTPN1; EFNA1; DLG4; GAS6; AFAP1L2;	GO:0061098~positive regulation of protein tyrosine kinase activity	6	39	15.3846153846154	0.00246534580101188	0.01713140686365	1	1	0.764072172114319	0.999998861753158	0.156806325646953
down	ADAM10; NRP1; LRP5; CD274; ANTXR1; ANTXR2;	GO:1901998~toxin transport	6	39	15.3846153846154	0.00246534580101188	0.01713140686365	1	1	0.764072172114319	0.999998861753158	0.156806325646953
down	CDH2; FLNA; MDK; LRP1; NTRK2; FAT4; PPP1R9B; SMO;	GO:0021987~cerebral cortex development	8	69	11.5942028985507	0.00255362361194822	0.0176984475693457	1	1	0.767471825827842	0.999998861753158	0.161996533915315
up	CCR2; IL12RB1; PLA2G4A; SLC11A1; IL23A;	GO:0002827~positive regulation of T-helper 1 type immune response	5	9	55.5555555555556	0.002590184847032	0.106018945290585	1	1	0.999996350881189	0.999996350881189	0.95870808925832
up	FES; LYN; RAC2; UNC13D; ADGRE2;	GO:0043304~regulation of mast cell degranulation	5	9	55.5555555555556	0.002590184847032	0.106018945290585	1	1	0.999996350881189	0.999996350881189	0.95870808925832
up	TLR4; CD74; CD36; HLA-G; LILRB1;	GO:0060907~positive regulation of macrophage cytokine production	5	9	55.5555555555556	0.002590184847032	0.106018945290585	1	1	0.999996350881189	0.999996350881189	0.95870808925832
up	AQP9; AMPD1; S100P; ABCG1; CRIP1; CTSC; HPR; JUND; TIMP2;	GO:0010033~response to organic substance	9	32	28.125	0.00275845837529243	0.11194154158879	1	1	0.999996350881189	0.999996350881189	1
down	ERBB2; EGR2; ADGRB2; ARTN; GDNF;	GO:0007422~peripheral nervous system development	5	27	18.5185185185185	0.00277477707742613	0.0191311678342176	1	1	0.77639591682584	0.999998861753158	0.175110436480503
down	VCL; FLNA; EMP2; PTPRK; PTPRU;	GO:0034394~protein localization to cell surface	5	27	18.5185185185185	0.00277477707742613	0.0191311678342176	1	1	0.77639591682584	0.999998861753158	0.175110436480503
down	SRC; NQO1; AKAP12; CYFIP1; S100A13;	GO:0051602~response to electrical stimulus	5	27	18.5185185185185	0.00277477707742613	0.0191311678342176	1	1	0.77639591682584	0.999998861753158	0.175110436480503
up	SCIMP; PIK3AP1; UNC93B1; TLR7;	GO:0034154~toll-like receptor 7 signaling pathway	4	5	80	0.00285795858963467	0.11403014608055	1	1	0.999996350881189	0.999996350881189	1
down	FLNB; FAT1; DACT2; PALLD;	GO:0003382~epithelial cell morphogenesis	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	GOT2; IDH2; AADAT; GPT2;	GO:0006103~2-oxoglutarate metabolic process	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	MT1E; MT2A; MT1H; MT1G;	GO:0010273~detoxification of copper ion	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	PTPRG; MCC; PFN2; DAB2IP;	GO:0010633~negative regulation of epithelial cell migration	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	CCL21; ADAM10; WNT5A; STK39;	GO:0010820~positive regulation of T cell chemotaxis	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	INHBA; CSF1; AKT1; EIF4G1;	GO:0032270~positive regulation of cellular protein metabolic process	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	PLCB3; PLCB4; PLCD3; PLCH2;	GO:0032959~inositol trisphosphate biosynthetic process	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	IL1B; ALOX15; CD44; BMP7;	GO:0034116~positive regulation of heterotypic cell-cell adhesion	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	NRP1; GCLM; BCAR1; LGMN;	GO:0035729~cellular response to hepatocyte growth factor stimulus	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	HGS; PSMD2; NEDD4L; ZDHHC2;	GO:0042176~regulation of protein catabolic process	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	MMP7; PTN; MDK; HAS2;	GO:0044849~estrous cycle	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	FOXA1; ISL1; SIX1; DMRTA2;	GO:0048665~neuron fate specification	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	PRKACA; NOS1; FKBP1A; FKBP1B;	GO:0060314~regulation of ryanodine-sensitive calcium-release channel activity	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	ADCY6; AKT1; P2RY6; SFRP1;	GO:0071380~cellular response to prostaglandin E stimulus	4	16	25	0.00292624825263954	0.0195646956042704	1	1	0.782233480110245	0.999998861753158	0.179078580908392
down	LRP5; PFKP; PFKL;	GO:0006007~glucose catabolic process	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	DPYSL3; CRMP1; DPYSL2;	GO:0006208~pyrimidine nucleobase catabolic process	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	SLC6A8; GATM; GAMT;	GO:0006600~creatine metabolic process	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	SPR; PCBD1; QDPR;	GO:0006729~tetrahydrobiopterin biosynthetic process	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	ACP5; SLC52A2; SLC52A3;	GO:0006771~riboflavin metabolic process	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	ITGA2; VEGFC; CSPG4;	GO:0006929~substrate-dependent cell migration	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	TBX3; HOXD8; WNT5A;	GO:0008595~anterior/posterior axis specification, embryo	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	ACSL4; GOT2; MFSD2A;	GO:0015908~fatty acid transport	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	HYAL2; GAS6; NECTIN2;	GO:0019064~fusion of virus membrane with host plasma membrane	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	CEP290; FGFR2; SOX9;	GO:0030916~otic vesicle formation	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	SRC; RASIP1; PIEZO1;	GO:0033625~positive regulation of integrin activation	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	GSN; FLII; SCIN;	GO:0051014~actin filament severing	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	ACTN4; ACTN1; CD9;	GO:0051271~negative regulation of cellular component movement	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	CYP7B1; TNC; FOXA1;	GO:0060740~prostate gland epithelium morphogenesis	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	IL33; CSF1; CX3CL1;	GO:0061518~microglial cell proliferation	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	BCAR3; EDNRA; BCAR1;	GO:0086100~endothelin receptor signaling pathway	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	RAMP2; COMP; SGCB;	GO:0097084~vascular smooth muscle cell development	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	LRP4; LDLR; LRP1;	GO:0150094~amyloid-beta clearance by cellular catabolic process	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	MDK; CD99L2; XG;	GO:2000391~positive regulation of neutrophil extravasation	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	LHX1; TENM4; FOXA2;	GO:2000543~positive regulation of gastrulation	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	CCL21; AXL; GAS6;	GO:2000669~negative regulation of dendritic cell apoptotic process	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
down	CD63; FLNA; EMP2;	GO:2001046~positive regulation of integrin-mediated signaling pathway	3	7	42.8571428571429	0.00297418797756355	0.0195646956042704	1	1	0.78431832414039	0.999998861753158	0.179078580908392
up	TLR4; CD14; UBB; UBE2D1; UBE2D3; UBA52; LY96;	GO:0002756~MyD88-independent toll-like receptor signaling pathway	7	20	35	0.0029789910742315	0.11593647229878	1	1	0.999996350881189	0.999996350881189	1
up	CYBA; NCF1; NCF2; PREX1; NCF1B; NCF1C; NCF4;	GO:0006801~superoxide metabolic process	7	20	35	0.0029789910742315	0.11593647229878	1	1	0.999996350881189	0.999996350881189	1
down	TERT; PARP1; PRDX3; PHB; CAV2; RAB38; CDK5; CHCHD10; CEP89;	GO:0007005~mitochondrion organization	9	88	10.2272727272727	0.00308262860095987	0.0202278426265956	1	1	0.788719661537362	0.999998861753158	0.185148464646614
down	IL1B; SERPINE1; HSPA1B; FADD; AFAP1L2;	GO:0032757~positive regulation of interleukin-8 production	5	28	17.8571428571429	0.0031883477521113	0.0208699009650544	1	1	0.792847231536436	0.999998861753158	0.191025320511753
down	TBX3; MSX2; GPC3; PITX1; TP63;	GO:0035116~embryonic hindlimb morphogenesis	5	28	17.8571428571429	0.0031883477521113	0.0208699009650544	1	1	0.792847231536436	0.999998861753158	0.191025320511753
down	ARL4D; COMP; LTBP2; ARFGAP3; COPG1; RAB3B; RAB13;	GO:0009306~protein secretion	7	56	12.5	0.00319376148754236	0.0208795603045001	1	1	0.792847231536436	0.999998861753158	0.191113733888349
down	CA12; CA2; SLC4A2; SLC4A3; SLC26A2; SLC4A11;	GO:0015701~bicarbonate transport	6	42	14.2857142857143	0.00343551710019208	0.0223498302640716	1	1	0.802361605884704	0.999998861753158	0.204571334417275
down	INHBA; BMP2; BMP7; TAF6; CDK5; PTPRK;	GO:0045786~negative regulation of cell cycle	6	42	14.2857142857143	0.00343551710019208	0.0223498302640716	1	1	0.802361605884704	0.999998861753158	0.204571334417275
up	RHOV; RAC2; PPP2R3C; RHOG; ANLN; RAC1;	GO:0030865~cortical cytoskeleton organization	6	15	40	0.00348077111860357	0.128170319156442	1	1	0.999996350881189	0.999996350881189	1
up	TYROBP; CD74; PTAFR; SYK; TLR1; TLR6;	GO:0045410~positive regulation of interleukin-6 biosynthetic process	6	15	40	0.00348077111860357	0.128170319156442	1	1	0.999996350881189	0.999996350881189	1
up	LYN; CYBA; PTPN6; CORO1A; ANK2; CASQ2;	GO:0051279~regulation of release of sequestered calcium ion into cytosol	6	15	40	0.00348077111860357	0.128170319156442	1	1	0.999996350881189	0.999996350881189	1
up	KLF4; ID1; KLF1; KLF5; SMPD3; KLF2;	GO:1901653~cellular response to peptide	6	15	40	0.00348077111860357	0.128170319156442	1	1	0.999996350881189	0.999996350881189	1
down	AGPAT2; PLPP2; PLA2G4E; PCSK9; GATA6; AGPAT1; PLPPR5;	GO:0006644~phospholipid metabolic process	7	57	12.280701754386	0.00349231715146781	0.0225875418205954	1	1	0.804136973228195	0.999998861753158	0.206747143797029
down	GSN; GPR143; NCS1; PLCB3; PLCB4; PLCH2; PLCD3;	GO:0048015~phosphatidylinositol-mediated signaling	7	57	12.280701754386	0.00349231715146781	0.0225875418205954	1	1	0.804136973228195	0.999998861753158	0.206747143797029
down	SEC31A; SPARC; SDC1; CCND1; CAV1; KCNMA1; AQP3;	GO:0051592~response to calcium ion	7	57	12.280701754386	0.00349231715146781	0.0225875418205954	1	1	0.804136973228195	0.999998861753158	0.206747143797029
up	TLR4; IL18RAP; ITGB2; S100A8; PRKCB; S100A9; UBB; CLU; CD36; CAPN3; CD40LG; CX3CR1; UBA52; ADAM8; S100A12; BTK; IL18; CARD16; MYD88; NLRC4; TERF2IP; PYCARD; TLR6; IL1RAP;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	24	154	15.5844155844156	0.00349248148107761	0.128170319156442	1	1	0.999996350881189	0.999996350881189	1
up	FES; DBH; CLU; FUT3; ERBB3; CCND3; PTGER2; PLA2G4A; PLCD1; BID; CADM4; MZB1; GNL3; TXNIP; ANXA1; FGR; BLK; SLA; HCK; PTK6; LYN; LCK; STAT5A; JUND; LTK;	GO:0042127~regulation of cell population proliferation	25	163	15.3374233128834	0.00351107681288554	0.128170319156442	1	1	0.999996350881189	0.999996350881189	1
down	CCL21; CXCR1; ANO6; TRPM4;	GO:0002407~dendritic cell chemotaxis	4	17	23.5294117647059	0.00352743957515145	0.0225875418205954	1	1	0.805350899616906	0.999998861753158	0.206747143797029
down	COL12A1; COL7A1; SCARA3; VWA1;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	4	17	23.5294117647059	0.00352743957515145	0.0225875418205954	1	1	0.805350899616906	0.999998861753158	0.206747143797029
down	ADAM10; TSPAN15; POSTN; LLGL1;	GO:0008593~regulation of Notch signaling pathway	4	17	23.5294117647059	0.00352743957515145	0.0225875418205954	1	1	0.805350899616906	0.999998861753158	0.206747143797029
down	AKT1; GCLM; AIFM2; BIK;	GO:0008637~apoptotic mitochondrial changes	4	17	23.5294117647059	0.00352743957515145	0.0225875418205954	1	1	0.805350899616906	0.999998861753158	0.206747143797029
down	PLAU; SERPINE1; PCSK9; MUC4;	GO:0010469~regulation of signaling receptor activity	4	17	23.5294117647059	0.00352743957515145	0.0225875418205954	1	1	0.805350899616906	0.999998861753158	0.206747143797029
down	CHCHD10; KCNK6; KCNK7; KCNK5;	GO:0030322~stabilization of membrane potential	4	17	23.5294117647059	0.00352743957515145	0.0225875418205954	1	1	0.805350899616906	0.999998861753158	0.206747143797029
down	LAMA1; WNT5A; PTK7; CAMSAP3;	GO:0045198~establishment of epithelial cell apical/basal polarity	4	17	23.5294117647059	0.00352743957515145	0.0225875418205954	1	1	0.805350899616906	0.999998861753158	0.206747143797029
down	IL1B; APP; SMO; BACE2;	GO:0048143~astrocyte activation	4	17	23.5294117647059	0.00352743957515145	0.0225875418205954	1	1	0.805350899616906	0.999998861753158	0.206747143797029
down	PKD1; DCTN1; DYNC1H1; PARP3;	GO:0060236~regulation of mitotic spindle organization	4	17	23.5294117647059	0.00352743957515145	0.0225875418205954	1	1	0.805350899616906	0.999998861753158	0.206747143797029
down	LDLR; ITGB1; CD9; CD81;	GO:0071404~cellular response to low-density lipoprotein particle stimulus	4	17	23.5294117647059	0.00352743957515145	0.0225875418205954	1	1	0.805350899616906	0.999998861753158	0.206747143797029
up	GNGT2; ARRB1; CABP4; UNC119; TRPC3; CDS1; PLEKHB1; OPN1SW;	GO:0007602~phototransduction	8	27	29.6296296296296	0.00359028063348921	0.128170319156442	1	1	0.999996350881189	0.999996350881189	1
up	CRTAM; IFNG; FGR; SYK; RGCC; IL26; CLEC4E; CD14;	GO:0050715~positive regulation of cytokine secretion	8	27	29.6296296296296	0.00359028063348921	0.128170319156442	1	1	0.999996350881189	0.999996350881189	1
down	GSN; CTTN; MICALL2; WASF1; WASF3;	GO:0030041~actin filament polymerization	5	29	17.2413793103448	0.00364450015201401	0.0231970465858082	1	1	0.809146828165735	0.999998861753158	0.212326031944279
down	IL33; AXL; GAS6; PDCD1LG2; CD274;	GO:0032689~negative regulation of interferon-gamma production	5	29	17.2413793103448	0.00364450015201401	0.0231970465858082	1	1	0.809146828165735	0.999998861753158	0.212326031944279
down	ITGB1; ITGAV; VCAM1; MADCAM1; PARVA;	GO:0034113~heterotypic cell-cell adhesion	5	29	17.2413793103448	0.00364450015201401	0.0231970465858082	1	1	0.809146828165735	0.999998861753158	0.212326031944279
down	DGKI; HRAS; CSF1; KITLG; SHC1;	GO:0046579~positive regulation of Ras protein signal transduction	5	29	17.2413793103448	0.00364450015201401	0.0231970465858082	1	1	0.809146828165735	0.999998861753158	0.212326031944279
down	APP; EIF4G1; NRXN1; LRFN4; GPC4;	GO:1905606~regulation of presynapse assembly	5	29	17.2413793103448	0.00364450015201401	0.0231970465858082	1	1	0.809146828165735	0.999998861753158	0.212326031944279
up	TLR4; CD36; MYD88; SMPD3; TLR6;	GO:0140052~cellular response to oxidised low-density lipoprotein particle stimulus	5	10	50	0.00364856110802514	0.129278866723159	1	1	0.999996350881189	0.999996350881189	1
up	SASH3; CD3E; HLA-E; CD40LG; FCER1G; SYK; IL20RB;	GO:0032753~positive regulation of interleukin-4 production	7	21	33.3333333333333	0.00371972331981596	0.129862105312398	1	1	0.999996350881189	0.999996350881189	1
up	SH2D1A; IL18RAP; CRTAM; CD160; HLA-E; LAG3; RAET1E;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	7	21	33.3333333333333	0.00371972331981596	0.129862105312398	1	1	0.999996350881189	0.999996350881189	1
down	TBX3; CEACAM1; GJA4; ANTXR1; SPHK1; EGFL7;	GO:0001568~blood vessel development	6	43	13.953488372093	0.00381451270277244	0.0241920410886358	1	1	0.815315212057582	0.999998861753158	0.221433365233896
down	G6PD; MAOB; YWHAQ; YWHAH; MAPKAP1; GNB4;	GO:0021762~substantia nigra development	6	43	13.953488372093	0.00381451270277244	0.0241920410886358	1	1	0.815315212057582	0.999998861753158	0.221433365233896
down	UNC13B; MYH10; VEGFC; TGFB2; ATP13A2; FRMD4A;	GO:0050714~positive regulation of protein secretion	6	43	13.953488372093	0.00381451270277244	0.0241920410886358	1	1	0.815315212057582	0.999998861753158	0.221433365233896
up	CD4; CD3D; LCK; ZAP70; TCIRG1; PREX1; TBX21; CD3E; CD3G;	GO:0030217~T cell differentiation	9	34	26.4705882352941	0.00388082811400159	0.13449760500204	1	1	0.999996350881189	0.999996350881189	1
down	CCL21; MYH9; SCRIB;	GO:0001768~establishment of T cell polarity	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	MMP2; CDH5; RECK;	GO:0001955~blood vessel maturation	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	FGFR2; MSX2; EVC;	GO:0003416~endochondral bone growth	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	GOT2; MDH2; ACLY;	GO:0006107~oxaloacetate metabolic process	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	SULT1C2; CYP1A1; VCAM1;	GO:0009308~amine metabolic process	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	SPARC; PKM; FOSL1;	GO:0009629~response to gravity	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	PDGFB; PDGFA; C1QTNF1;	GO:0010544~negative regulation of platelet activation	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	CEACAM1; PTN; EMP2;	GO:0010594~regulation of endothelial cell migration	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	HGS; APOD; NDRG4;	GO:0010642~negative regulation of platelet-derived growth factor receptor signaling pathway	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	EXT1; EXT2; NDST1;	GO:0015014~heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	GJB1; GJB2; GJC1;	GO:0016264~gap junction assembly	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	PDLIM1; SLC9A1; DLG5;	GO:0030011~maintenance of cell polarity	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	TGM2; RAP1GDS1; BAK1;	GO:0032471~negative regulation of endoplasmic reticulum calcium ion concentration	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	NRP1; PLEKHG5; RAB13;	GO:0035767~endothelial cell chemotaxis	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	MAOA; COMT; MAOB;	GO:0042135~neurotransmitter catabolic process	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	WDR1; RHOC; VCL;	GO:0043297~apical junction assembly	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	PLXNB1; FAT4; XYLT1;	GO:0043931~ossification involved in bone maturation	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	PC; CFL1; CAV2;	GO:0044794~positive regulation by host of viral process	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	MMP14; CSPG4; MMP2;	GO:0048771~tissue remodeling	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	CYP1A1; MAOB; DUOX2;	GO:0050665~hydrogen peroxide biosynthetic process	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	PROM1; LRP5; MFSD2A;	GO:0060042~retina morphogenesis in camera-type eye	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	DVL1; LRP4; ETV5;	GO:0071340~skeletal muscle acetylcholine-gated channel clustering	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	SPP1; ELK1; AACS;	GO:0071394~cellular response to testosterone stimulus	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	MELTF; FSCN1; PDPN;	GO:0090091~positive regulation of extracellular matrix disassembly	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	RAB3B; PRKAR1B; NRXN1;	GO:0098693~regulation of synaptic vesicle cycle	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	DVL1; WNT5A; DLG4;	GO:0150012~positive regulation of neuron projection arborization	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	LMNA; NF2; ATP13A2;	GO:1900180~regulation of protein localization to nucleus	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	LDLR; GRN; CX3CL1;	GO:1903979~negative regulation of microglial cell activation	3	8	37.5	0.00399624618331806	0.0245232607221671	1	1	0.821340145161245	0.999998861753158	0.224465068008196
down	UPK1B; C3; TF; CYP2E1; BMP2; GPC3; CAV1; FER1L6; BAIAP2L1;	GO:0009617~response to bacterium	9	92	9.78260869565217	0.00404125281220402	0.0247707773529546	1	1	0.822934980394568	0.999998861753158	0.226730624697101
down	APP; BMP7; WNT5A; PLK1; SPHK1;	GO:0010800~positive regulation of peptidyl-threonine phosphorylation	5	30	16.6666666666667	0.0041455854861483	0.0252781197276015	1	1	0.826239940155189	0.999998861753158	0.231374405225259
down	RALA; SYT1; PCLO; RAB13; RAB3B;	GO:0017157~regulation of exocytosis	5	30	16.6666666666667	0.0041455854861483	0.0252781197276015	1	1	0.826239940155189	0.999998861753158	0.231374405225259
down	RNF180; SHANK3; NRXN1; SHANK2; SLC7A11;	GO:0030534~adult behavior	5	30	16.6666666666667	0.0041455854861483	0.0252781197276015	1	1	0.826239940155189	0.999998861753158	0.231374405225259
down	SERPINE2; SYT1; CDK5; CDH2; DGKI;	GO:0051966~regulation of synaptic transmission, glutamatergic	5	30	16.6666666666667	0.0041455854861483	0.0252781197276015	1	1	0.826239940155189	0.999998861753158	0.231374405225259
down	ADCY6; ADCY3; ADCY9; EDNRA; AKAP12; GPR176; LPAR1;	GO:0007193~adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway	7	59	11.864406779661	0.00415262962707297	0.0252781197276015	1	1	0.826373295787521	0.999998861753158	0.231374405225259
down	CD63; WNT5A; ITSN1; DUOXA1; DUOXA2; AJUBA; FRMD6;	GO:0034613~cellular protein localization	7	59	11.864406779661	0.00415262962707297	0.0252781197276015	1	1	0.826373295787521	0.999998861753158	0.231374405225259
down	HOXB7; PRDX3; CLEC5A; CSF2;	GO:0030099~myeloid cell differentiation	4	18	22.2222222222222	0.00420726789960391	0.025464536990525	1	1	0.828825108066104	0.999998861753158	0.233080710274743
down	FOSL1; ADORA2B; AXL; SFRP2;	GO:0031668~cellular response to extracellular stimulus	4	18	22.2222222222222	0.00420726789960391	0.025464536990525	1	1	0.828825108066104	0.999998861753158	0.233080710274743
down	DVL1; DLG4; SHANK3; SHANK2;	GO:0060997~dendritic spine morphogenesis	4	18	22.2222222222222	0.00420726789960391	0.025464536990525	1	1	0.828825108066104	0.999998861753158	0.233080710274743
down	IL1B; EGR2; TIMP3; SATB2;	GO:0071310~cellular response to organic substance	4	18	22.2222222222222	0.00420726789960391	0.025464536990525	1	1	0.828825108066104	0.999998861753158	0.233080710274743
down	GSTP1; TPM1; CNN1; APLN;	GO:1904706~negative regulation of vascular smooth muscle cell proliferation	4	18	22.2222222222222	0.00420726789960391	0.025464536990525	1	1	0.828825108066104	0.999998861753158	0.233080710274743
down	PLXNB2; TADA3; FN1; LOX; CDH5; PPP1R9B;	GO:0001932~regulation of protein phosphorylation	6	44	13.6363636363636	0.00422360895840246	0.025476194195051	1	1	0.828825108066104	0.999998861753158	0.233187410408806
down	AKR1B15; AKR1B10; CYP1A1; ALDH1A3; CYP27C1; RETSAT;	GO:0042572~retinol metabolic process	6	44	13.6363636363636	0.00422360895840246	0.025476194195051	1	1	0.828825108066104	0.999998861753158	0.233187410408806
down	FOXE1; HOXA3; PRDX2; FADD; SIX1; SIX4;	GO:0048538~thymus development	6	44	13.6363636363636	0.00422360895840246	0.025476194195051	1	1	0.828825108066104	0.999998861753158	0.233187410408806
up	TLR4; CD19; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	4	6	66.6666666666667	0.00448338740913967	0.149007262808171	1	1	0.999996350881189	0.999996350881189	1
up	DSP; NECTIN1; GRHL1; PERP;	GO:0002934~desmosome organization	4	6	66.6666666666667	0.00448338740913967	0.149007262808171	1	1	0.999996350881189	0.999996350881189	1
up	HLA-B; HLA-A; HLA-E; HLA-G;	GO:0042270~protection from natural killer cell mediated cytotoxicity	4	6	66.6666666666667	0.00448338740913967	0.149007262808171	1	1	0.999996350881189	0.999996350881189	1
up	PTGES; CD74; TBXAS1; PLA2G4A; PLA2G4F; MGST1;	GO:0001516~prostaglandin biosynthetic process	6	16	37.5	0.0044877924561012	0.149007262808171	1	1	0.999996350881189	0.999996350881189	1
up	TYROBP; CTLA4; MNDA; BTK; CD300A; LYN;	GO:0030889~negative regulation of B cell proliferation	6	16	37.5	0.0044877924561012	0.149007262808171	1	1	0.999996350881189	0.999996350881189	1
down	UNC13B; ICAM1; LGALS1; PRKACA; GCLM; GAS6; AACS;	GO:0071333~cellular response to glucose stimulus	7	60	11.6666666666667	0.00451619796477098	0.0271792072749328	1	1	0.839177118165514	0.999998861753158	0.248775343478773
up	TLR4; TRIM16; ORM2; CASP1; GSDMD; NLRP12; P2RX7; TLR8; PYCARD;	GO:0050718~positive regulation of interleukin-1 beta secretion	9	35	25.7142857142857	0.00456166014592507	0.150374153873189	1	1	0.999996350881189	0.999996350881189	1
up	IFNG; CD4; HLA-DRB1; CSF1R; MMP9; SPI1; CEBPA;	GO:0030225~macrophage differentiation	7	22	31.8181818181818	0.00459230250876419	0.150374153873189	1	1	0.999996350881189	0.999996350881189	1
down	ATP2B4; CALR; CDH5; STC1; ATP2C1; CAV1; GRIK2; ATP13A2; ATP13A5;	GO:0006874~cellular calcium ion homeostasis	9	94	9.57446808510638	0.00460055091951106	0.0276554659583307	1	1	0.841900818270524	0.999998861753158	0.253134610338493
down	SPARC; NR2F2; XDH; CAV2; CAV1;	GO:0001937~negative regulation of endothelial cell proliferation	5	31	16.1290322580645	0.00469394058700146	0.028153023746925	1	1	0.844909305660262	0.999998861753158	0.257688831089157
down	SLC6A8; SCNN1B; ASIC1; FXYD3; SLC4A11; NEDD4L; SLC6A15; SLC38A7;	GO:0006814~sodium ion transport	8	77	10.3896103896104	0.00471215204643127	0.0282303165538741	1	1	0.845481144240995	0.999998861753158	0.258396303695061
down	IL1B; VCAM1; EFNB1; CD276; CARD11; CD274; PDCD1LG2;	GO:0042102~positive regulation of T cell proliferation	7	61	11.4754098360656	0.00490326141025921	0.029342090290287	1	1	0.85232551540866	0.999998861753158	0.268572534750994
up	RHOD; MCF2L; RAC2; ARHGAP25; RAP1GAP; ARHGDIB; RAC1; RHOG; ARHGAP4; FGD3; ARHGAP40; ARHGAP30; FGD2; TAGAP; PREX1; ARHGAP45; SIPA1; RHOV; ARHGAP9; RHOF; ARHGEF4; GMIP;	GO:0051056~regulation of small GTPase mediated signal transduction	22	141	15.6028368794326	0.0049499996620368	0.156726612282833	1	1	0.999996350881189	0.999996350881189	1
down	MAP4K4; NF2; JAG1; POSTN;	GO:0001953~negative regulation of cell-matrix adhesion	4	19	21.0526315789474	0.00497023862850554	0.0293707941114629	1	1	0.8547392308446	0.999998861753158	0.268835265113212
down	SORD; FMO1; KCNMA1; TSC22D4;	GO:0006970~response to osmotic stress	4	19	21.0526315789474	0.00497023862850554	0.0293707941114629	1	1	0.8547392308446	0.999998861753158	0.268835265113212
down	APP; QDPR; SPARC; PPP5C;	GO:0010288~response to lead ion	4	19	21.0526315789474	0.00497023862850554	0.0293707941114629	1	1	0.8547392308446	0.999998861753158	0.268835265113212
down	MYH9; MYH10; MYH14; WASF2;	GO:0030048~actin filament-based movement	4	19	21.0526315789474	0.00497023862850554	0.0293707941114629	1	1	0.8547392308446	0.999998861753158	0.268835265113212
down	WDR1; ACTN1; MYH9; ZNF385A;	GO:0030220~platelet formation	4	19	21.0526315789474	0.00497023862850554	0.0293707941114629	1	1	0.8547392308446	0.999998861753158	0.268835265113212
down	ITGB1; ITGAV; ITGA2; GAS6;	GO:0031589~cell-substrate adhesion	4	19	21.0526315789474	0.00497023862850554	0.0293707941114629	1	1	0.8547392308446	0.999998861753158	0.268835265113212
down	EGR2; TENM4; PARD3; WASF3;	GO:0031643~positive regulation of myelination	4	19	21.0526315789474	0.00497023862850554	0.0293707941114629	1	1	0.8547392308446	0.999998861753158	0.268835265113212
down	GLI3; SOX9; ZNF219; LOXL2;	GO:0032332~positive regulation of chondrocyte differentiation	4	19	21.0526315789474	0.00497023862850554	0.0293707941114629	1	1	0.8547392308446	0.999998861753158	0.268835265113212
down	PDGFA; APP; EFNA1; PDGFC;	GO:0050730~regulation of peptidyl-tyrosine phosphorylation	4	19	21.0526315789474	0.00497023862850554	0.0293707941114629	1	1	0.8547392308446	0.999998861753158	0.268835265113212
down	SRC; MAP1B; CAV1; CYP11A1;	GO:0071375~cellular response to peptide hormone stimulus	4	19	21.0526315789474	0.00497023862850554	0.0293707941114629	1	1	0.8547392308446	0.999998861753158	0.268835265113212
down	WFS1; PTPN1; GRINA; CREB3L1;	GO:1902236~negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	4	19	21.0526315789474	0.00497023862850554	0.0293707941114629	1	1	0.8547392308446	0.999998861753158	0.268835265113212
up	CRTAM; HLA-A; PRF1; GZMM; CTSC;	GO:0001913~T cell mediated cytotoxicity	5	11	45.4545454545455	0.00498435519265117	0.156726612282833	1	1	0.999996350881189	0.999996350881189	1
up	TLR4; TUSC2; IFNG; NCKAP1L; IL36RN;	GO:0032700~negative regulation of interleukin-17 production	5	11	45.4545454545455	0.00498435519265117	0.156726612282833	1	1	0.999996350881189	0.999996350881189	1
up	CD74; CD3D; ZAP70; CD3E; CD3G;	GO:0045059~positive thymic T cell selection	5	11	45.4545454545455	0.00498435519265117	0.156726612282833	1	1	0.999996350881189	0.999996350881189	1
up	CD4; HLA-DRB1; CD74; FES; CTNNBIP1;	GO:0045657~positive regulation of monocyte differentiation	5	11	45.4545454545455	0.00498435519265117	0.156726612282833	1	1	0.999996350881189	0.999996350881189	1
up	LYN; CD19; BLK; PAX5; GCSAML;	GO:0050855~regulation of B cell receptor signaling pathway	5	11	45.4545454545455	0.00498435519265117	0.156726612282833	1	1	0.999996350881189	0.999996350881189	1
down	SEMA7A; ALOX15; WNT5A; ZYX; DUOXA1; DUOXA2; STK39; GRN;	GO:0050727~regulation of inflammatory response	8	78	10.2564102564103	0.00505821456509337	0.0293707941114629	1	1	0.857223937911009	0.999998861753158	0.268835265113212
down	TBX3; SOX18; ISL1; FZD2; SIX1; SFRP2;	GO:0003151~outflow tract morphogenesis	6	46	13.0434782608696	0.00513766286953288	0.0293707941114629	1	1	0.859782815337609	0.999998861753158	0.268835265113212
down	GOT2; CCND1; XDH; CAV1; DDR1; APLN;	GO:0007595~lactation	6	46	13.0434782608696	0.00513766286953288	0.0293707941114629	1	1	0.859782815337609	0.999998861753158	0.268835265113212
down	G6PD; COMT; MMP14; BAK1; SFRP1; SLC7A11;	GO:0014070~response to organic cyclic compound	6	46	13.0434782608696	0.00513766286953288	0.0293707941114629	1	1	0.859782815337609	0.999998861753158	0.268835265113212
down	IGFBP2; GJB2; IGFBP7; MICB; TRIML2; AQP3;	GO:0032526~response to retinoic acid	6	46	13.0434782608696	0.00513766286953288	0.0293707941114629	1	1	0.859782815337609	0.999998861753158	0.268835265113212
down	HRAS; IL1B; WNT5A; ISL1; FADD; SCRIB;	GO:0032729~positive regulation of interferon-gamma production	6	46	13.0434782608696	0.00513766286953288	0.0293707941114629	1	1	0.859782815337609	0.999998861753158	0.268835265113212
down	DGKI; HRAS; DAB2IP; RTKN; FZD10; F11R;	GO:0034260~negative regulation of GTPase activity	6	46	13.0434782608696	0.00513766286953288	0.0293707941114629	1	1	0.859782815337609	0.999998861753158	0.268835265113212
down	TGFB1I1; TRIO; MSX2; WNT5A; JAG1; CCDC85B;	GO:0045599~negative regulation of fat cell differentiation	6	46	13.0434782608696	0.00513766286953288	0.0293707941114629	1	1	0.859782815337609	0.999998861753158	0.268835265113212
down	SH3PXD2B; SPARC; FGFR2; STC1; P3H1; PDGFC;	GO:0060348~bone development	6	46	13.0434782608696	0.00513766286953288	0.0293707941114629	1	1	0.859782815337609	0.999998861753158	0.268835265113212
up	VIL1; HCLS1; AIF1; CORO7; RAC1; LMOD2; PREX1; MSRB1;	GO:0030041~actin filament polymerization	8	29	27.5862068965517	0.0051566851181698	0.156900447044529	1	1	0.999996350881189	0.999996350881189	1
up	TLR4; PTPN6; ARRB1; NCKAP1L; SLAMF1; NLRX1; IL36RN; KLF2;	GO:0032715~negative regulation of interleukin-6 production	8	29	27.5862068965517	0.0051566851181698	0.156900447044529	1	1	0.999996350881189	0.999996350881189	1
up	ITGB3; ITGB2; CD1D; ITGAX; ITGB7; GLDN; LILRB2; PERP;	GO:0034113~heterotypic cell-cell adhesion	8	29	27.5862068965517	0.0051566851181698	0.156900447044529	1	1	0.999996350881189	0.999996350881189	1
up	TLR4; CD14; UBB; UBE2D1; UBE2D3; UBA52; TLR6; LY96;	GO:0035666~TRIF-dependent toll-like receptor signaling pathway	8	29	27.5862068965517	0.0051566851181698	0.156900447044529	1	1	0.999996350881189	0.999996350881189	1
up	RAB27B; PCDH7; CFD; SERPINA1; EGF; PPBP; ITGB3; PROS1; LYN; ITGA2B; PLEK; CLU; PECAM1; CD36; ORM2; CTSW; ITIH3; FERMT3; SCG3; TEX264;	GO:0002576~platelet degranulation	20	124	16.1290322580645	0.00519228917957315	0.156900447044529	1	1	0.999996350881189	0.999996350881189	1
down	ACVR1; TEAD2; MEGF8;	GO:0003143~embryonic heart tube morphogenesis	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	FLNB; KDF1; PALLD;	GO:0003334~keratinocyte development	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	ALDOA; PFKL; PFKP;	GO:0030388~fructose 1,6-bisphosphate metabolic process	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	CFL1; SEMA5A; WDR1;	GO:0030836~positive regulation of actin filament depolymerization	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	CSF2; AKT1; PKD1;	GO:0034405~response to fluid shear stress	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	WTIP; DLG5; AJUBA;	GO:0035331~negative regulation of hippo signaling	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	LRP5; GPC3; MEGF8;	GO:0042074~cell migration involved in gastrulation	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	MYH9; SOX18; EMP2;	GO:0043534~blood vessel endothelial cell migration	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	AKR7A2; AKR1B10; AKR1A1;	GO:0044597~daunorubicin metabolic process	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	AKR7A2; AKR1B10; AKR1A1;	GO:0044598~doxorubicin metabolic process	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	HOXB4; TGFB2; VANGL2;	GO:0048103~somatic stem cell division	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	HOXA5; FGFR2; PTK7;	GO:0060484~lung-associated mesenchyme development	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	SLC9A1; RAB11B; RAB11FIP5;	GO:0071468~cellular response to acidic pH	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	WNT5A; LHX1; FOXA2;	GO:0090009~primitive streak formation	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	CDC20; DAB2IP; NRXN1;	GO:0090129~positive regulation of synapse maturation	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	MMP14; MMP16; MEGF8;	GO:0097094~craniofacial suture morphogenesis	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	ADAM10; NRP1; ACTN1;	GO:0099173~postsynapse organization	3	9	33.3333333333333	0.00520701326385198	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	SLC9A1; SLC9A3; SLC26A2; WNK4; SLC9A7; SLC25A10; STEAP1; SLC12A4; SLC12A7;	GO:0006811~ion transport	9	96	9.375	0.00521825498922601	0.0293707941114629	1	1	0.862419234504409	0.999998861753158	0.268835265113212
down	KCNK5; ADORA2B; SCNN1B; NEDD4L; UGT1A7;	GO:0007588~excretion	5	32	15.625	0.00529188117606538	0.0293707941114629	1	1	0.865136774260956	0.999998861753158	0.268835265113212
up	PES1; IL18RAP; CD74; CSF1R; GLUL; LTK; YAP1; GNG2; RAC1; BCL2L1; FOXC1; PPP1R8; IL18; FAM83B; GRHL2; RASGRP4; MAP4K1; CITED2; GNL3; SDCBP2; PAK1IP1; TACC2;	GO:0008283~cell population proliferation	22	142	15.4929577464789	0.00532384411483255	0.157240234755151	1	1	0.999996350881189	0.999996350881189	1
up	MT-CO2; FOS; ADRB2; ADM; GMPR; METRNL; PCSK1N; UCP2; SLC25A27;	GO:0009409~response to cold	9	36	25	0.0053318613722787	0.157240234755151	1	1	0.999996350881189	0.999996350881189	1
up	RAB3D; ADRB2; RAC2; RAC1; TCIRG1; GPR55; SNX10;	GO:0045453~bone resorption	7	23	30.4347826086957	0.00561061888680636	0.163430788187464	1	1	0.999996350881189	0.999996350881189	1
down	PLCH2; INPP1; PLCB3; INPP5A; PLCB4; PLCD3;	GO:0043647~inositol phosphate metabolic process	6	47	12.7659574468085	0.00564540510880041	0.0303569349765312	1	1	0.876897929928638	0.999998861753158	0.277861559734104
up	IFIT2; PPIF; HK2; BCL2L1; PIM2; BID;	GO:0008637~apoptotic mitochondrial changes	6	17	35.2941176470588	0.00569398521184694	0.16389480279585	1	1	0.999996350881189	0.999996350881189	1
up	IRGM; EGFR; IFNG; CD4; HLA-DRB1; CD74; WNT1; ITGB3; CSF1R; LYN; MMP9; PECAM1; FPR2; CCND3; FLT4; ARRB1; EFNA5; AIF1; RAC1; GPNMB; TMEM119; PROM2; FAXDC2; MARCO;	GO:0001934~positive regulation of protein phosphorylation	24	161	14.9068322981366	0.00569558602807818	0.16389480279585	1	1	0.999996350881189	0.999996350881189	1
down	UBE2C; CCNB1; ERCC2; PLK1; ANAPC15; CDC20; PSMD2; FZR1;	GO:1901990~regulation of mitotic cell cycle phase transition	8	80	10	0.00580828547902801	0.0312011444881525	1	1	0.882859392812257	0.999998861753158	0.285588735479047
down	PDGFB; CSF2; PKD1; HSF1;	GO:0001892~embryonic placenta development	4	20	20	0.00582068129112723	0.0312045017245264	1	1	0.883215288787288	0.999998861753158	0.28561946476499
down	PARP1; FGF5; EPCAM; MSX2;	GO:0023019~signal transduction involved in regulation of gene expression	4	20	20	0.00582068129112723	0.0312045017245264	1	1	0.883215288787288	0.999998861753158	0.28561946476499
down	SLC28A2; TK1; FPGS; CRMP1; DPYSL2;	GO:0006139~nucleobase-containing compound metabolic process	5	33	15.1515151515152	0.0059416954155499	0.0317249436991395	1	1	0.885312616916935	0.999998861753158	0.290383147888102
down	LDLR; PRKCZ; NFATC4; LRRN4; EIF2AK4;	GO:0007616~long-term memory	5	33	15.1515151515152	0.0059416954155499	0.0317249436991395	1	1	0.885312616916935	0.999998861753158	0.290383147888102
down	SH3PXD2B; CSF1; GHR; HSF1; SMO;	GO:0040018~positive regulation of multicellular organism growth	5	33	15.1515151515152	0.0059416954155499	0.0317249436991395	1	1	0.885312616916935	0.999998861753158	0.290383147888102
down	IL1B; NOS1; CX3CL1; DOCK7; HES2;	GO:0050767~regulation of neurogenesis	5	33	15.1515151515152	0.0059416954155499	0.0317249436991395	1	1	0.885312616916935	0.999998861753158	0.290383147888102
down	ADORA2B; IRAK1; MAP3K10; TAB1; CDC42EP5; TNFRSF19;	GO:0007254~JNK cascade	6	48	12.5	0.00618881179182729	0.0329448595585023	1	1	0.891188898023129	0.999998861753158	0.301549219946726
down	AKT1; DAP; EIF4G1; RASIP1; BMF; DAPL1;	GO:0010507~negative regulation of autophagy	6	48	12.5	0.00618881179182729	0.0329448595585023	1	1	0.891188898023129	0.999998861753158	0.301549219946726
down	INHBA; BMP2; BMP7; ACVR1; TWSG1; TGFB2;	GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation	6	48	12.5	0.00618881179182729	0.0329448595585023	1	1	0.891188898023129	0.999998861753158	0.301549219946726
down	KIF3C; KIF3B; CENPE; DYNC1I2; KLC2; DYNC1H1; WDR34; KIF1C;	GO:0007018~microtubule-based movement	8	81	9.87654320987654	0.00621362089428157	0.0329775955770579	1	1	0.891597832511757	0.999998861753158	0.301848857613782
down	PLCH2; PLCB3; PLCB4; NCEH1; ASPG; PLCD3; PNLIPRP3; LIPG;	GO:0016042~lipid catabolic process	8	81	9.87654320987654	0.00621362089428157	0.0329775955770579	1	1	0.891597832511757	0.999998861753158	0.301848857613782
down	UBE2C; CCNB1; PLK1; ANAPC15; CDC20; PSMD2; AURKB; FZR1;	GO:0031145~anaphase-promoting complex-dependent catabolic process	8	81	9.87654320987654	0.00621362089428157	0.0329775955770579	1	1	0.891597832511757	0.999998861753158	0.301848857613782
up	TLR4; EGFR; CD4; HLA-DRB1; CD74; CSF1R; CD36; FGFR3; FPR2; ACKR3; CCR1; CCR7; FLT4; CHI3L1; ARRB1; SLAMF1; GPNMB; TNFAIP8L3; SCIMP; NECAB2; GPBAR1; GLIPR2; IL26; C5AR2; MARCO; PYCARD; GPR55; CCL4; CCL5;	GO:0070374~positive regulation of ERK1 and ERK2 cascade	29	209	13.8755980861244	0.00628380188543376	0.17865563683856	1	1	0.999996350881189	0.999996350881189	1
down	HOXC11; GDNF; SIX1;	GO:0001759~organ induction	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	HOXB4; LAMA1; JAG1;	GO:0002011~morphogenesis of an epithelial sheet	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	ADCY6; ADCY3; ADCY9;	GO:0006171~cAMP biosynthetic process	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	CPS1; WNT5A; SMO;	GO:0007494~midgut development	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	SRC; AKT1; SLC45A3;	GO:0010907~positive regulation of glucose metabolic process	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	STXBP1; DLG4; UNC13B;	GO:0016188~synaptic vesicle maturation	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	B4GALT2; MYH10; NAGLU;	GO:0021680~cerebellar Purkinje cell layer development	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	LDLR; CEL; LIMA1;	GO:0030299~intestinal cholesterol absorption	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	EMP2; ANO6; LPAR1;	GO:0032060~bleb assembly	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	MSX2; MMP12; AJUBA;	GO:0035313~wound healing, spreading of epidermal cells	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	ECE1; DDR1; SHROOM2;	GO:0043583~ear development	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	TMPRSS2; P4HB; LGALS1;	GO:0046598~positive regulation of viral entry into host cell	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	ONECUT2; ETV1; NTRK2;	GO:0048935~peripheral nervous system neuron development	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	ACTN4; STMN1; PDPN;	GO:0051272~positive regulation of cellular component movement	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	NTN1; PDLIM5; RAB17;	GO:0051963~regulation of synapse assembly	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	WNT7B; PKD1; DLG5;	GO:0072205~metanephric collecting duct development	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	HAS3; GAS6; HAS2;	GO:0085029~extracellular matrix assembly	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	HSPA1B; HSF1; SACS;	GO:0090084~negative regulation of inclusion body assembly	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	LRP4; NLGN4Y; CEL;	GO:0097105~presynaptic membrane assembly	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	PSCA; CDK5; LYPD6;	GO:0099601~regulation of neurotransmitter receptor activity	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	BAK1; CHCHD10; BOK;	GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	CAV1; NEDD4L; STK39;	GO:1901380~negative regulation of potassium ion transmembrane transport	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	APP; GSN; FKBP1A;	GO:1990000~amyloid fibril formation	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	RAB11B; GBF1; RAB11FIP5;	GO:2000008~regulation of protein localization to cell surface	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
down	SEMA5A; LGMN; SMOC2;	GO:2001028~positive regulation of endothelial cell chemotaxis	3	10	30	0.00661525246460526	0.0342089042543645	1	1	0.899889261630526	0.999998861753158	0.313119209836595
up	FLT4; SYK; FOXC1; TMEM204;	GO:0001945~lymph vessel development	4	7	57.1428571428571	0.00663253513916384	0.182038204461919	1	1	0.999996350881189	0.999996350881189	1
up	PTGES; VNN1; S100A8; GJA1;	GO:0002544~chronic inflammatory response	4	7	57.1428571428571	0.00663253513916384	0.182038204461919	1	1	0.999996350881189	0.999996350881189	1
up	CD22; GPS2; FCRL3; CD300A;	GO:0050859~negative regulation of B cell receptor signaling pathway	4	7	57.1428571428571	0.00663253513916384	0.182038204461919	1	1	0.999996350881189	0.999996350881189	1
up	CR1; SPINK5; ANXA8L1; SPINK2;	GO:1900004~negative regulation of serine-type endopeptidase activity	4	7	57.1428571428571	0.00663253513916384	0.182038204461919	1	1	0.999996350881189	0.999996350881189	1
up	KLF4; IFNG; GTF2B; FOXC1;	GO:1904798~positive regulation of core promoter binding	4	7	57.1428571428571	0.00663253513916384	0.182038204461919	1	1	0.999996350881189	0.999996350881189	1
up	IL18RAP; CCL5; CXCR2; IL18; PREX1;	GO:0042119~neutrophil activation	5	12	41.6666666666667	0.00663281579020891	0.182038204461919	1	1	0.999996350881189	0.999996350881189	1
down	TUBB; TUBA1B; TUBB3; TUBG1; TUBB6;	GO:0007017~microtubule-based process	5	34	14.7058823529412	0.00664563775594029	0.0342089042543645	1	1	0.901156873601064	0.999998861753158	0.313119209836595
down	CDH5; MSX2; GPC3; FOXD1; TWSG1;	GO:0030513~positive regulation of BMP signaling pathway	5	34	14.7058823529412	0.00664563775594029	0.0342089042543645	1	1	0.901156873601064	0.999998861753158	0.313119209836595
down	EIF4G1; PLVAP; MSC; COMT; TWIST2;	GO:0032502~developmental process	5	34	14.7058823529412	0.00664563775594029	0.0342089042543645	1	1	0.901156873601064	0.999998861753158	0.313119209836595
down	MMP2; TPM1; PRDX3; AKT1; PTPRK;	GO:0034614~cellular response to reactive oxygen species	5	34	14.7058823529412	0.00664563775594029	0.0342089042543645	1	1	0.901156873601064	0.999998861753158	0.313119209836595
down	MAP3K10; DAB2IP; FZD8; VANGL2; FZD10;	GO:0043507~positive regulation of JUN kinase activity	5	34	14.7058823529412	0.00664563775594029	0.0342089042543645	1	1	0.901156873601064	0.999998861753158	0.313119209836595
down	TBX3; SLIT3; TGFB2; ACVR1; ROBO1;	GO:0060412~ventricular septum morphogenesis	5	34	14.7058823529412	0.00664563775594029	0.0342089042543645	1	1	0.901156873601064	0.999998861753158	0.313119209836595
down	DAPK3; DAP; CAV1; FADD; BAK1; ANXA6; DAPL1;	GO:0097190~apoptotic signaling pathway	7	65	10.7692307692308	0.00670498636631633	0.0344440106534548	1	1	0.902446921181701	0.999998861753158	0.315271173821273
down	SNAI2; EDNRA; SOX9; FOXC2;	GO:0014032~neural crest cell development	4	21	19.047619047619	0.00676273591732635	0.0344440106534548	1	1	0.903760005326278	0.999998861753158	0.315271173821273
down	CLDN7; CLDN12; CLDN18; CLDN23;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	4	21	19.047619047619	0.00676273591732635	0.0344440106534548	1	1	0.903760005326278	0.999998861753158	0.315271173821273
down	CDH13; CYFIP1; WASF1; WASF2;	GO:0016601~Rac protein signal transduction	4	21	19.047619047619	0.00676273591732635	0.0344440106534548	1	1	0.903760005326278	0.999998861753158	0.315271173821273
down	FSTL3; MDK; TSPO; DKK3;	GO:0030325~adrenal gland development	4	21	19.047619047619	0.00676273591732635	0.0344440106534548	1	1	0.903760005326278	0.999998861753158	0.315271173821273
down	TUBB; TUBA1B; MYO10; KIF1C;	GO:0030705~cytoskeleton-dependent intracellular transport	4	21	19.047619047619	0.00676273591732635	0.0344440106534548	1	1	0.903760005326278	0.999998861753158	0.315271173821273
down	CYP1A1; G6PD; CPS1; AKT1;	GO:0032094~response to food	4	21	19.047619047619	0.00676273591732635	0.0344440106534548	1	1	0.903760005326278	0.999998861753158	0.315271173821273
down	BAG3; ALDOA; LOX; LARGE2;	GO:0046716~muscle cell cellular homeostasis	4	21	19.047619047619	0.00676273591732635	0.0344440106534548	1	1	0.903760005326278	0.999998861753158	0.315271173821273
down	LRP4; NGFR; ARHGDIA; EFNB3;	GO:0050771~negative regulation of axonogenesis	4	21	19.047619047619	0.00676273591732635	0.0344440106534548	1	1	0.903760005326278	0.999998861753158	0.315271173821273
down	FOXA1; SFRP1; DMRTA2; FOXA2;	GO:0071542~dopaminergic neuron differentiation	4	21	19.047619047619	0.00676273591732635	0.0344440106534548	1	1	0.903760005326278	0.999998861753158	0.315271173821273
down	STK39; PAK4; PAK6; MAP2K2; STK25; MAP4K4;	GO:0023014~signal transduction by protein phosphorylation	6	49	12.2448979591837	0.00676926803110145	0.0344440106534548	1	1	0.903760005326278	0.999998861753158	0.315271173821273
down	CBR3; APP; ST3GAL4; CYFIP1; MFSD2A; TMPRSS11E;	GO:0050890~cognition	6	49	12.2448979591837	0.00676926803110145	0.0344440106534548	1	1	0.903760005326278	0.999998861753158	0.315271173821273
up	CLEC4D; CLEC4E; FCER1G;	GO:0002292~T cell differentiation involved in immune response	3	3	100	0.0069631734330855	0.18265827326127	1	1	0.999996350881189	0.999996350881189	1
up	FCER1G; SYK; P2RX1;	GO:0002554~serotonin secretion by platelet	3	3	100	0.0069631734330855	0.18265827326127	1	1	0.999996350881189	0.999996350881189	1
up	ANXA1; CXCR3; SMPD3;	GO:0002685~regulation of leukocyte migration	3	3	100	0.0069631734330855	0.18265827326127	1	1	0.999996350881189	0.999996350881189	1
up	HLA-G; LILRB2; LILRB1;	GO:0002767~immune response-inhibiting cell surface receptor signaling pathway	3	3	100	0.0069631734330855	0.18265827326127	1	1	0.999996350881189	0.999996350881189	1
up	LYN; LILRB2; LILRB1;	GO:0002774~Fc receptor mediated inhibitory signaling pathway	3	3	100	0.0069631734330855	0.18265827326127	1	1	0.999996350881189	0.999996350881189	1
up	CLEC4D; CLEC4E; FCER1G;	GO:0038094~Fc-gamma receptor signaling pathway	3	3	100	0.0069631734330855	0.18265827326127	1	1	0.999996350881189	0.999996350881189	1
up	CD4; CD74; CD1D;	GO:0045058~T cell selection	3	3	100	0.0069631734330855	0.18265827326127	1	1	0.999996350881189	0.999996350881189	1
up	RAC2; RHOG; RAC1;	GO:1902622~regulation of neutrophil migration	3	3	100	0.0069631734330855	0.18265827326127	1	1	0.999996350881189	0.999996350881189	1
down	B4GALT2; PTN; ITGA3; HRH1; ASIC1; LGMN; SHANK3; PAK6;	GO:0007613~memory	8	83	9.63855421686747	0.00708823702893724	0.0359290943856838	1	1	0.910693580482219	0.999998861753158	0.328864367023812
down	HGS; RAB13; ARHGAP1; VPS37D; SNX33; MVB12A; TINAGL1; CLEC16A;	GO:0016197~endosomal transport	8	83	9.63855421686747	0.00708823702893724	0.0359290943856838	1	1	0.910693580482219	0.999998861753158	0.328864367023812
down	LRP5; LDLR; CAV1; PCSK9; LIMA1; LIPG; CYP7B1; CYP39A1;	GO:0042632~cholesterol homeostasis	8	83	9.63855421686747	0.00708823702893724	0.0359290943856838	1	1	0.910693580482219	0.999998861753158	0.328864367023812
up	FOS; ASGR1; LYN; CDKN2B; AIF1; GSDMD;	GO:0031668~cellular response to extracellular stimulus	6	18	33.3333333333333	0.00712049841895668	0.184720903273231	1	1	0.999996350881189	0.999996350881189	1
up	CCL5; FPR2; CCR1; CCR2; AIF1; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	6	18	33.3333333333333	0.00712049841895668	0.184720903273231	1	1	0.999996350881189	0.999996350881189	1
up	ASS1; BGLAP; S100A8; HAAO; CRIP1; HAMP; HVCN1; P2RX7;	GO:0010043~response to zinc ion	8	31	25.8064516129032	0.00719742356898645	0.184720903273231	1	1	0.999996350881189	0.999996350881189	1
up	JCHAIN; IGHM; HLA-A; HLA-E; CAMP; HIST2H2BE; RNASE6; RNASE7;	GO:0019731~antibacterial humoral response	8	31	25.8064516129032	0.00719742356898645	0.184720903273231	1	1	0.999996350881189	0.999996350881189	1
down	TBX3; SNAI2; MSC; TFAP2A; INHBA; GLI3; SATB2;	GO:0060021~roof of mouth development	7	66	10.6060606060606	0.0072234423797739	0.036579457017728	1	1	0.91303991317433	0.999998861753158	0.334817233328407
down	PAK6; PAK4; MAP2K2; STK25; MAP4K4; STK39;	GO:0031098~stress-activated protein kinase signaling cascade	6	50	12	0.00738815135039061	0.0373778420417663	1	1	0.916130767448436	0.999998861753158	0.342124970694486
down	CFL1; PKD1; PRKCZ; FEZ1; PARD3;	GO:0030010~establishment of cell polarity	5	35	14.2857142857143	0.00740592309227528	0.0374320345426535	1	1	0.916466584421066	0.999998861753158	0.34262100274891
down	ASIC1; KCNMA1; NEDD4L; POPDC3; HCN2; BVES; GABRP; GABRR2; PIEZO1;	GO:0042391~regulation of membrane potential	9	102	8.82352941176471	0.0074612862031439	0.0376759423324466	1	1	0.917651910952956	0.999998861753158	0.344853527177203
down	KDM6A; ERCC1; ERCC2; HOXA5; COMP; PPP1R13L; SMO; ETNK2;	GO:0035264~multicellular organism growth	8	84	9.52380952380952	0.0075588641530947	0.0381323479921105	1	1	0.918859815133072	0.999998861753158	0.34903107634558
down	ERCC2; FGFR2; LHX1; PPP1R13L; NDN; SEMA3C; ETNK2;	GO:0009791~post-embryonic development	7	67	10.4477611940298	0.00777097473428456	0.0391271623234559	1	1	0.922625634047551	0.999998861753158	0.358136760498713
down	FOXE1; HOXA3; HOXA5; SIX1;	GO:0030878~thyroid gland development	4	22	18.1818181818182	0.00780034148922915	0.0391271623234559	1	1	0.922625634047551	0.999998861753158	0.358136760498713
down	TBX3; ITGA2; SOX9; CAV1;	GO:0030879~mammary gland development	4	22	18.1818181818182	0.00780034148922915	0.0391271623234559	1	1	0.922625634047551	0.999998861753158	0.358136760498713
down	KRT18; KRT16; FAM83H; PLEC;	GO:0045104~intermediate filament cytoskeleton organization	4	22	18.1818181818182	0.00780034148922915	0.0391271623234559	1	1	0.922625634047551	0.999998861753158	0.358136760498713
down	BMP7; MMP14; PKD1; RASIP1;	GO:0048754~branching morphogenesis of an epithelial tube	4	22	18.1818181818182	0.00780034148922915	0.0391271623234559	1	1	0.922625634047551	0.999998861753158	0.358136760498713
down	APP; LGMN; SHANK3; EIF2AK4;	GO:1900273~positive regulation of long-term synaptic potentiation	4	22	18.1818181818182	0.00780034148922915	0.0391271623234559	1	1	0.922625634047551	0.999998861753158	0.358136760498713
up	SH2B2; MCF2L; RGS14; TYROBP; HSPB1; LYN; HCLS1; DUSP1; PTPN6; PRKAR2B; CD80; ZAP70; RGS6; BLK; BMX; JAK3; RAC1; GUCY2D; BTK; CDC42BPG; DEF8; CLNK; NFAM1; PREX1; RASSF5; DEDD2; ASB15; ASB13; ARHGAP45; SIPA1; MAP3K3; LAT2; SDCBP2; TREM1; ARHGEF4; GMIP; SIRPG; DAPK2; STYXL1; RPS6KA1; PRKCB; MAPK10; GCOM1; NLRX1; MAPKAPK3;	GO:0035556~intracellular signal transduction	45	371	12.1293800539084	0.00794532170687956	0.199599933673355	1	1	0.999996350881189	0.999996350881189	1
down	DVL1; DLG4; NLGN4Y; SHANK3; NRXN1; SHANK2;	GO:0035176~social behavior	6	51	11.7647058823529	0.00804682913518417	0.0403254140593067	1	1	0.926619684411394	0.999998861753158	0.369104537599233
up	CLDN4; FLG; HRNR; GRHL3; TMEM79; ELOVL1; GRHL1;	GO:0061436~establishment of skin barrier	7	25	28	0.00814092763018759	0.203437496779635	1	1	0.999996350881189	0.999996350881189	1
down	RAB11B; EHD3; PLEKHJ1;	GO:0001881~receptor recycling	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	NR2F2; PRDX3; AKT1;	GO:0001893~maternal placenta development	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	ITGA2; KITLG; MADCAM1;	GO:0002687~positive regulation of leukocyte migration	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	MYH10; NDST1; TAB1;	GO:0003279~cardiac septum development	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	CXCL11; CXCL10; CCL26;	GO:0010818~T cell chemotaxis	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	GLI3; CDK5; DAB2IP;	GO:0021819~layer formation in cerebral cortex	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	FUT1; FUOM; FUT6;	GO:0036065~fucosylation	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	ITGB4; ITGA2; TP63;	GO:0043589~skin morphogenesis	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	IL1B; APP; WNT5A;	GO:0045080~positive regulation of chemokine biosynthetic process	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	ADAM10; ANO6; PDZD11;	GO:0046931~pore complex assembly	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	CAPN2; TSPO; VWA1;	GO:0048266~behavioral response to pain	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	LHX1; NDST1; FOXC2;	GO:0048703~embryonic viscerocranium morphogenesis	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	CA12; SLC12A4; SLC12A7;	GO:0055064~chloride ion homeostasis	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	KRT18; KRT8; GSN;	GO:0097284~hepatocyte apoptotic process	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	DAPK3; INHBA; SRPX;	GO:2001241~positive regulation of extrinsic apoptotic signaling pathway in absence of ligand	3	11	27.2727272727273	0.00822835307391245	0.0406586467827436	1	1	0.929803897352107	0.999998861753158	0.372154666486098
down	KCNK5; KCNMA1; KCNJ12; FXYD3; KCNS3; KCNK6; KCNK7;	GO:0006813~potassium ion transport	7	68	10.2941176470588	0.00834851489345523	0.0412139906565173	1	1	0.932337482826999	0.999998861753158	0.377237811904925
up	PANO1; SAP18; MCF2L; BNIP3L; NEURL1; LTA; S100B; IFIT2; UBB; CLU; GZMA; CTLA4; DUSP1; TNFRSF8; ADM; SNCA; MNDA; BID; UBA52; ID3; ZBTB16; EEF1A2; IRF5; PLEKHN1; FGD3; ADAMTSL4; FGD2; SIAH1; LILRB1; PREX1; FAM162A; TXNIP; CALHM2; NLRC4; ARHGEF4; TOMM22; BCLAF1; PYCARD; TNFRSF10C; GZMK; SCIMP;	GO:0043065~positive regulation of apoptotic process	41	332	12.3493975903614	0.00839876112013183	0.207948041582234	1	1	0.999996350881189	0.999996350881189	1
up	CRYBA1; SLC11A1; BTK; GPNMB; NDRG2;	GO:0001818~negative regulation of cytokine production	5	13	38.4615384615385	0.00862800425267485	0.207948041582234	1	1	0.999996350881189	0.999996350881189	1
up	CR1; C3AR1; FPR1; FPR2; C5AR2;	GO:0002430~complement receptor mediated signaling pathway	5	13	38.4615384615385	0.00862800425267485	0.207948041582234	1	1	0.999996350881189	0.999996350881189	1
up	CD27; SYK; NCKAP1L; BTK; PPP2R3C;	GO:0045579~positive regulation of B cell differentiation	5	13	38.4615384615385	0.00862800425267485	0.207948041582234	1	1	0.999996350881189	0.999996350881189	1
up	RGS13; RGS14; PLEK; CCL5; RGS2;	GO:0045744~negative regulation of G protein-coupled receptor signaling pathway	5	13	38.4615384615385	0.00862800425267485	0.207948041582234	1	1	0.999996350881189	0.999996350881189	1
down	SPTLC2; PLPP2; DEGS2; FA2H; SPHK1; HACD1;	GO:0030148~sphingolipid biosynthetic process	6	52	11.5384615384615	0.00874665613844994	0.041312270174239	1	1	0.938557944839581	0.999998861753158	0.378137379008955
down	ELAVL1; KCTD11; ATL3; ATL1; NACC2; KCTD14; KCNS3; EHD4; EHD3;	GO:0051260~protein homooligomerization	9	105	8.57142857142857	0.008827139864377	0.041312270174239	1	1	0.940199455648457	0.999998861753158	0.378137379008955
down	ADAM10; MYH9; ADAM19; BACE2;	GO:0006509~membrane protein ectodomain proteolysis	4	23	17.3913043478261	0.00893722630891214	0.041312270174239	1	1	0.941877854340678	0.999998861753158	0.378137379008955
down	FAT4; A4GALT; BAIAP2L1; FER1L6;	GO:0007009~plasma membrane organization	4	23	17.3913043478261	0.00893722630891214	0.041312270174239	1	1	0.941877854340678	0.999998861753158	0.378137379008955
down	DAPK3; OBSL1; CAV2; CUL7;	GO:0007088~regulation of mitotic nuclear division	4	23	17.3913043478261	0.00893722630891214	0.041312270174239	1	1	0.941877854340678	0.999998861753158	0.378137379008955
down	PRKACA; VCAM1; GPR143; FKBP1B;	GO:0035584~calcium-mediated signaling using intracellular calcium source	4	23	17.3913043478261	0.00893722630891214	0.041312270174239	1	1	0.941877854340678	0.999998861753158	0.378137379008955
down	NRP1; LDLR; COMP; FOXC2;	GO:0048844~artery morphogenesis	4	23	17.3913043478261	0.00893722630891214	0.041312270174239	1	1	0.941877854340678	0.999998861753158	0.378137379008955
down	TSHZ3; SHANK3; NRXN1; SHANK2;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	4	23	17.3913043478261	0.00893722630891214	0.041312270174239	1	1	0.941877854340678	0.999998861753158	0.378137379008955
down	MMP7; ITGA3; DSG2; APOL2;	GO:0060135~maternal process involved in female pregnancy	4	23	17.3913043478261	0.00893722630891214	0.041312270174239	1	1	0.941877854340678	0.999998861753158	0.378137379008955
down	CCL21; POU2F2; AXL; SOX18; LHX6;	GO:0048469~cell maturation	5	37	13.5135135135135	0.00910415169609702	0.0420472232514864	1	1	0.945350403359067	0.999998861753158	0.384864514292316
up	KLF4; SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	4	8	50	0.00936758210167032	0.222386399093653	1	1	0.999996350881189	0.999996350881189	1
up	TLR4; IRF1; SYK; LTB;	GO:0045084~positive regulation of interleukin-12 biosynthetic process	4	8	50	0.00936758210167032	0.222386399093653	1	1	0.999996350881189	0.999996350881189	1
down	ITGB1; FOSL1; ADORA2B; CXCL9; LGALS3BP; CLEC5A;	GO:0006968~cellular defense response	6	53	11.3207547169811	0.00948897204590382	0.0436723348848803	1	1	0.95086927590615	0.999998861753158	0.399739403787779
down	IL33; IL1B; ADORA2B; WNT5A; ISL1; IL36A;	GO:0032755~positive regulation of interleukin-6 production	6	53	11.3207547169811	0.00948897204590382	0.0436723348848803	1	1	0.95086927590615	0.999998861753158	0.399739403787779
down	CCL21; CSF1; VEGFC; CDK5; CENPE; GAS6;	GO:0045860~positive regulation of protein kinase activity	6	53	11.3207547169811	0.00948897204590382	0.0436723348848803	1	1	0.95086927590615	0.999998861753158	0.399739403787779
down	PRKACA; ATP2B4; NOS1; FKBP1B; FXYD3; EHD3;	GO:1903779~regulation of cardiac conduction	6	53	11.3207547169811	0.00948897204590382	0.0436723348848803	1	1	0.95086927590615	0.999998861753158	0.399739403787779
down	BCAR3; PTPN1; SHC1; AKT1; CAV2; BCAR1; FOXC2; PIK3R3;	GO:0008286~insulin receptor signaling pathway	8	88	9.09090909090909	0.00967927088784526	0.044509535340291	1	1	0.954772868683355	0.999998861753158	0.407402424594405
up	RRS1; MRTO4; MRPL11; RPF2; RPLP0; BRIX1; MRPL20;	GO:0000027~ribosomal large subunit assembly	7	26	26.9230769230769	0.00968124780775359	0.228689376075692	1	1	0.999996350881189	0.999996350881189	1
up	BNIP3L; OAS1; IFNG; ISG15; IRF1; PRF1; IRF9; BST2; IRF5; OASL; UNC13D; NLRP9; LILRB1; RSAD2; RNASE6; ISG20; UNC93B1; CARD9; IL23A; DDX21; TLR8; TLR7; PYCARD; IFITM1; IFITM2; IFIT1B; IFIT2;	GO:0051607~defense response to virus	27	198	13.6363636363636	0.00988776422393634	0.231266524804186	1	1	0.999996350881189	0.999996350881189	1
down	TPM2; TPM1; TNNT1; MYL6B; TPM4;	GO:0030049~muscle filament sliding	5	38	13.1578947368421	0.010046278807015	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	SLC4A2; SLC9A1; SLC4A3; SLC9A3; SLC9A7;	GO:0098656~anion transmembrane transport	5	38	13.1578947368421	0.010046278807015	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	TNFRSF10B; SERPINE1; ICAM1; FADD; SFRP2;	GO:1902042~negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	5	38	13.1578947368421	0.010046278807015	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	TAB1; DAB2IP; TRAF7;	GO:0000185~activation of MAPKKK activity	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	LHX1; SOX7; DUSP4;	GO:0001706~endoderm formation	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	ONECUT2; DDR1; EMP2;	GO:0001952~regulation of cell-matrix adhesion	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	DDAH1; PLCB3; POSTN;	GO:0003073~regulation of systemic arterial blood pressure	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	PFKL; HK1; PFKP;	GO:0006002~fructose 6-phosphate metabolic process	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	G6PD; TKT; PGD;	GO:0006098~pentose-phosphate shunt	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	SLC9A1; SLC9A7; RHCG;	GO:0006885~regulation of pH	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	DAPK3; CNN1; CAV1;	GO:0006940~regulation of smooth muscle contraction	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	CCNB1; PLK1; NEK6;	GO:0007077~mitotic nuclear envelope disassembly	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	C3; APP; CX3CL1;	GO:0016322~neuron remodeling	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	CSPG4; DSEL; CHST14;	GO:0030208~dermatan sulfate biosynthetic process	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	B4GALNT1; ST3GAL4; SLC35C1;	GO:0030259~lipid glycosylation	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	CSF1; EGR2; ACVR1;	GO:0030278~regulation of ossification	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	LRP5; ITGAV; BMP2;	GO:0033690~positive regulation of osteoblast proliferation	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	APOC1; P4HB; MFSD2A;	GO:0034379~very-low-density lipoprotein particle assembly	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	DLG4; CDK5; PCLO;	GO:0035418~protein localization to synapse	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	HIC1; SPRED1; SPRED3;	GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	SNAI2; PRKACA; FGFR2;	GO:0045667~regulation of osteoblast differentiation	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	PRKCZ; SFRP1; SFRP2;	GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	F3; ITGA2; CDH13;	GO:0050927~positive regulation of positive chemotaxis	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	MAP4K4; HAS2; EPB41L4B;	GO:0051549~positive regulation of keratinocyte migration	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	C3; ITGA2; ANO6;	GO:0060100~positive regulation of phagocytosis, engulfment	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	NF2; FZR1; SLC7A11;	GO:0070306~lens fiber cell differentiation	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	PTN; TNC; SFRP1;	GO:0071305~cellular response to vitamin D	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	NRP1; GDNF; SMO;	GO:0071679~commissural neuron axon guidance	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	CSF2; AXL; GAS6;	GO:0097028~dendritic cell differentiation	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	ICAM1; MDK; IRAK1;	GO:1904996~positive regulation of leukocyte adhesion to vascular endothelial cell	3	12	25	0.0100524267802296	0.0450532263641395	1	1	0.960998852100162	0.999998861753158	0.412378909737479
down	ZDHHC1; ZDHHC12; ZDHHC2; ZDHHC8;	GO:0018345~protein palmitoylation	4	24	16.6666666666667	0.0101769001302794	0.0454573921573221	1	1	0.963180606972718	0.999998861753158	0.416078299605781
down	CAV2; DNER; SMO; SIX1;	GO:0048741~skeletal muscle fiber development	4	24	16.6666666666667	0.0101769001302794	0.0454573921573221	1	1	0.963180606972718	0.999998861753158	0.416078299605781
down	PIP5K1C; AP2A2; AP2A1; AP2B1;	GO:0072583~clathrin-dependent endocytosis	4	24	16.6666666666667	0.0101769001302794	0.0454573921573221	1	1	0.963180606972718	0.999998861753158	0.416078299605781
down	HRAS; ITGB1; ACTG1; DUOX2;	GO:0090303~positive regulation of wound healing	4	24	16.6666666666667	0.0101769001302794	0.0454573921573221	1	1	0.963180606972718	0.999998861753158	0.416078299605781
down	RAPGEF3; APP; IGFBP5; CPS1; STC1; HCN2;	GO:0071320~cellular response to cAMP	6	54	11.1111111111111	0.0102750991067933	0.0458573867543921	1	1	0.965419030803004	0.999998861753158	0.419739509893085
up	CSF1R; PLEK; CCR7; RAC1; TCIRG1;	GO:0031529~ruffle organization	5	14	35.7142857142857	0.0110022608065072	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	CD4; CD3E; CD80; CD86; IRF4;	GO:0045086~positive regulation of interleukin-2 biosynthetic process	5	14	35.7142857142857	0.0110022608065072	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	AIF1; RAC1; INPP5K; SNX10; AIF1L;	GO:0097178~ruffle assembly	5	14	35.7142857142857	0.0110022608065072	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
down	BMP7; FBN2; TGFB2; MEGF8; HOXC10;	GO:0030326~embryonic limb morphogenesis	5	39	12.8205128205128	0.0110531071494486	0.0492467009297283	1	1	0.977543826550382	0.999998861753158	0.450762408743574
down	DDAH1; IL1B; ICAM1; PTX3; AKT1;	GO:0045429~positive regulation of nitric oxide biosynthetic process	5	39	12.8205128205128	0.0110531071494486	0.0492467009297283	1	1	0.977543826550382	0.999998861753158	0.450762408743574
up	TLR4; LYN; HCK; CCL5; PTAFR; IL18; LY96; CD14;	GO:0031663~lipopolysaccharide-mediated signaling pathway	8	34	23.5294117647059	0.0113258929062843	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	C2CD2L; BAIAP3; NADK; HLA-DRB1; ARRB1; VSNL1; RAC1; GPR27;	GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus	8	34	23.5294117647059	0.0113258929062843	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	GJB6; OXT; CD14; AIF1; BTG2; EEF1A2; P2RX7;	GO:0051602~response to electrical stimulus	7	27	25.9259259259259	0.0114237236361096	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	ITGAL; FGL2; APBB1IP;	GO:0002291~T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	3	4	75	0.0115131363336363	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	HLA-DRB1; FGL2; GAPT;	GO:0002381~immunoglobulin production involved in immunoglobulin mediated immune response	3	4	75	0.0115131363336363	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	TLR4; PLEK; PLA2G4A;	GO:0010572~positive regulation of platelet activation	3	4	75	0.0115131363336363	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	CD14; TLR1; SCIMP;	GO:0038123~toll-like receptor TLR1:TLR2 signaling pathway	3	4	75	0.0115131363336363	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	CD14; CD36; TLR6;	GO:0038124~toll-like receptor TLR6:TLR2 signaling pathway	3	4	75	0.0115131363336363	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	FCER1G; CSF2RB; SYK;	GO:0038156~interleukin-3-mediated signaling pathway	3	4	75	0.0115131363336363	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	ITGB2; ITGAM; PTAFR;	GO:0043315~positive regulation of neutrophil degranulation	3	4	75	0.0115131363336363	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	PLD1; TNFAIP8L3; ADAP2;	GO:0048017~inositol lipid-mediated signaling	3	4	75	0.0115131363336363	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	IL18; RASAL3; IL23A;	GO:0051142~positive regulation of NK T cell proliferation	3	4	75	0.0115131363336363	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	SYK; BTK; SCIMP;	GO:0071226~cellular response to molecule of fungal origin	3	4	75	0.0115131363336363	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	CD14; CD36; TLR6;	GO:0071726~cellular response to diacyl bacterial lipopeptide	3	4	75	0.0115131363336363	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	ULK3; IL17RA; RGCC;	GO:0072537~fibroblast activation	3	4	75	0.0115131363336363	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
up	CCR6; SPNS2; TBX21;	GO:0072676~lymphocyte migration	3	4	75	0.0115131363336363	0.245131709919753	1	1	0.999996350881189	0.999996350881189	1
down	AGPAT2; AGPAT1; HILPDA; IL33;	GO:0001819~positive regulation of cytokine production	4	25	16	0.0115226479117438	0.0510384955957108	1	1	0.9856621680508	0.999998861753158	0.467162972930903
down	PIP5K1C; CDK5; PCLO; SYT1;	GO:0016079~synaptic vesicle exocytosis	4	25	16	0.0115226479117438	0.0510384955957108	1	1	0.9856621680508	0.999998861753158	0.467162972930903
down	SERPINB7; ITGA2; CREB3L1; LARP6;	GO:0032967~positive regulation of collagen biosynthetic process	4	25	16	0.0115226479117438	0.0510384955957108	1	1	0.9856621680508	0.999998861753158	0.467162972930903
down	ALDH1A3; CYP27C1; CYP2S1; UGT1A7;	GO:0042573~retinoic acid metabolic process	4	25	16	0.0115226479117438	0.0510384955957108	1	1	0.9856621680508	0.999998861753158	0.467162972930903
down	TERT; ERCC1; SPARC; SORD;	GO:0046686~response to cadmium ion	4	25	16	0.0115226479117438	0.0510384955957108	1	1	0.9856621680508	0.999998861753158	0.467162972930903
down	NRP1; MAP4K4; COL16A1; SFRP1;	GO:0051894~positive regulation of focal adhesion assembly	4	25	16	0.0115226479117438	0.0510384955957108	1	1	0.9856621680508	0.999998861753158	0.467162972930903
down	PRKACA; HMGA2; DAB2IP; GATA6;	GO:0071158~positive regulation of cell cycle arrest	4	25	16	0.0115226479117438	0.0510384955957108	1	1	0.9856621680508	0.999998861753158	0.467162972930903
down	MRAS; NTN1; HRAS; SHC1; MAPK11; RALA; RRAS;	GO:0007265~Ras protein signal transduction	7	73	9.58904109589041	0.0117186515593958	0.0518633477194628	1	1	0.988527465050948	0.999998861753158	0.474712967613597
down	APOD; G6PD; AKR1A1; AKT1; PGM1; SORD;	GO:0006006~glucose metabolic process	6	56	10.7142857142857	0.011983974781438	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
up	EGFR; FES; CSF1R; LYN; HCK; FGR; PIM1; FGFR3; FLT4; FLT3; ZAP70; SYK; BMX; EPHB3; EPHB1; BTK; PTK6; ULK3; MAP4K1; MAP3K3; DAPK2; PIM2; MAPKAPK3; PIM3;	GO:0046777~protein autophosphorylation	24	173	13.8728323699422	0.0120767659738867	0.25484659930673	1	1	0.999996350881189	0.999996350881189	1
down	APOD; GSTP1; HYAL2;	GO:0000302~response to reactive oxygen species	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	IGHA1; CD34; MCAM;	GO:0003094~glomerular filtration	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	TPM1; MYL9; ANXA6;	GO:0006937~regulation of muscle contraction	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	C3; CFH; VSIG4;	GO:0006957~complement activation, alternative pathway	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	NTN1; MYH10; DYNC1H1;	GO:0007097~nuclear migration	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	ERCC1; ERCC2; SCARA3;	GO:0009650~UV protection	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	HGS; PTPN1; DAB2IP;	GO:0030948~negative regulation of vascular endothelial growth factor receptor signaling pathway	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	PLOD3; P3H1; P3H3;	GO:0032963~collagen metabolic process	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	PLAU; EFNA1; EPHA2;	GO:0033628~regulation of cell adhesion mediated by integrin	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	BMP1; PRKACA; ZDHHC8;	GO:0034380~high-density lipoprotein particle assembly	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	GLI3; BAK1; MEGF8;	GO:0035108~limb morphogenesis	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	CDH3; IGFBP4; IGFBP5;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	SCRIB; PDCD1LG2; CD274;	GO:0046007~negative regulation of activated T cell proliferation	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	HGS; NF2; CAV1;	GO:0046426~negative regulation of receptor signaling pathway via JAK-STAT	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	DLX1; DLX2; TMEM98;	GO:0048715~negative regulation of oligodendrocyte differentiation	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	ACVR1; NFATC4; GATA6;	GO:0051145~smooth muscle cell differentiation	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	GSN; SPTAN1; SCIN;	GO:0051693~actin filament capping	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	MMP12; WNT5A; FADD;	GO:0060340~positive regulation of type I interferon-mediated signaling pathway	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	BMP2; TGFB2; ACVR1;	GO:0060389~pathway-restricted SMAD protein phosphorylation	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	ISL1; TGFB2; SMO;	GO:0060413~atrial septum morphogenesis	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	CAV1; FADD; BOK;	GO:0060546~negative regulation of necroptotic process	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	PRKACA; SLC9A1; ATP2B4;	GO:0071872~cellular response to epinephrine stimulus	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	PARD3; FERMT1; FRMD4A;	GO:0090162~establishment of epithelial cell polarity	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	CEACAM1; EPCAM; FLRT3;	GO:0098742~cell-cell adhesion via plasma-membrane adhesion molecules	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	TAX1BP3; SNX33; NEDD4L;	GO:2000009~negative regulation of protein localization to cell surface	3	13	23.0769230769231	0.0120923987860869	0.0523806359181641	1	1	0.991957357905003	0.999998861753158	0.479447783754763
down	B3GALNT1; ARSA; B4GALNT1; SUMF2; ESYT1;	GO:0006687~glycosphingolipid metabolic process	5	40	12.5	0.0121265773181073	0.0524429958732503	1	1	0.992256140241721	0.999998861753158	0.480018573737302
down	BAG3; GLI3; FLNA; HYAL2; SMO;	GO:0042307~positive regulation of protein import into nucleus	5	40	12.5	0.0121265773181073	0.0524429958732503	1	1	0.992256140241721	0.999998861753158	0.480018573737302
down	CYP1A1; G0S2; HMGCS2; FHL2; LSR; CARM1; ANGPTL4; RGL1;	GO:0019216~regulation of lipid metabolic process	8	92	8.69565217391304	0.0122127131635846	0.0527724573702736	1	1	0.992256140241721	0.999998861753158	0.483034184025561
up	TBXAS1; PLA2G4A; CYP4F3; CYP4F22;	GO:0006690~icosanoid metabolic process	4	9	44.4444444444444	0.0127427766521159	0.258558562154898	1	1	0.999996350881189	0.999996350881189	1
up	PLEK; VIL1; DSTN; PDXP;	GO:0030836~positive regulation of actin filament depolymerization	4	9	44.4444444444444	0.0127427766521159	0.258558562154898	1	1	0.999996350881189	0.999996350881189	1
up	LY86; SCIMP; CD180; LY96;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	4	9	44.4444444444444	0.0127427766521159	0.258558562154898	1	1	0.999996350881189	0.999996350881189	1
up	CD3E; CCR2; ZAP70; SYK;	GO:0046641~positive regulation of alpha-beta T cell proliferation	4	9	44.4444444444444	0.0127427766521159	0.258558562154898	1	1	0.999996350881189	0.999996350881189	1
up	TLR4; CD36; NLRC4; TLR6;	GO:0050702~interleukin-1 beta secretion	4	9	44.4444444444444	0.0127427766521159	0.258558562154898	1	1	0.999996350881189	0.999996350881189	1
up	CRTAM; CD4; CCL5; SIT1;	GO:0050863~regulation of T cell activation	4	9	44.4444444444444	0.0127427766521159	0.258558562154898	1	1	0.999996350881189	0.999996350881189	1
up	FES; RAB25; RAB11A; VAMP2;	GO:0060627~regulation of vesicle-mediated transport	4	9	44.4444444444444	0.0127427766521159	0.258558562154898	1	1	0.999996350881189	0.999996350881189	1
up	BID; RAB10; RAB11A; COLQ;	GO:0090150~establishment of protein localization to membrane	4	9	44.4444444444444	0.0127427766521159	0.258558562154898	1	1	0.999996350881189	0.999996350881189	1
up	SLC24A4; RELT; PERP; CSF3R;	GO:0097186~amelogenesis	4	9	44.4444444444444	0.0127427766521159	0.258558562154898	1	1	0.999996350881189	0.999996350881189	1
up	LYN; NCKAP1L; SPNS2; TNFSF13B; PPP2R3C; GAPT;	GO:0001782~B cell homeostasis	6	21	28.5714285714286	0.0129288762029106	0.260992190987718	1	1	0.999996350881189	0.999996350881189	1
down	CAV1; DUSP4; SPRED1; SPRED3;	GO:0000188~inactivation of MAPK activity	4	26	15.3846153846154	0.0129775250577961	0.0528623860571347	1	1	0.99386956486	0.999998861753158	0.483857314727503
down	NRP1; DSCAM; APP; APLN;	GO:0042327~positive regulation of phosphorylation	4	26	15.3846153846154	0.0129775250577961	0.0528623860571347	1	1	0.99386956486	0.999998861753158	0.483857314727503
down	TGFB2; DAB2IP; MAPKAP1; SPRY4;	GO:0046580~negative regulation of Ras protein signal transduction	4	26	15.3846153846154	0.0129775250577961	0.0528623860571347	1	1	0.99386956486	0.999998861753158	0.483857314727503
down	STMN1; DLC1; F11R; WASF2;	GO:0051497~negative regulation of stress fiber assembly	4	26	15.3846153846154	0.0129775250577961	0.0528623860571347	1	1	0.99386956486	0.999998861753158	0.483857314727503
down	GPC3; KREMEN1; SOX7; ZNF703;	GO:0060828~regulation of canonical Wnt signaling pathway	4	26	15.3846153846154	0.0129775250577961	0.0528623860571347	1	1	0.99386956486	0.999998861753158	0.483857314727503
down	IL1B; BMP2; XDH; SPHK1;	GO:1900745~positive regulation of p38MAPK cascade	4	26	15.3846153846154	0.0129775250577961	0.0528623860571347	1	1	0.99386956486	0.999998861753158	0.483857314727503
up	IFNG; VIL1; CCR6; RAB25; RAB11A; HYAL1; GLIPR2; PLCG2;	GO:0010634~positive regulation of epithelial cell migration	8	35	22.8571428571429	0.0130276220017037	0.260992190987718	1	1	0.999996350881189	0.999996350881189	1
up	UBE2L6; ISG15; UBB; RPA2; UBA52; PARP10; SPRTN; POLD4;	GO:0019985~translesion synthesis	8	35	22.8571428571429	0.0130276220017037	0.260992190987718	1	1	0.999996350881189	0.999996350881189	1
down	PDPN; SLC38A5; SLC6A15; SLC6A14; SLC7A11;	GO:0006865~amino acid transport	5	41	12.1951219512195	0.0132685620012626	0.0534573827740838	1	1	0.994576819487191	0.999998861753158	0.489303408542177
down	PRKACA; FKBP1B; CAV1; BOK; ATP2B4;	GO:0051480~regulation of cytosolic calcium ion concentration	5	41	12.1951219512195	0.0132685620012626	0.0534573827740838	1	1	0.994576819487191	0.999998861753158	0.489303408542177
up	ZMPSTE24; HPR; CFD; MMP1; MMP3; MME; MMP10; GZMB; CTSA; MMP9; CAPN3; PRTN3; CTSS; CASP1; KLK7; GZMK; GZMM; CASP5; CTSC; TMPRSS3; ADAM8; ADAM15; FGL2; PRSS36; PM20D1; GGT6; ADAMTSL4; TMPRSS11F; ASRGL1; OVCH1; TMPRSS9; ATG4D; UNC5CL; SVBP; KY; ADAMTS14; CAPNS2; TMEM59; TMPRSS13; PRSS22; ADAMTS10; DPEP2; DPEP3; MMP25; KLK11; NAALADL1; CPA5; HGFAC; CPA4; DPP7;	GO:0006508~proteolysis	50	436	11.4678899082569	0.0133744566030336	0.263643720614995	1	1	0.999996350881189	0.999996350881189	1
up	ITGB2; CCL5; PECAM1; ITGAL; CD40LG; SYK; FERMT3;	GO:0007159~leukocyte cell-cell adhesion	7	28	25	0.0133820843867342	0.263643720614995	1	1	0.999996350881189	0.999996350881189	1
up	CD4; GJA1; ADORA2A; P2RX1; ANK2; IL16; ORAI1;	GO:0051924~regulation of calcium ion transport	7	28	25	0.0133820843867342	0.263643720614995	1	1	0.999996350881189	0.999996350881189	1
up	ATP6V0E1; ATP6V1G1; TCIRG1; ATP6V1F; ATP6V1C2; ATP6V0E2; ATP6V0B;	GO:0090383~phagosome acidification	7	28	25	0.0133820843867342	0.263643720614995	1	1	0.999996350881189	0.999996350881189	1
up	SIAH2; BNIP3L; NUPR1; SLC25A27; EGFR; MYC; CRYAB; ANXA1; CD74; WNT1; HSPB1; MPO; CSF1R; HCK; UBB; PIM1; MMP9; IL2RB; CAPN3; CD27; DUSP1; LTK; CD40LG; PPIF; EVI2B; BTC; FLT4; SNCA; ID1; PPT1; AIF1; NCKAP1L; BID; SOX8; UBA52; YWHAZ; UBE2B; BCL2L1; NAIP; PDCD1; DHCR24; RPS6KA1; BCL2A1; CIAPIN1; PIM3; THOC6; BCL2L2; PSMG2; RNF157; MYD88; BAG1; CITED2; C8orf17; PIM2; PRELID1;	GO:0043066~negative regulation of apoptotic process	55	489	11.2474437627812	0.0136696728399485	0.26716210452385	1	1	0.999996350881189	0.999996350881189	1
up	TLR4; CD74; SYK; TLR8; TLR7;	GO:0045416~positive regulation of interleukin-8 biosynthetic process	5	15	33.3333333333333	0.0137857446521363	0.26716210452385	1	1	0.999996350881189	0.999996350881189	1
up	PLA2G4B; PRDX6; GDPD3; PLA2G4A; PLA2G4F;	GO:0046475~glycerophospholipid catabolic process	5	15	33.3333333333333	0.0137857446521363	0.26716210452385	1	1	0.999996350881189	0.999996350881189	1
up	CLU; ACKR3; CDKN2D; BID; BCL2L1;	GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	5	15	33.3333333333333	0.0137857446521363	0.26716210452385	1	1	0.999996350881189	0.999996350881189	1
up	RGS14; GNG7; RGS2; GRK6; RGS6; RGS1; RASGRP4; RGS18; HOMER2;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	9	43	20.9302325581395	0.0138660180731952	0.267625421998093	1	1	0.999996350881189	0.999996350881189	1
down	ECE1; SCRIB; BVES;	GO:0001921~positive regulation of receptor recycling	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	ATP2B4; SMARCA4; TGFB2;	GO:0003407~neural retina development	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	VASP; CAP2; CAP1;	GO:0008154~actin polymerization or depolymerization	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	ST3GAL4; B3GALT5; B3GALNT1;	GO:0009312~oligosaccharide biosynthetic process	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	SRC; MMP14; CCBE1;	GO:0010954~positive regulation of protein processing	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	CXCL10; PTN; MDK;	GO:0010996~response to auditory stimulus	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	F12; SERPINE1; PRDX2;	GO:0030194~positive regulation of blood coagulation	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	GSTP1; ACP5; CX3CL1;	GO:0032691~negative regulation of interleukin-1 beta production	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	IDO1; PDCD1LG2; CD274;	GO:0032693~negative regulation of interleukin-10 production	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	PRDX2; MAP3K6; PRDX4;	GO:0033554~cellular response to stress	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	JAG1; LRP1; SIX1;	GO:0035909~aorta morphogenesis	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	PPP1R14C; PPP1R14B; BARD1;	GO:0042325~regulation of phosphorylation	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	GHR; ALDH9A1; FOXA1;	GO:0042445~hormone metabolic process	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	SAA1; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	IGFBP5; CPS1; AKT1;	GO:0060416~response to growth hormone	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	SOX15; NR2F2; E2F7;	GO:0060707~trophoblast giant cell differentiation	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	UBA6; ACSL4; PAK4;	GO:0060996~dendritic spine development	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	PRKACA; FKBP1B; PKP2;	GO:0086064~cell communication by electrical coupling involved in cardiac conduction	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	ICAM1; RAB1B; F11R;	GO:0090557~establishment of endothelial intestinal barrier	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	C3; LDLR; LRP1;	GO:0097242~amyloid-beta clearance	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	PDGFB; SOX9; NFATC4;	GO:1902894~negative regulation of pri-miRNA transcription by RNA polymerase II	3	14	21.4285714285714	0.0143520939293098	0.0569145863973078	1	1	0.996526970113637	0.999998861753158	0.520947709648666
down	ACSL4; ISL1; DOC2B; AACS; TM7SF3;	GO:0032024~positive regulation of insulin secretion	5	42	11.9047619047619	0.0144808623828514	0.0573823111762916	1	1	0.996951928309847	0.999998861753158	0.525228864406719
down	APP; GHR; GAMT; MFSD2A;	GO:0040014~regulation of multicellular organism growth	4	27	14.8148148148148	0.01454435402242	0.0575049701915519	1	1	0.996951928309847	0.999998861753158	0.526351580692867
down	VEGFC; APLN; RNPEP; NOS1;	GO:0045776~negative regulation of blood pressure	4	27	14.8148148148148	0.01454435402242	0.0575049701915519	1	1	0.996951928309847	0.999998861753158	0.526351580692867
down	GAPDH; SAA1; SRC; CLEC5A;	GO:0050715~positive regulation of cytokine secretion	4	27	14.8148148148148	0.01454435402242	0.0575049701915519	1	1	0.996951928309847	0.999998861753158	0.526351580692867
down	APOL1; HMGB3; C1R; F12; SLPI; APP; CFI; KRT16; CSF1; C1S; SAA1; HK1; PTX3; AXL; MST1R; FADD; TTLL12; DAB2IP; SUSD4; NLRP10; LGR4; CLEC5A; IL36A; IGHA1; IRAK1; PPP1R14B;	GO:0045087~innate immune response	26	505	5.14851485148515	0.0148399298747667	0.0586298868822749	1	1	0.997389764027155	0.999998861753158	0.536648111172538
down	KIF3B; NKX3-2; ACVR1; AP1B1; RTTN; BICC1;	GO:0007368~determination of left/right symmetry	6	59	10.1694915254237	0.0149076765193727	0.0588536864525051	1	1	0.997841071612688	0.999998861753158	0.538696582063952
up	FOS; JUND; FECH; DUSP1; SLC1A3; MAPK10;	GO:0009416~response to light stimulus	6	22	27.2727272727273	0.0154404633528692	0.292123811046266	1	1	0.999996350881189	0.999996350881189	1
up	KRT3; KRT6C; PPL; DSP; EPPK1; EVPL;	GO:0045104~intermediate filament cytoskeleton organization	6	22	27.2727272727273	0.0154404633528692	0.292123811046266	1	1	0.999996350881189	0.999996350881189	1
down	SLC2A10; COX6A1; SLC9A1; SLC9A3; ATP2C1; OTOP3; SLC4A11; SLC9A7; NDUFA4L2;	GO:1902600~proton transmembrane transport	9	116	7.75862068965517	0.0154928247814872	0.0611182715710156	1	1	0.998786668458566	0.999998861753158	0.559424667875857
up	PRMT5; EGFR; LYN; PTPN6; SYK; EPHB1; YWHAZ;	GO:0070372~regulation of ERK1 and ERK2 cascade	7	29	24.1379310344828	0.0155696810778643	0.292123811046266	1	1	0.999996350881189	0.999996350881189	1
up	ZMPSTE24; BGLAP; ASGR2; FGR; FGFR3; GPNMB; FBXL15; SMPD3; SNX10;	GO:0030282~bone mineralization	9	44	20.4545454545455	0.015627516429181	0.292123811046266	1	1	0.999996350881189	0.999996350881189	1
down	DVL1; TUBG1; DYNC1H1; FIGN; CAMSAP3;	GO:0031122~cytoplasmic microtubule organization	5	43	11.6279069767442	0.0157652048577863	0.0620082464065156	1	1	0.999068783687346	0.999998861753158	0.567570740465442
down	IDO1; DLG5; PDCD1LG2; CD274; VSIG4;	GO:0042130~negative regulation of T cell proliferation	5	43	11.6279069767442	0.0157652048577863	0.0620082464065156	1	1	0.999068783687346	0.999998861753158	0.567570740465442
down	KCNK5; HCN2; KCNJ12; SLC12A7; SLC12A4;	GO:1990573~potassium ion import across plasma membrane	5	43	11.6279069767442	0.0157652048577863	0.0620082464065156	1	1	0.999068783687346	0.999998861753158	0.567570740465442
down	MAP1B; NAV3; CAMSAP3; APC2;	GO:0007026~negative regulation of microtubule depolymerization	4	28	14.2857142857143	0.0162257221574312	0.0636307536085062	1	1	0.999580601711776	0.999998861753158	0.582421791211292
down	SHANK2; SHANK3; ADRA1D; ADRA1B;	GO:0007610~behavior	4	28	14.2857142857143	0.0162257221574312	0.0636307536085062	1	1	0.999580601711776	0.999998861753158	0.582421791211292
down	WTIP; SPARC; CFL1; CAPZB;	GO:0022604~regulation of cell morphogenesis	4	28	14.2857142857143	0.0162257221574312	0.0636307536085062	1	1	0.999580601711776	0.999998861753158	0.582421791211292
down	LRP5; PDGFB; IL1B; SPHK1;	GO:0045840~positive regulation of mitotic nuclear division	4	28	14.2857142857143	0.0162257221574312	0.0636307536085062	1	1	0.999580601711776	0.999998861753158	0.582421791211292
up	CD24; SLURP1; TLR1; TLR6;	GO:0001775~cell activation	4	10	40	0.0168038133741435	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	NEURL1; EGF; NCF1; EPGN;	GO:0045741~positive regulation of epidermal growth factor-activated receptor activity	4	10	40	0.0168038133741435	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	HLA-E; HLA-G; HLA-F; LILRB1;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	4	10	40	0.0168038133741435	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	HCK; FGR; SYK; OLFM4;	GO:0050764~regulation of phagocytosis	4	10	40	0.0168038133741435	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	GSDMD; NLRP9; NLRC4; GSDMC;	GO:0070269~pyroptosis	4	10	40	0.0168038133741435	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
down	TGFB2; JAG1; ROBO1;	GO:0003184~pulmonary valve morphogenesis	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	FADS2; DECR2; FADS3;	GO:0006636~unsaturated fatty acid biosynthetic process	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	OPLAH; GCLM; CNDP2;	GO:0006750~glutathione biosynthetic process	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	ICA1; SLC6A15; SLC6A14;	GO:0006836~neurotransmitter transport	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	CSF1; MDK; CXCL17;	GO:0010759~positive regulation of macrophage chemotaxis	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	SERPINE2; GLG1; TMEM98;	GO:0010955~negative regulation of protein processing	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	NRP1; CTSV; NGFR;	GO:0021675~nerve development	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	SPINT2; NF2; JAG1;	GO:0022408~negative regulation of cell-cell adhesion	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	"NAV3; HOMER3; VSIG4;"	GO:0032703~negative regulation of interleukin-2 production	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	SOX18; FOXC2; NDRG4;	GO:0035050~embryonic heart tube development	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	KRT14; KRT16; PPP1R13L;	GO:0042633~hair cycle	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	CD81; NECTIN2; CARD11;	GO:0050862~positive regulation of T cell receptor signaling pathway	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	IL1B; SNX33; PACSIN3;	GO:0051044~positive regulation of membrane protein ectodomain proteolysis	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	KRT1; KRT10; PKD1;	GO:0051290~protein heterotetramerization	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	OBSL1; MYH10; FHOD3;	GO:0055003~cardiac myofibril assembly	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	HOXB4; ERCC2; SFRP1;	GO:0060218~hematopoietic stem cell differentiation	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	IL1B; TSPO; ETV5;	GO:0060252~positive regulation of glial cell proliferation	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	FKBP1A; FHL2; ADAMTS1;	GO:0060347~heart trabecula formation	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	PHB; SMARCA4; SFRP1;	GO:0060766~negative regulation of androgen receptor signaling pathway	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	PDGFB; PRKCZ; PLVAP;	GO:0070528~protein kinase C signaling	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	ATP2B4; FHL2; HOMER3;	GO:0070885~negative regulation of calcineurin-NFAT signaling cascade	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	SPRED1; CARD10; STARD13;	GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	FADD; BAK1; LGMN;	GO:0097202~activation of cysteine-type endopeptidase activity	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	HRAS; CYFIP1; EPS8L2;	GO:1900029~positive regulation of ruffle assembly	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	HGS; SDC1; ATP13A2;	GO:1903543~positive regulation of exosomal secretion	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	DVL1; PARP1; WNT5A;	GO:1903827~regulation of cellular protein localization	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	CCL21; CXCL10; APP;	GO:2000406~positive regulation of T cell migration	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
down	PDGFB; SRC; SMOC2;	GO:2000573~positive regulation of DNA biosynthetic process	3	15	20	0.0168343180504968	0.0646779379012567	1	1	0.999998861753158	0.999998861753158	0.592006825442767
up	CST7; CST3; CSTA; CSTB; PI16;	GO:0010466~negative regulation of peptidase activity	5	16	31.25	0.0170060488813919	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	PIK3AP1; MYD88; UNC93B1; TLR8; TLR7;	GO:0034162~toll-like receptor 9 signaling pathway	5	16	31.25	0.0170060488813919	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
down	RAMP2; LRP5; EDNRA; CD34; ACTA2; STK39;	GO:0008217~regulation of blood pressure	6	61	9.83606557377049	0.0171110811998205	0.0656936658373993	1	1	0.999998861753158	0.999998861753158	0.601303934944114
up	PRKCB; FABP5; INPP5K;	GO:0010829~negative regulation of glucose transmembrane transport	3	5	60	0.0174087182821612	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	IFNG; IL17RA; MYD88;	GO:0032747~positive regulation of interleukin-23 production	3	5	60	0.0174087182821612	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	CNR2; MILR1; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0174087182821612	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	CETP; CD36; MTTP;	GO:0034197~triglyceride transport	3	5	60	0.0174087182821612	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	PECAM1; CCR2; JAML;	GO:0035696~monocyte extravasation	3	5	60	0.0174087182821612	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	OXT; SLC4A1; AVPR2;	GO:0035811~negative regulation of urine volume	3	5	60	0.0174087182821612	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	IRF1; CTLA4; LAG3;	GO:0045590~negative regulation of regulatory T cell differentiation	3	5	60	0.0174087182821612	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	ANXA1; IL17RA; ADGRE2;	GO:0071621~granulocyte chemotaxis	3	5	60	0.0174087182821612	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	CST7; CAST; CARD16;	GO:0097340~inhibition of cysteine-type endopeptidase activity	3	5	60	0.0174087182821612	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	GJB5; GJA1; PTPN6;	GO:1905867~epididymis development	3	5	60	0.0174087182821612	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
up	DBI; CETP; PRELID1;	GO:2001140~positive regulation of phospholipid transport	3	5	60	0.0174087182821612	0.300569434195277	1	1	0.999996350881189	0.999996350881189	1
down	SCNN1B; ASIC1; SHROOM2; ANO6; SLC4A11; HCN2; TPCN1;	GO:0035725~sodium ion transmembrane transport	7	80	8.75	0.0179508140948493	0.0660191559180967	1	1	0.999998861753158	0.999998861753158	0.604283194265599
up	AIP; TIMM44; BID; TOMM20; TOMM22; FBXO7; TIMM10B;	GO:0006626~protein targeting to mitochondrion	7	30	23.3333333333333	0.01799938013503	0.307413873673102	1	1	0.999996350881189	0.999996350881189	1
up	ZMPSTE24; CRYAB; CYBA; YAP1; RPL26; BCL2L1; TMEM109;	GO:0071480~cellular response to gamma radiation	7	30	23.3333333333333	0.01799938013503	0.307413873673102	1	1	0.999996350881189	0.999996350881189	1
down	FGFR2; NDST1; WLS; DLG5;	GO:0030901~midbrain development	4	29	13.7931034482759	0.0180239806961225	0.0661336648102711	1	1	0.999998861753158	0.999998861753158	0.605331311257898
down	CDIP1; TP63; DDIT4; PHLDA3;	GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	4	29	13.7931034482759	0.0180239806961225	0.0661336648102711	1	1	0.999998861753158	0.999998861753158	0.605331311257898
down	CXCL11; CXCL10; CX3CL1; CXCL9;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	4	29	13.7931034482759	0.0180239806961225	0.0661336648102711	1	1	0.999998861753158	0.999998861753158	0.605331311257898
up	FFAR2; DYSF; CD36; PLIN5; PNPLA2; DGAT2;	GO:0019915~lipid storage	6	23	26.0869565217391	0.0182704183556821	0.310924538898848	1	1	0.999996350881189	0.999996350881189	1
up	SH2B2; MAFK; SERPINA1; SLC4A1; ITGB3; THBD; PROS1; GP1BA; LYN; IRF1; CD36; PRTN3; ADORA2A; FCER1G; PRKAR2B; GP5; P2RX1; RAC1; HBB; NFE2; P2RX5; P2RX7; PROCR;	GO:0007596~blood coagulation	23	171	13.4502923976608	0.0185214846935258	0.314071461874501	1	1	0.999996350881189	0.999996350881189	1
down	EPHA2; HIC1; NFATC4; BAK1; BOK;	GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage	5	45	11.1111111111111	0.018556530179213	0.0679935888114632	1	1	0.999998861753158	0.999998861753158	0.622355473425708
down	COL4A2; PTN; UQCRC1; GCLM; HSF1;	GO:0014823~response to activity	5	45	11.1111111111111	0.018556530179213	0.0679935888114632	1	1	0.999998861753158	0.999998861753158	0.622355473425708
up	MEIS1; SRPX2; DYSF; CD160; EGF; GLUL; PECAM1; TYMP; ACKR3; ID1; SYK; CXCR3; PLCD1; EPHB3; EPHB1; YWHAZ; ADAM8; TNFAIP2; FOXC1; ADAM15; GAB1; AAMP; KLF5; IL18; EPGN; UNC5B; OVOL2; SEMA4A; AMOTL2;	GO:0001525~angiogenesis	29	230	12.6086956521739	0.0187769108866395	0.316462377926085	1	1	0.999996350881189	0.999996350881189	1
down	BMP2; ETV5; NBL1; FOXA1; EIF4G1; DUOXA1; TCF12;	GO:0045666~positive regulation of neuron differentiation	7	81	8.64197530864197	0.0190001684197786	0.0695710586751837	1	1	0.999998861753158	0.999998861753158	0.636794290687918
down	LRP5; POLR2E; SOX9; POLR2L; SFRP1; VANGL2;	GO:0035019~somatic stem cell population maintenance	6	63	9.52380952380952	0.019528458374199	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	CD34; MMP14; LOXL2;	GO:0001935~endothelial cell proliferation	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	STMN1; NCKAP5L; NCKAP5;	GO:0007019~microtubule depolymerization	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	NLGN4Y; NRXN1; CEL;	GO:0007158~neuron cell-cell adhesion	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	LHX1; GPC3; WLS;	GO:0009948~anterior/posterior axis specification	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	MGST3; CYP2E1; CCND1;	GO:0010243~response to organonitrogen compound	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	AKT1; CNTN1; PKP2;	GO:0010765~positive regulation of sodium ion transport	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	UNC13B; STXBP1; CADPS2;	GO:0016082~synaptic vesicle priming	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	CD44; SLC9A1; HYAL2;	GO:0030214~hyaluronan catabolic process	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	PDLIM1; RHOC; MAPKAP1;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	EDNRA; CAV1; TRPM4;	GO:0042310~vasoconstriction	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	STXBP1; CDK5; DOC2B;	GO:0045956~positive regulation of calcium ion-dependent exocytosis	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	MAP4K4; GRIK2; MAPK8IP1;	GO:0046328~regulation of JNK cascade	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	GLI3; CXCL8; TGFB2;	GO:0048566~embryonic digestive tract development	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	CDH2; PRDX2; CARD11;	GO:0048872~homeostasis of number of cells	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	HOXA5; CCND1; DDR1;	GO:0060749~mammary gland alveolus development	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	DSCAM; VSTM2L; PALLD;	GO:0070593~dendrite self-avoidance	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	CCL21; LOX; STK39;	GO:1990869~cellular response to chemokine	3	16	18.75	0.0195409348352296	0.0706726033399639	1	1	0.999998861753158	0.999998861753158	0.646876893523456
down	UNC13B; SYT1; STXBP1; NTRK2;	GO:0014047~glutamate secretion	4	30	13.3333333333333	0.019941244768662	0.0717289550633961	1	1	0.999998861753158	0.999998861753158	0.656545838617142
down	NUDT14; DDOST; STT3A; MCFD2;	GO:0018279~protein N-linked glycosylation via asparagine	4	30	13.3333333333333	0.019941244768662	0.0717289550633961	1	1	0.999998861753158	0.999998861753158	0.656545838617142
down	TXN; ITGA2; ERCC2; ISL1;	GO:0043388~positive regulation of DNA binding	4	30	13.3333333333333	0.019941244768662	0.0717289550633961	1	1	0.999998861753158	0.999998861753158	0.656545838617142
down	APOD; COMT; IGFBP5; NDRG4;	GO:0048662~negative regulation of smooth muscle cell proliferation	4	30	13.3333333333333	0.019941244768662	0.0717289550633961	1	1	0.999998861753158	0.999998861753158	0.656545838617142
down	APOD; LGALS1; DPYSL3; FLRT3;	GO:0048678~response to axon injury	4	30	13.3333333333333	0.019941244768662	0.0717289550633961	1	1	0.999998861753158	0.999998861753158	0.656545838617142
down	EPCAM; MSX2; HMGA2; SHC4;	GO:0048863~stem cell differentiation	4	30	13.3333333333333	0.019941244768662	0.0717289550633961	1	1	0.999998861753158	0.999998861753158	0.656545838617142
down	SH3PXD2B; SPTLC2; LRP5; AACS;	GO:0060612~adipose tissue development	4	30	13.3333333333333	0.019941244768662	0.0717289550633961	1	1	0.999998861753158	0.999998861753158	0.656545838617142
down	TF; ITGAV; MAP2K2; SOX9;	GO:0070371~ERK1 and ERK2 cascade	4	30	13.3333333333333	0.019941244768662	0.0717289550633961	1	1	0.999998861753158	0.999998861753158	0.656545838617142
down	EPHA2; AKT1; XDH; HYAL2; PHLDA3;	GO:0051898~negative regulation of protein kinase B signaling	5	46	10.8695652173913	0.0200665666149802	0.0721308041983898	1	1	0.999998861753158	0.999998861753158	0.660224023767041
up	LYN; FGR; CD19; FGFR3; CCR7; FLT3; TNFAIP8L3;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	7	31	22.5806451612903	0.0206834632692892	0.342251209068963	1	1	0.999996350881189	0.999996350881189	1
up	GZMB; GZMA; PRF1; GZMM; LYZ;	GO:0019835~cytolysis	5	17	29.4117647058824	0.0206878890064853	0.342251209068963	1	1	0.999996350881189	0.999996350881189	1
up	EGFR; IFNG; IFNGR1; FPR2; ADORA2A;	GO:0048143~astrocyte activation	5	17	29.4117647058824	0.0206878890064853	0.342251209068963	1	1	0.999996350881189	0.999996350881189	1
down	AP1S1; DCTN1; GBF1; RGP1; DENND2A; RAB9B; PLEKHJ1;	GO:0042147~retrograde transport, endosome to Golgi	7	83	8.43373493975904	0.0212261799420648	0.0762474295750863	1	1	0.999998861753158	0.999998861753158	0.697904110669563
up	MEFV; IFITM1; SNCA; SLC11A1; IFITM2; BST2;	GO:0034341~response to interferon-gamma	6	24	25	0.0214353682228972	0.348137726491921	1	1	0.999996350881189	0.999996350881189	1
up	CCDC88B; SLC11A1; IRF8; IRF4; TSPAN32; MYD88;	GO:0042832~defense response to protozoan	6	24	25	0.0214353682228972	0.348137726491921	1	1	0.999996350881189	0.999996350881189	1
up	RND1; RHOF; RHOD; RND3;	GO:0000910~cytokinesis	4	11	36.3636363636364	0.0215875414709222	0.348137726491921	1	1	0.999996350881189	0.999996350881189	1
up	ALOX5; ALOX5AP; SYK; PLA2G4A;	GO:0019370~leukotriene biosynthetic process	4	11	36.3636363636364	0.0215875414709222	0.348137726491921	1	1	0.999996350881189	0.999996350881189	1
up	EFNA5; EPHB3; ADAM8; CELSR2;	GO:0022407~regulation of cell-cell adhesion	4	11	36.3636363636364	0.0215875414709222	0.348137726491921	1	1	0.999996350881189	0.999996350881189	1
up	CD74; CD3E; CCR7; ZAP70;	GO:0045060~negative thymic T cell selection	4	11	36.3636363636364	0.0215875414709222	0.348137726491921	1	1	0.999996350881189	0.999996350881189	1
up	TLR4; CYBA; CD36; TLR6;	GO:1903428~positive regulation of reactive oxygen species biosynthetic process	4	11	36.3636363636364	0.0215875414709222	0.348137726491921	1	1	0.999996350881189	0.999996350881189	1
down	ACOT11; DOCK7; FOXC2; LGR4; HOXC10;	GO:0120163~negative regulation of cold-induced thermogenesis	5	47	10.6382978723404	0.021654747864548	0.0777342404724669	1	1	0.999998861753158	0.999998861753158	0.711513112872691
up	ERBB3; RGS6; RGS19; NLRP12; RGS1; PTK6; RGS18; PAK1IP1;	GO:0009968~negative regulation of signal transduction	8	39	20.5128205128205	0.0217270487256175	0.348513605909567	1	1	0.999996350881189	0.999996350881189	1
down	EDNRA; P2RY6; NTRK2; LPAR1;	GO:0007202~activation of phospholipase C activity	4	31	12.9032258064516	0.0219793943534703	0.0786334337800941	1	1	0.999998861753158	0.999998861753158	0.719743563514462
down	LHX1; SIX1; SOSTDC1; APC2;	GO:0007389~pattern specification process	4	31	12.9032258064516	0.0219793943534703	0.0786334337800941	1	1	0.999998861753158	0.999998861753158	0.719743563514462
down	CA2; KRT14; CPS1; SLC39A13;	GO:0010043~response to zinc ion	4	31	12.9032258064516	0.0219793943534703	0.0786334337800941	1	1	0.999998861753158	0.999998861753158	0.719743563514462
down	CCL21; PDGFB; SRC; VAV2;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	4	31	12.9032258064516	0.0219793943534703	0.0786334337800941	1	1	0.999998861753158	0.999998861753158	0.719743563514462
down	SPTLC2; ALOX12B; FA2H; DEGS2;	GO:0046513~ceramide biosynthetic process	4	31	12.9032258064516	0.0219793943534703	0.0786334337800941	1	1	0.999998861753158	0.999998861753158	0.719743563514462
up	SPTBN2; EGFR; MYC; EGF; IL2RA; SPTB; CCL5; IL2RB; ERBB3; FGFR3; PSMB8; PSMB9; PEBP1; IL2RG; CSF2RB; BTC; FLT3; PSMB10; PSMB3; CCR5; JAK3; GRB2; PSME1; IL18; MAPKAPK3; EPGN; RASAL3; RASGRP4; PSMF1; MAP3K3; MAP4K1;	GO:0000165~MAPK cascade	31	254	12.2047244094488	0.0224397208902721	0.357529512708094	1	1	0.999996350881189	0.999996350881189	1
down	MSX2; COMP; SFRP2;	GO:0002063~chondrocyte development	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	FOXE1; SLC16A2; DUOX2;	GO:0006590~thyroid hormone generation	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	EDNRA; SMTN; FKBP1B;	GO:0006939~smooth muscle contraction	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	TNFRSF10B; IRAK1; CARD10;	GO:0007250~activation of NF-kappaB-inducing kinase activity	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	LGALS1; CX3CL1; SPOCK1;	GO:0010812~negative regulation of cell-substrate adhesion	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	CSF2; MT1G; MYH9;	GO:0030224~monocyte differentiation	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	GBF1; PSD3; ARFGAP1;	GO:0032012~regulation of ARF protein signal transduction	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	WFS1; BAK1; GRINA;	GO:0032469~endoplasmic reticulum calcium ion homeostasis	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	APOC1; PLTP; LIPG;	GO:0034375~high-density lipoprotein particle remodeling	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	G6PD; PCSK9; AKT1S1;	GO:0043523~regulation of neuron apoptotic process	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	EPHA2; LGR4; LRP5;	GO:0046849~bone remodeling	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	CCL21; PDGFB; CCL26;	GO:0050921~positive regulation of chemotaxis	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	FOSL1; CCND1; MAOB;	GO:0051412~response to corticosterone	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	CLDN18; TMEM98; MAGED1;	GO:1900181~negative regulation of protein localization to nucleus	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	WNT5A; HYAL2; NLRP10;	GO:2000484~positive regulation of interleukin-8 secretion	3	17	17.6470588235294	0.0224729383497784	0.0794148987011742	1	1	0.999998861753158	0.999998861753158	0.726896428651099
down	ADCY3; ATP2B4; PLTP; SORD; CCDC40; WDR66;	GO:0030317~flagellated sperm motility	6	66	9.09090909090909	0.0235739788729536	0.0797633924597321	1	1	0.999998861753158	0.999998861753158	0.730086244071706
up	EGFR; AIF1; HYAL1; LSM10; RGCC; ANXA1; CCND3;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	7	32	21.875	0.0236335344537616	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
down	MDK; ASIC1; EIF4G1; GRIK2;	GO:0001662~behavioral fear response	4	32	12.5	0.0241400760742991	0.0815227282458178	1	1	0.999998861753158	0.999998861753158	0.746189707283513
down	UQCRC1; MDH2; NDUFS8; COX6A1;	GO:0009060~aerobic respiration	4	32	12.5	0.0241400760742991	0.0815227282458178	1	1	0.999998861753158	0.999998861753158	0.746189707283513
down	ICAM1; GSTP1; CFL1; CPS1;	GO:0043200~response to amino acid	4	32	12.5	0.0241400760742991	0.0815227282458178	1	1	0.999998861753158	0.999998861753158	0.746189707283513
up	PIM1; GJA1; SNCA;	GO:0022898~regulation of transmembrane transporter activity	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	HCLS1; EVI2B; TESC;	GO:0030854~positive regulation of granulocyte differentiation	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	ISG15; UBE2E1; UBE2L6;	GO:0032020~ISG15-protein conjugation	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	CD3E; CCL5; SKAP1;	GO:0033634~positive regulation of cell-cell adhesion mediated by integrin	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	IL13RA2; CD300A; CD84;	GO:0043305~negative regulation of mast cell degranulation	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	CORO1A; VAMP2; UNC13D;	GO:0043320~natural killer cell degranulation	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	ZBTB7B; SASH3; NCKAP1L;	GO:0043372~positive regulation of CD4-positive, alpha-beta T cell differentiation	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	ANXA1; CD80; HLX;	GO:0045627~positive regulation of T-helper 1 cell differentiation	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	LYN; SPI1; B2M;	GO:0045646~regulation of erythrocyte differentiation	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	IFNG; PRF1; SYK;	GO:0051712~positive regulation of killing of cells of other organism	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	CLDN4; KCNQ1; HBB;	GO:0070293~renal absorption	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	PECAM1; PRTN3; JAML;	GO:0072672~neutrophil extravasation	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	EGFR; EGF; PTPN18;	GO:1901185~negative regulation of ERBB signaling pathway	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	HLA-G; LILRB1; TMEM176A;	GO:2001199~negative regulation of dendritic cell differentiation	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	DAPK2; PYCARD; STYXL1;	GO:2001242~regulation of intrinsic apoptotic signaling pathway	3	6	50	0.0246840981284224	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	RHOD; CLDN4; EGFR; EGF; CSF1R; LYN; VIL1; FGR; CCL5; MMP9; PECAM1; ITGAX; CORO1A; CCR1; CEACAM6; AIF1; TJP1; GRB7; GPNMB; CARMIL2; PLET1; FERMT3; FAM89B; PREX1; SUN2; PTP4A1; SEMA3A; SEMA4A;	GO:0030335~positive regulation of cell migration	28	226	12.3893805309735	0.0247450014731363	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	MFNG; TM4SF1; RPL7L1; WDR74; PTPN18;	GO:0001825~blastocyst formation	5	18	27.7777777777778	0.0248528622827608	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	FUT3; AFDN; CITED2; SIRPG; SIRPB1;	GO:0022409~positive regulation of cell-cell adhesion	5	18	27.7777777777778	0.0248528622827608	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	CEBPA; IRF8; ZBTB16; RASGRP4; KAT8;	GO:0030099~myeloid cell differentiation	5	18	27.7777777777778	0.0248528622827608	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	SELL; P2RX1; TRPC3; P2RX5; P2RX7;	GO:0033198~response to ATP	5	18	27.7777777777778	0.0248528622827608	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	FCHO1; AP2S1; FCHO2; CLTB; NSG1;	GO:0048268~clathrin coat assembly	5	18	27.7777777777778	0.0248528622827608	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	UBB; CLU; CCL5; EPHB1; DHCR24;	GO:1901214~regulation of neuron death	5	18	27.7777777777778	0.0248528622827608	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	IL2RA; HLA-DRB1; IL20RB; IL1RN; IL36RN; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	6	25	24	0.0249505524953596	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	WNT1; RAC2; RAC1; OCLN; CARMIL2; FRMD7;	GO:0010592~positive regulation of lamellipodium assembly	6	25	24	0.0249505524953596	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
up	SH2D1B; CCL5; CD1D; FPR2; ADAM8; TLR8;	GO:0045089~positive regulation of innate immune response	6	25	24	0.0249505524953596	0.358985524993841	1	1	0.999996350881189	0.999996350881189	1
down	GSN; BMP2; SRC; PLK1; ISOC2;	GO:0031648~protein destabilization	5	49	10.2040816326531	0.0250707118106984	0.0846116575559026	1	1	0.999998861753158	0.999998861753158	0.77446313859903
down	MELTF; HEPH; HEPHL1;	GO:0006826~iron ion transport	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
down	SCG5; ECE1; BACE2;	GO:0016486~peptide hormone processing	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
down	FUT1; DLX2; EXT1;	GO:0021772~olfactory bulb development	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
down	FSTL3; MAGI1; MYO10;	GO:0022409~positive regulation of cell-cell adhesion	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
down	RBFOX2; TADA3; CARM1;	GO:0030520~intracellular estrogen receptor signaling pathway	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
down	CEP290; BMP7; WLS;	GO:0030902~hindbrain development	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
down	CSF2; LTBR; DHRS2;	GO:0043011~myeloid dendritic cell differentiation	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
down	SLCO2B1; SLC16A2; SLCO2A1;	GO:0043252~sodium-independent organic anion transport	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
down	LGALS1; MAPK12; JAG1;	GO:0045445~myoblast differentiation	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
down	LOX; COMP; SGCB;	GO:0048747~muscle fiber development	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
down	RAPGEF3; ICAM1; SOX18;	GO:0061028~establishment of endothelial barrier	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
down	PRKACA; PKD1; RHBDF1;	GO:0061136~regulation of proteasomal protein catabolic process	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
down	INHBA; AACS; SMO;	GO:0071397~cellular response to cholesterol	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
down	SNTA1; NEDD4L; PKP2;	GO:0086005~ventricular cardiac muscle cell action potential	3	18	16.6666666666667	0.0256305214788941	0.0857369242152029	1	1	0.999998861753158	0.999998861753158	0.784762872393356
up	A2ML1; CST3; CSTA; CSTB; PROS1; PZP; PEBP1; SERPINB1; RARRES1; RENBP; ITIH3; BST2; CST6; PSMF1; PCSK1N; SERPINB13; SERPINB12; SERPINB5; TIMP2; SERPINA1;	GO:0010951~negative regulation of endopeptidase activity	20	148	13.5135135135135	0.0256361070413804	0.366627217567693	1	1	0.999996350881189	0.999996350881189	1
down	ACP5; NT5E; PTPRB; DUSP4; LPIN3; G6PC3; NT5DC2;	GO:0016311~dephosphorylation	7	87	8.04597701149425	0.0262080483238334	0.0876135385958163	1	1	0.999998861753158	0.999998861753158	0.801939804096765
down	APOC1; CYP2E1; CAV1; PCSK9;	GO:0006641~triglyceride metabolic process	4	33	12.1212121212121	0.0264247057588285	0.0880048931741889	1	1	0.999998861753158	0.999998861753158	0.80552193100252
down	TNFRSF10B; BAG3; FADD; DAB2IP;	GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors	4	33	12.1212121212121	0.0264247057588285	0.0880048931741889	1	1	0.999998861753158	0.999998861753158	0.80552193100252
down	LPAR1; F11R; ROBO1; NET1;	GO:0035025~positive regulation of Rho protein signal transduction	4	33	12.1212121212121	0.0264247057588285	0.0880048931741889	1	1	0.999998861753158	0.999998861753158	0.80552193100252
down	HSPA1B; AK4; VCP; FAM20C;	GO:0046034~ATP metabolic process	4	33	12.1212121212121	0.0264247057588285	0.0880048931741889	1	1	0.999998861753158	0.999998861753158	0.80552193100252
down	SAA1; CCL26; CX3CL1; CCL21;	GO:0048247~lymphocyte chemotaxis	4	33	12.1212121212121	0.0264247057588285	0.0880048931741889	1	1	0.999998861753158	0.999998861753158	0.80552193100252
down	IL1B; APP; SRC; IRAK1;	GO:0070555~response to interleukin-1	4	33	12.1212121212121	0.0264247057588285	0.0880048931741889	1	1	0.999998861753158	0.999998861753158	0.80552193100252
down	TGFB1I1; ONECUT2; CAV2; CAV1; HTRA1; GLG1;	GO:0030512~negative regulation of transforming growth factor beta receptor signaling pathway	6	68	8.82352941176471	0.0265617852527988	0.0884058916574636	1	1	0.999998861753158	0.999998861753158	0.809192330010189
up	ARRB1; RAC1; ABRA; GPR55; GPR174; GPR65; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	7	33	21.2121212121212	0.0268604347217145	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
down	TGFB2; TSPAN5; JAG1; TP63; JAG2;	GO:0045747~positive regulation of Notch signaling pathway	5	50	10	0.0269008561886537	0.089366127513936	1	1	0.999998861753158	0.999998861753158	0.817981512218416
down	PTN; HRH1; CX3CL1; CDK5; YWHAH;	GO:0048167~regulation of synaptic plasticity	5	50	10	0.0269008561886537	0.089366127513936	1	1	0.999998861753158	0.999998861753158	0.817981512218416
down	DVL1; DGKI; ADORA2B; PFN2; NCS1;	GO:2000300~regulation of synaptic vesicle exocytosis	5	50	10	0.0269008561886537	0.089366127513936	1	1	0.999998861753158	0.999998861753158	0.817981512218416
up	FBP1; TALDO1; HK2; HK3;	GO:0006002~fructose 6-phosphate metabolic process	4	12	33.3333333333333	0.0271219368970126	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	SULT1C4; ALDH3B1; ALDH3B2; SULT1A1;	GO:0006068~ethanol catabolic process	4	12	33.3333333333333	0.0271219368970126	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	CD4; TRPC3; P2RX5; P2RX7;	GO:0010524~positive regulation of calcium ion transport into cytosol	4	12	33.3333333333333	0.0271219368970126	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	CAPN3; TMOD1; LMOD3; LMOD2;	GO:0030239~myofibril assembly	4	12	33.3333333333333	0.0271219368970126	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	FOS; OXT; PTGDR; IL18;	GO:0030431~sleep	4	12	33.3333333333333	0.0271219368970126	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	MEFV; JAK3; SLAMF1; TIGIT;	GO:0032695~negative regulation of interleukin-12 production	4	12	33.3333333333333	0.0271219368970126	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	WNT1; BID; GRB2; CEP63;	GO:0042770~signal transduction in response to DNA damage	4	12	33.3333333333333	0.0271219368970126	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	APOB; PRKCB; CD36; UNC119;	GO:0042953~lipoprotein transport	4	12	33.3333333333333	0.0271219368970126	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	CCL4; CCL5; INPP5K; POU2F3;	GO:0043922~negative regulation by host of viral transcription	4	12	33.3333333333333	0.0271219368970126	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	JAK3; GPNMB; TIGIT; TNFAIP8L2;	GO:0050868~negative regulation of T cell activation	4	12	33.3333333333333	0.0271219368970126	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	PDE6B; RYR2; CDH23; CALCB; CALCA; TRPC5; TRPC3; CALB2;	GO:0051480~regulation of cytosolic calcium ion concentration	8	41	19.5121951219512	0.027341532777698	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
down	WFS1; FLNA; MAP3K10; GAS6; GLIS2; FOXA2;	GO:0043433~negative regulation of DNA-binding transcription factor activity	6	69	8.69565217391304	0.0281455478928729	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	FKBP1A; SIX1; TBC1D1; DZIP1L; SIX4;	GO:0032880~regulation of protein localization	5	51	9.80392156862745	0.0288138664670023	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
up	PLA2G4B; PLA2G4A; PLA2G4F; PLBD1; MBOAT2; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	6	26	23.0769230769231	0.0288296966950331	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
down	LRP1; ANO1; TRPM4; PHPT1;	GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus	4	34	11.7647058823529	0.0288344716816574	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	TNFRSF10B; BAK1; DAB2IP; ERN2;	GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	4	34	11.7647058823529	0.0288344716816574	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	GYS1; AKT1; PGM1;	GO:0005978~glycogen biosynthetic process	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	GRN; LRP1; PCSK9;	GO:0007041~lysosomal transport	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	DIAPH2; CGB7; C17orf53;	GO:0007292~female gamete generation	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	DLX2; DLX1; SCRIB;	GO:0009790~embryo development	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	PLTP; CAV1; LRP1;	GO:0010875~positive regulation of cholesterol efflux	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	ACTN4; MYO1D; MYO1C;	GO:0030050~vesicle transport along actin filament	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	PFN2; FHOD3; KANK3;	GO:0030837~negative regulation of actin filament polymerization	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	PTN; AKT1; TENM4;	GO:0031641~regulation of myelination	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	PLOD3; NOS1; CPS1;	GO:0042311~vasodilation	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	CA2; TF; SPP1;	GO:0045780~positive regulation of bone resorption	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	PLK1; FADD; BAK1;	GO:0045862~positive regulation of proteolysis	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	LAMA5; LAMA1; LAMA3;	GO:0045995~regulation of embryonic development	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	ITGB1; VCAM1; MADCAM1;	GO:0050901~leukocyte tethering or rolling	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	COMP; DCTN1; HOXC10;	GO:0050905~neuromuscular process	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	UNC13B; SERPINE2; ISL1;	GO:0060384~innervation	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	ADCY6; GCLM; FOXC2;	GO:0097746~regulation of blood vessel diameter	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	CAPN2; CXCL9; EHD2;	GO:1901741~positive regulation of myoblast fusion	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
down	MMP14; CDK5; ZDHHC2;	GO:1903076~regulation of protein localization to plasma membrane	3	19	15.7894736842105	0.0290131404651073	0.0924298950123505	1	1	0.999998861753158	0.999998861753158	0.846024633713726
up	SULT2B1; PTGES; IRF6; KLF4; CBFA2T3; NEURL1; GJB6; CSF1R; LYN; ADORA3; IRF1; IFITM1; OSM; TIMP2; CD33; DUSP1; TNFRSF8; ADORA2A; PTPN6; AVPR2; SSTR3; ADM; CDKN2B; CEBPA; RARRES1; MXI1; SLURP1; CDKN2D; BTG1; BTG2; ZBTB16; FGFBP1; GPNMB; DHCR24; BNIPL; RASSF5; HIST1H2AC; TESC; TSPAN32; CGRRF1; RGCC; SIRPG; PIM2; NUPR1;	GO:0008285~negative regulation of cell population proliferation	44	396	11.1111111111111	0.0293351061907204	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	AQP9; EGFR; MAP7; NOLC1; TSC22D3;	GO:0006970~response to osmotic stress	5	19	26.3157894736842	0.0295192738258975	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	MYO5B; MYO1F; MYO1G; MYO7B; MYO6;	GO:0030050~vesicle transport along actin filament	5	19	26.3157894736842	0.0295192738258975	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	CST7; S100B; TNFRSF1B; ITGAX; RNF10;	GO:0031643~positive regulation of myelination	5	19	26.3157894736842	0.0295192738258975	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	IL2RA; CD74; CD27; ZAP70; IL36B;	GO:0045582~positive regulation of T cell differentiation	5	19	26.3157894736842	0.0295192738258975	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	SELL; SPN; ITGB7; CX3CR1; SELPLG;	GO:0050901~leukocyte tethering or rolling	5	19	26.3157894736842	0.0295192738258975	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	TLR4; IL17RA; MYD88; TLR6; GPSM3;	GO:1900017~positive regulation of cytokine production involved in inflammatory response	5	19	26.3157894736842	0.0295192738258975	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
up	EGFR; EGF; VIL1; BTC; GRB2; GAB1; GRB7; FAM83B; EPGN;	GO:0007173~epidermal growth factor receptor signaling pathway	9	50	18	0.0297823363715313	0.36912894449096	1	1	0.999996350881189	0.999996350881189	1
down	CCNK; POU2F2; POLR2E; TAF6; POLR2L; INTS1;	GO:0042795~snRNA transcription by RNA polymerase II	6	70	8.57142857142857	0.0297902813161515	0.0930748801050295	1	1	0.999998861753158	0.999998861753158	0.851928278597361
down	EGR2; IL11; CCND1; GRK5; HMGA2; WNT5B;	GO:0045444~fat cell differentiation	6	70	8.57142857142857	0.0297902813161515	0.0930748801050295	1	1	0.999998861753158	0.999998861753158	0.851928278597361
up	CLDN4; FOS; OXT; PTGER2; YAP1; DSG1; CATSPER1; TXNIP;	GO:0032570~response to progesterone	8	42	19.047619047619	0.0304944473624297	0.372204719991815	1	1	0.999996350881189	0.999996350881189	1
up	NEURL1; EGFR; EGF; ARRB1; NRARP; ARRDC1; CHAC1; NOTCH3;	GO:0045746~negative regulation of Notch signaling pathway	8	42	19.047619047619	0.0304944473624297	0.372204719991815	1	1	0.999996350881189	0.999996350881189	1
up	IRF6; KLF4; TRIM16; EOMES; EGFR; FOS; MYC; EGF; CD4; HLA-DRB1; CD74; WNT1; IRF1; PIM1; LYL1; NCF1; SPI1; TFEB; CAPN3; HNF1A; CD80; CD86; MAP2K3; YAP1; TNNI2; SOX8; CNBP; RHOG; ID2; CREB5; POU3F1; ZBTB16; FOXC1; KLF1; RUNX3; NOLC1; IRF4; NFE2; PHF5A; CASZ1; SKAP1; RNF10; ARNTL2; TESC; MED30; DNAJC2; NPAS2; CITED2; INPP5K; PITHD1; TFB2M; KAT8; EHF; CXXC1; PIM2; TBX21; USP16; KLF2; ABRA; SS18L2;	GO:0045893~positive regulation of transcription, DNA-templated	60	570	10.5263157894737	0.0310809109564639	0.378390167234079	1	1	0.999996350881189	0.999996350881189	1
down	PHB; MIER2; HDAC11; MTA1;	GO:0016575~histone deacetylation	4	35	11.4285714285714	0.0313703384160711	0.0977810313239323	1	1	0.999998861753158	0.999998861753158	0.895004383580945
down	NMU; EIF4G1; MFSD2A; MRAP2;	GO:0097009~energy homeostasis	4	35	11.4285714285714	0.0313703384160711	0.0977810313239323	1	1	0.999998861753158	0.999998861753158	0.895004383580945
down	ANO1; PIEZO1; ATP13A2; ANO10;	GO:0098655~cation transmembrane transport	4	35	11.4285714285714	0.0313703384160711	0.0977810313239323	1	1	0.999998861753158	0.999998861753158	0.895004383580945
down	APP; AKT1; MICALL1; NTRK2;	GO:1990090~cellular response to nerve growth factor stimulus	4	35	11.4285714285714	0.0313703384160711	0.0977810313239323	1	1	0.999998861753158	0.999998861753158	0.895004383580945
down	BMP1; SOX9; PKD1;	GO:0001502~cartilage condensation	3	20	15	0.0326195757405651	0.101139760571039	1	1	0.999998861753158	0.999998861753158	0.925747334015401
down	NRP1; SEMA5A; NDN;	GO:0007413~axonal fasciculation	3	20	15	0.0326195757405651	0.101139760571039	1	1	0.999998861753158	0.999998861753158	0.925747334015401
down	HOXC11; LAMC1; EXT1;	GO:0007492~endoderm development	3	20	15	0.0326195757405651	0.101139760571039	1	1	0.999998861753158	0.999998861753158	0.925747334015401
down	ERCC1; CCND1; IKBIP;	GO:0010165~response to X-ray	3	20	15	0.0326195757405651	0.101139760571039	1	1	0.999998861753158	0.999998861753158	0.925747334015401
down	GSTP1; GAS6; CCDC3;	GO:0010804~negative regulation of tumor necrosis factor-mediated signaling pathway	3	20	15	0.0326195757405651	0.101139760571039	1	1	0.999998861753158	0.999998861753158	0.925747334015401
down	PDGFA; CYFIP1; PARVA;	GO:0030031~cell projection assembly	3	20	15	0.0326195757405651	0.101139760571039	1	1	0.999998861753158	0.999998861753158	0.925747334015401
down	SRC; PTN; HAS2;	GO:0036120~cellular response to platelet-derived growth factor stimulus	3	20	15	0.0326195757405651	0.101139760571039	1	1	0.999998861753158	0.999998861753158	0.925747334015401
down	"NAGLU; NKX3-2; SIX1;"	GO:0042474~middle ear morphogenesis	3	20	15	0.0326195757405651	0.101139760571039	1	1	0.999998861753158	0.999998861753158	0.925747334015401
down	CDH2; SHANK3; SHANK2;	GO:0048854~brain morphogenesis	3	20	15	0.0326195757405651	0.101139760571039	1	1	0.999998861753158	0.999998861753158	0.925747334015401
down	ERBB2; EGR2; MAL; LPAR1; MARVELD1;	GO:0042552~myelination	5	53	9.43396226415094	0.0328922102665192	0.10192548149216	1	1	0.999998861753158	0.999998861753158	0.932939154956058
up	PLA2G4B; PLA2G4A; CYP4F3; MGLL; ALOX5; CYP2D7;	GO:0019369~arachidonic acid metabolic process	6	27	22.2222222222222	0.033084907558915	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
down	INHBA; CX3CL1; HSF1; MST1R; CXCL9; DUOX2;	GO:0006952~defense response	6	72	8.33333333333333	0.0332655850934453	0.103022273461126	1	1	0.999998861753158	0.999998861753158	0.942978255656982
up	CD74; CCR7; SLC11A1;	GO:0002606~positive regulation of dendritic cell antigen processing and presentation	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	SKAP1; PYCARD; SASH3;	GO:0002821~positive regulation of adaptive immune response	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	VNN1; VNN2; VNN3;	GO:0015939~pantothenate metabolic process	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	ACSL1; ADIPOR2; ADIPOR1;	GO:0033211~adiponectin-activated signaling pathway	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	TLR4; CD14; LY96;	GO:0034128~negative regulation of MyD88-independent toll-like receptor signaling pathway	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	IL18RAP; ALOX5; IL18;	GO:0035655~interleukin-18-mediated signaling pathway	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	RGS14; RPS6KA1; BCLAF1;	GO:0043620~regulation of DNA-templated transcription in response to stress	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	CD74; NRARP; DTX1;	GO:0045581~negative regulation of T cell differentiation	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	FMNL1; VIL1; DSTN;	GO:0051014~actin filament severing	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	SLC4A1; GZMA; GZMK;	GO:0051354~negative regulation of oxidoreductase activity	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	S100B; FECH; ANK2;	GO:0051597~response to methylmercury	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	TMOD1; LMOD3; LMOD2;	GO:0051694~pointed-end actin filament capping	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	RNF113A; CCL5; PADI2;	GO:0070100~negative regulation of chemokine-mediated signaling pathway	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	CCL5; PDCD1; PRELID1;	GO:0070234~positive regulation of T cell apoptotic process	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	ARPC3; NCKAP1L; ENAH;	GO:0070358~actin polymerization-dependent cell motility	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	FBP1; SLFN14; SMPD3;	GO:0071286~cellular response to magnesium ion	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	KLF4; ASS1; KLF2;	GO:0071499~cellular response to laminar fluid shear stress	3	7	42.8571428571429	0.0333415455795667	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	PES1; RPF2; RPL7L1; RPL35;	GO:0000463~maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	4	13	30.7692307692308	0.0334262818529172	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	CST3; APOB; LYN; ME1;	GO:0009743~response to carbohydrate	4	13	30.7692307692308	0.0334262818529172	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	FLT4; FLT3; FOXC1; GAB1;	GO:0038084~vascular endothelial growth factor signaling pathway	4	13	30.7692307692308	0.0334262818529172	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	XKR8; RHOG; RAC1; RAC2;	GO:0043652~engulfment of apoptotic cell	4	13	30.7692307692308	0.0334262818529172	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
up	SRD5A1; SNCA; KCNQ1; RYR2;	GO:0071872~cellular response to epinephrine stimulus	4	13	30.7692307692308	0.0334262818529172	0.384280838347823	1	1	0.999996350881189	0.999996350881189	1
down	C1R; C3; CFI; CFH; C1S; CD59; CD81; SUSD4;	GO:0030449~regulation of complement activation	8	113	7.07964601769912	0.0339114498408584	0.104961183336971	1	1	0.999998861753158	0.999998861753158	0.960725387332254
up	EGFR; EGF; PTPN3; BTC; GRB2; EPGN; ERRFI1;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	7	35	20	0.0341838198380557	0.392040523166881	1	1	0.999996350881189	0.999996350881189	1
down	MYO1C; SRC; VAV2; ACTG1; DOCK1; CYFIP1; ARPC1A; MYO10; WASF2;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	9	135	6.66666666666667	0.0346949720670041	0.107323653383463	1	1	0.999998861753158	0.999998861753158	0.982349428509367
down	ERCC1; ERCC2; POLR2E; POLD2; POLR2L; COPS6;	GO:0006283~transcription-coupled nucleotide-excision repair	6	73	8.21917808219178	0.0350975030175248	0.108505516617444	1	1	0.999998861753158	0.999998861753158	0.993167199204604
down	CD34; SOX9; BARD1;	GO:0001894~tissue homeostasis	3	21	14.2857142857143	0.0364479892333529	0.108810382272093	1	1	0.999998861753158	0.999998861753158	0.995957680074152
down	ERCC1; PARP1; ERCC2;	GO:0006293~nucleotide-excision repair, preincision complex stabilization	3	21	14.2857142857143	0.0364479892333529	0.108810382272093	1	1	0.999998861753158	0.999998861753158	0.995957680074152
down	BCAT2; IVD; HIBCH;	GO:0009083~branched-chain amino acid catabolic process	3	21	14.2857142857143	0.0364479892333529	0.108810382272093	1	1	0.999998861753158	0.999998861753158	0.995957680074152
down	TGFB2; CAMSAP3; USP22;	GO:0009792~embryo development ending in birth or egg hatching	3	21	14.2857142857143	0.0364479892333529	0.108810382272093	1	1	0.999998861753158	0.999998861753158	0.995957680074152
down	MDK; HSF1; SFRP2;	GO:0010667~negative regulation of cardiac muscle cell apoptotic process	3	21	14.2857142857143	0.0364479892333529	0.108810382272093	1	1	0.999998861753158	0.999998861753158	0.995957680074152
down	GOT2; ITGA2; POSTN;	GO:0014850~response to muscle activity	3	21	14.2857142857143	0.0364479892333529	0.108810382272093	1	1	0.999998861753158	0.999998861753158	0.995957680074152
down	LAMP1; PVR; NECTIN2;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	3	21	14.2857142857143	0.0364479892333529	0.108810382272093	1	1	0.999998861753158	0.999998861753158	0.995957680074152
down	OBSL1; CUL7; FBXW8;	GO:0050775~positive regulation of dendrite morphogenesis	3	21	14.2857142857143	0.0364479892333529	0.108810382272093	1	1	0.999998861753158	0.999998861753158	0.995957680074152
down	ADCY9; ADRA1D; ADRA1B;	GO:0071880~adenylate cyclase-activating adrenergic receptor signaling pathway	3	21	14.2857142857143	0.0364479892333529	0.108810382272093	1	1	0.999998861753158	0.999998861753158	0.995957680074152
down	LRP5; AKT1; DAB2IP;	GO:0071901~negative regulation of protein serine/threonine kinase activity	3	21	14.2857142857143	0.0364479892333529	0.108810382272093	1	1	0.999998861753158	0.999998861753158	0.995957680074152
down	DVL1; CAV1; FZD2;	GO:1904886~beta-catenin destruction complex disassembly	3	21	14.2857142857143	0.0364479892333529	0.108810382272093	1	1	0.999998861753158	0.999998861753158	0.995957680074152
down	SHANK2; SHANK3; SHISA9;	GO:2000311~regulation of AMPA receptor activity	3	21	14.2857142857143	0.0364479892333529	0.108810382272093	1	1	0.999998861753158	0.999998861753158	0.995957680074152
down	ERCC1; PARP1; ERCC2; POLD2;	GO:0006296~nucleotide-excision repair, DNA incision, 5'-to lesion	4	37	10.8108108108108	0.0368231409589148	0.109744965353663	1	1	0.999998861753158	0.999998861753158	1
down	FN1; SAA1; SAA2; APOL2;	GO:0006953~acute-phase response	4	37	10.8108108108108	0.0368231409589148	0.109744965353663	1	1	0.999998861753158	0.999998861753158	1
down	HSPA1B; FKBP1A; FKBP1B; PPIC;	GO:0042026~protein refolding	4	37	10.8108108108108	0.0368231409589148	0.109744965353663	1	1	0.999998861753158	0.999998861753158	1
up	HSPB1; LYN; CADM4; ROPN1L; ROPN1B; TLR8; SMPD3; TLR7;	GO:0001932~regulation of protein phosphorylation	8	44	18.1818181818182	0.0375280172351796	0.427297424059072	1	1	0.999996350881189	0.999996350881189	1
up	NUPR1; MYC; LTA; PARP10; CD300A; MED31;	GO:0048147~negative regulation of fibroblast proliferation	6	28	21.4285714285714	0.0377265898280936	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	ATP6V0E1; ATP6V1G1; TCIRG1; ATP6V1F; ATP6V1C2; ATP6V0E2; ATP6V0B;	GO:0033572~transferrin transport	7	36	19.4444444444444	0.0382975249729405	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	LCK; CSF1R; FLT3; CCR2; ZBTB16; CIAPIN1; GLRX5; AHSP; RUNX3;	GO:0030097~hemopoiesis	9	53	16.9811320754717	0.0394645964604672	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
down	CCNB1; PCBP4; CARM1; E2F7; ZNF385A;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	5	56	8.92857142857143	0.0396520903539824	0.118109765762256	1	1	0.999998861753158	0.999998861753158	1
down	ERCC1; PARP1; ERCC2; POLD2;	GO:0033683~nucleotide-excision repair, DNA incision	4	38	10.5263157894737	0.0397409293024495	0.11817521433628	1	1	0.999998861753158	0.999998861753158	1
down	TERT; AKT1; GPC3; ITLN1;	GO:0046326~positive regulation of glucose import	4	38	10.5263157894737	0.0397409293024495	0.11817521433628	1	1	0.999998861753158	0.999998861753158	1
down	CAV1; DSG2; TRPM4; PKP2;	GO:0086091~regulation of heart rate by cardiac conduction	4	38	10.5263157894737	0.0397409293024495	0.11817521433628	1	1	0.999998861753158	0.999998861753158	1
up	SRD5A1; CAPN3; TOMM20; METRNL; RYR2;	GO:0014850~response to muscle activity	5	21	23.8095238095238	0.0404125566249611	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	CLU; PPIF; BCL2L1; BCL2L2; PRELID1;	GO:0090201~negative regulation of release of cytochrome c from mitochondria	5	21	23.8095238095238	0.0404125566249611	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
down	CAPN2; NOS1; MYH9;	GO:0007520~myoblast fusion	3	22	13.6363636363636	0.040495978321945	0.119615418976575	1	1	0.999998861753158	0.999998861753158	1
down	NR2F2; STC1; DAB2IP;	GO:0010596~negative regulation of endothelial cell migration	3	22	13.6363636363636	0.040495978321945	0.119615418976575	1	1	0.999998861753158	0.999998861753158	1
down	ZDHHC2; ZDHHC12; ZDHHC1;	GO:0018230~peptidyl-L-cysteine S-palmitoylation	3	22	13.6363636363636	0.040495978321945	0.119615418976575	1	1	0.999998861753158	0.999998861753158	1
down	CSF2; CSF1; PARP1;	GO:0030225~macrophage differentiation	3	22	13.6363636363636	0.040495978321945	0.119615418976575	1	1	0.999998861753158	0.999998861753158	1
down	GPR143; SHROOM2; RAB38;	GO:0032438~melanosome organization	3	22	13.6363636363636	0.040495978321945	0.119615418976575	1	1	0.999998861753158	0.999998861753158	1
down	CYP1A1; ERCC1; PPP1R9B;	GO:0035902~response to immobilization stress	3	22	13.6363636363636	0.040495978321945	0.119615418976575	1	1	0.999998861753158	0.999998861753158	1
down	PRDX2; CD151; FKBP1B;	GO:0042098~T cell proliferation	3	22	13.6363636363636	0.040495978321945	0.119615418976575	1	1	0.999998861753158	0.999998861753158	1
down	CCNF; CCND1; CCNB1;	GO:0044772~mitotic cell cycle phase transition	3	22	13.6363636363636	0.040495978321945	0.119615418976575	1	1	0.999998861753158	0.999998861753158	1
down	AGR2; AKT1; AFAP1L2;	GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway	3	22	13.6363636363636	0.040495978321945	0.119615418976575	1	1	0.999998861753158	0.999998861753158	1
down	SERPINE2; AKT1; CDK5;	GO:0045861~negative regulation of proteolysis	3	22	13.6363636363636	0.040495978321945	0.119615418976575	1	1	0.999998861753158	0.999998861753158	1
down	CACNB3; CAV1; PRKCZ;	GO:0051899~membrane depolarization	3	22	13.6363636363636	0.040495978321945	0.119615418976575	1	1	0.999998861753158	0.999998861753158	1
down	FLNA; MDK; CTSZ;	GO:2000179~positive regulation of neural precursor cell proliferation	3	22	13.6363636363636	0.040495978321945	0.119615418976575	1	1	0.999998861753158	0.999998861753158	1
up	ATP6V0E1; SLC11A1; ATP6V0E2; TCIRG1;	GO:0007035~vacuolar acidification	4	14	28.5714285714286	0.0405115040244246	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	MEFV; CD33; CX3CR1; ERRFI1;	GO:0032691~negative regulation of interleukin-1 beta production	4	14	28.5714285714286	0.0405115040244246	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	APOB; MPO; CETP; ABCG1;	GO:0034374~low-density lipoprotein particle remodeling	4	14	28.5714285714286	0.0405115040244246	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	CD33; LILRB2; LILRB1; INPP5K;	GO:0051926~negative regulation of calcium ion transport	4	14	28.5714285714286	0.0405115040244246	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	TRMT10C; METTL16; TRMT61A; TRMT6;	GO:0080009~mRNA methylation	4	14	28.5714285714286	0.0405115040244246	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	ITGB2; MME; ITGAM; MARCO;	GO:0097242~amyloid-beta clearance	4	14	28.5714285714286	0.0405115040244246	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	GJA1; TJP1; OCLN; GPBAR1;	GO:2000810~regulation of bicellular tight junction assembly	4	14	28.5714285714286	0.0405115040244246	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	RHOD; LCP1; AIF1; RND1; RHOF; AIF1L; RND3; PLS3;	GO:0051017~actin filament bundle assembly	8	45	17.7777777777778	0.0414214396005198	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	ALPL; CYBA; CCL5; CEBPA; RAE1; KLF5; IL18; PLA2G4F;	GO:0071407~cellular response to organic cyclic compound	8	45	17.7777777777778	0.0414214396005198	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
down	G0S2; GATM; MFAP2; HSF1; CAV1; DYNC1H1; PDGFC;	GO:0120162~positive regulation of cold-induced thermogenesis	7	97	7.21649484536082	0.0419927767296961	0.123967540212054	1	1	0.999998861753158	0.999998861753158	1
up	CASQ2; ATP6V0E1; ATP10A; ATP2C2; ATP6V1G1; ATP1B1; GJA1; SCNN1A; ATP12A; TCIRG1; SLC12A1; ATP6V1F; ATP13A4; TMC6; TMC8; ATP6V1C2; ATP6V0E2; RYR2; ATP2A3; ATP6V0B; TSC22D3; TMEM109; FXYD6; CHRNA2; GABRE;	GO:0034220~ion transmembrane transport	25	208	12.0192307692308	0.0425920589912118	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	TLR4; IFNG; AIF1; IL16; IL1RAP; TLR8; PYCARD;	GO:2000778~positive regulation of interleukin-6 secretion	7	37	18.9189189189189	0.0427223911026441	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	ALPL; FGFR3; FOXC1; TMEM119; PHOSPHO1; SMPD3;	GO:0001958~endochondral ossification	6	29	20.6896551724138	0.0427633840573119	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	TLR4; PGLYRP1; HLA-DRB1; IL20RB; LILRB1; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	6	29	20.6896551724138	0.0427633840573119	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	EGFR; TIMP2; PTPN3; FOXC1; BTG2; BTG1;	GO:0045930~negative regulation of mitotic cell cycle	6	29	20.6896551724138	0.0427633840573119	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	FTL; EPB42; SLC11A1; B2M; STEAP4; SLC25A37;	GO:0055072~iron ion homeostasis	6	29	20.6896551724138	0.0427633840573119	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	EGFR; EGF; FES; ERBB3; BTC; CADM4;	GO:2000145~regulation of cell motility	6	29	20.6896551724138	0.0427633840573119	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
down	RGS12; RGS5; PTPN1; ACVR1;	GO:0009968~negative regulation of signal transduction	4	39	10.2564102564103	0.0427865344814697	0.124838728848927	1	1	0.999998861753158	0.999998861753158	1
down	WTIP; ITGB1; AKT1; RAB34;	GO:0030030~cell projection organization	4	39	10.2564102564103	0.0427865344814697	0.124838728848927	1	1	0.999998861753158	0.999998861753158	1
down	PDGFB; AKT1; VEGFC; AMOTL1;	GO:0043536~positive regulation of blood vessel endothelial cell migration	4	39	10.2564102564103	0.0427865344814697	0.124838728848927	1	1	0.999998861753158	0.999998861753158	1
down	HSBP1; BAG3; HSPA1B; SEC13; HSF1; AKT1S1;	GO:1900034~regulation of cellular response to heat	6	77	7.79220779220779	0.0430671443699165	0.124838728848927	1	1	0.999998861753158	0.999998861753158	1
up	PALM3; SIGIRR; IL36RN;	GO:0001960~negative regulation of cytokine-mediated signaling pathway	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	ATP1B1; ANK2; RYR2;	GO:0010882~regulation of cardiac muscle contraction by calcium ion signaling	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	APOA5; ABHD5; PNPLA2;	GO:0010898~positive regulation of triglyceride catabolic process	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	CCR5; RYR2; TMEM38A;	GO:0014808~release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	FOLR3; SLC19A1; SLC25A32;	GO:0015884~folic acid transport	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	ISG15; UBA52; UBB;	GO:0019941~modification-dependent protein catabolic process	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	ZG16; IL18RAP; IL18;	GO:0032635~interleukin-6 production	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	HLA-E; IL18; IL23A;	GO:0032819~positive regulation of natural killer cell proliferation	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	P2RX1; P2RX5; P2RX7;	GO:0035590~purinergic nucleotide receptor signaling pathway	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	PNPLA2; DGAT2; MGLL;	GO:0036155~acylglycerol acyl-chain remodeling	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	CD36; ACSL1; SPX;	GO:0044539~long-chain fatty acid import into cell	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	CSF1R; PRTN3; PARD6A;	GO:0045217~cell-cell junction maintenance	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	TLR4; TLR8; TLR7;	GO:0045359~positive regulation of interferon-beta biosynthetic process	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	PRKCB; NFAM1; CMTM3;	GO:0050861~positive regulation of B cell receptor signaling pathway	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	ARHGAP25; CGNL1; SH3BP1;	GO:0051058~negative regulation of small GTPase mediated signal transduction	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	CARMIL2; PLS3; LCP1;	GO:0051639~actin filament network formation	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	PTAFR; SNCA; CD244;	GO:0060732~positive regulation of inositol phosphate biosynthetic process	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	CCL5; CD27; SLC46A2;	GO:0070233~negative regulation of T cell apoptotic process	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	PLA2G4A; CRIP1; PLA2G4F;	GO:0071236~cellular response to antibiotic	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	MAPK10; RCSD1; ERRFI1;	GO:0071474~cellular hyperosmotic response	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	MME; CRIP1; HYAL1;	GO:0071493~cellular response to UV-B	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	AQP9; SLC14A1; AQP10;	GO:0071918~urea transmembrane transport	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	NSG1; MAPK10; RAB11A;	GO:0099003~vesicle-mediated transport in synapse	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	B2M; ADAM15; ATP2A3;	GO:1900121~negative regulation of receptor binding	3	8	37.5	0.0433574244946957	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
down	SLC16A3; GLO1; PC;	GO:0006090~pyruvate metabolic process	3	23	13.0434782608696	0.0447606266044756	0.128073849032342	1	1	0.999998861753158	0.999998861753158	1
down	ERCC1; PARP1; ERCC2;	GO:0006295~nucleotide-excision repair, DNA incision, 3'-to lesion	3	23	13.0434782608696	0.0447606266044756	0.128073849032342	1	1	0.999998861753158	0.999998861753158	1
down	LLGL1; STEAP2; EXOC5;	GO:0006893~Golgi to plasma membrane transport	3	23	13.0434782608696	0.0447606266044756	0.128073849032342	1	1	0.999998861753158	0.999998861753158	1
down	AKT1; MFSD2A; SLC35C1;	GO:0008643~carbohydrate transport	3	23	13.0434782608696	0.0447606266044756	0.128073849032342	1	1	0.999998861753158	0.999998861753158	1
down	PIP5K1C; CEACAM1; CRNN;	GO:0014066~regulation of phosphatidylinositol 3-kinase signaling	3	23	13.0434782608696	0.0447606266044756	0.128073849032342	1	1	0.999998861753158	0.999998861753158	1
down	CYP7B1; CYP11A1; CYP39A1;	GO:0016125~sterol metabolic process	3	23	13.0434782608696	0.0447606266044756	0.128073849032342	1	1	0.999998861753158	0.999998861753158	1
down	ARHGDIA; KANK2; EPS8L2;	GO:0035023~regulation of Rho protein signal transduction	3	23	13.0434782608696	0.0447606266044756	0.128073849032342	1	1	0.999998861753158	0.999998861753158	1
down	PTN; MDK; TENM4;	GO:0048714~positive regulation of oligodendrocyte differentiation	3	23	13.0434782608696	0.0447606266044756	0.128073849032342	1	1	0.999998861753158	0.999998861753158	1
down	GSTP1; STC1; ISL1;	GO:0071385~cellular response to glucocorticoid stimulus	3	23	13.0434782608696	0.0447606266044756	0.128073849032342	1	1	0.999998861753158	0.999998861753158	1
down	TBX3; HRAS; CALR;	GO:0090398~cellular senescence	3	23	13.0434782608696	0.0447606266044756	0.128073849032342	1	1	0.999998861753158	0.999998861753158	1
down	MMP12; MAPK11; GBF1;	GO:0098586~cellular response to virus	3	23	13.0434782608696	0.0447606266044756	0.128073849032342	1	1	0.999998861753158	0.999998861753158	1
down	SRC; MAPK8IP1; IVNS1ABP;	GO:2001243~negative regulation of intrinsic apoptotic signaling pathway	3	23	13.0434782608696	0.0447606266044756	0.128073849032342	1	1	0.999998861753158	0.999998861753158	1
up	ITGB3; ITGB2; ITGA2B; ITGAM; ICAM2; PECAM1; ITGAL; ITGAX; COL9A1; ITGB7; ITGB8; SERPINB5; MFAP5; ADAM15; COL9A3; COL9A2; COL19A1; OLFML2A; MPZL3; ADAMTSL4; SPINK5; MMP25; MMP10; MMP1; MMP9; MMP3; COLQ;	GO:0030198~extracellular matrix organization	27	230	11.7391304347826	0.0452653957569784	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
down	PTPRF; PTPN1; PTPRG; DUSP4; PTPRK; PTPN21; PTPRU;	GO:0035335~peptidyl-tyrosine dephosphorylation	7	99	7.07070707070707	0.0457543723665954	0.130846646325614	1	1	0.999998861753158	0.999998861753158	1
down	KIF3C; KIF3B; WDR34; IFT22;	GO:0035735~intraciliary transport involved in cilium assembly	4	40	10	0.0459598772146004	0.131363487327122	1	1	0.999998861753158	0.999998861753158	1
up	CA1; CA6; AHCY; ALDH1L2; GNMT;	GO:0006730~one-carbon metabolic process	5	22	22.7272727272727	0.0466588476299002	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	TNFSF14; CCND3; PSMB10; P2RX7; IL23A;	GO:0042098~T cell proliferation	5	22	22.7272727272727	0.0466588476299002	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	MMP9; PTK6; SHKBP1; DOK1; PDE6G;	GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway	5	22	22.7272727272727	0.0466588476299002	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
down	APP; EGR2; PRKAR1B; GATM; ZNF385A;	GO:0007611~learning or memory	5	59	8.47457627118644	0.0471963316144549	0.132422872195076	1	1	0.999998861753158	0.999998861753158	1
down	TF; BMP2; BMP7; TGFB2; INHBA;	GO:0060395~SMAD protein signal transduction	5	59	8.47457627118644	0.0471963316144549	0.132422872195076	1	1	0.999998861753158	0.999998861753158	1
down	ANXA4; BMP7; PRDX2; DAP; IRAK1; DAB2IP;	GO:0032088~negative regulation of NF-kappaB transcription factor activity	6	79	7.59493670886076	0.0474437566511947	0.132422872195076	1	1	0.999998861753158	0.999998861753158	1
up	LRMP; STX19; DYSF; STX10; STX16-NPEPL1; STX11; VAMP2;	GO:0006906~vesicle fusion	7	38	18.4210526315789	0.0474644716660213	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	PECAM1; AFDN; OCLN; GRHL2; POF1B; CRB3; PARD6A;	GO:0070830~bicellular tight junction assembly	7	38	18.4210526315789	0.0474644716660213	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	TYROBP; FOS; IFNG; ITGB2; CLU; ITGAM; SNCA;	GO:1901216~positive regulation of neuron death	7	38	18.4210526315789	0.0474644716660213	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	EGFR; DBH; GJA1; HRH2; PTAFR; AVPR2;	GO:0045907~positive regulation of vasoconstriction	6	30	20	0.0482021246532078	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	KLF4; IFNG; PTGIR; AIF1; CTNNBIP1; NDRG2;	GO:0048662~negative regulation of smooth muscle cell proliferation	6	30	20	0.0482021246532078	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	GGCT; HAGH; GGT6; CHAC1;	GO:0006750~glutathione biosynthetic process	4	15	26.6666666666667	0.0483806355492278	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	HSPB1; CASP1; PYCARD; MNDA;	GO:0032731~positive regulation of interleukin-1 beta production	4	15	26.6666666666667	0.0483806355492278	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	IFNG; IL2RA; CTLA4; CR1;	GO:0045589~regulation of regulatory T cell differentiation	4	15	26.6666666666667	0.0483806355492278	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	TESPA1; LCK; CCR7; TRAT1;	GO:0050862~positive regulation of T cell receptor signaling pathway	4	15	26.6666666666667	0.0483806355492278	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	CYFIP2; PERP; NLRC4; PYCARD;	GO:0097202~activation of cysteine-type endopeptidase activity	4	15	26.6666666666667	0.0483806355492278	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	NSG1; LILRB2; PAIP2; CALB2;	GO:1900271~regulation of long-term synaptic potentiation	4	15	26.6666666666667	0.0483806355492278	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	DKC1; CCT6A; CCT8; NOP10;	GO:1904874~positive regulation of telomerase RNA localization to Cajal body	4	15	26.6666666666667	0.0483806355492278	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
up	CCL5; SPN; AIF1; PYCARD;	GO:2000406~positive regulation of T cell migration	4	15	26.6666666666667	0.0483806355492278	0.42776770500509	1	1	0.999996350881189	0.999996350881189	1
down	PLK1; CDC20; AURKB;	GO:0007094~mitotic spindle assembly checkpoint	3	24	12.5	0.0492385516413429	0.132422872195076	1	1	0.999998861753158	0.999998861753158	1
down	DBN1; CTTN; PFN2;	GO:0030833~regulation of actin filament polymerization	3	24	12.5	0.0492385516413429	0.132422872195076	1	1	0.999998861753158	0.999998861753158	1
down	CYP1A1; CYP2E1; ALOX15;	GO:0042759~long-chain fatty acid biosynthetic process	3	24	12.5	0.0492385516413429	0.132422872195076	1	1	0.999998861753158	0.999998861753158	1
down	FSTL3; FBN1; SFRP1;	GO:0045671~negative regulation of osteoclast differentiation	3	24	12.5	0.0492385516413429	0.132422872195076	1	1	0.999998861753158	0.999998861753158	1
down	CYP1A1; GJB2; HYAL2;	GO:0046677~response to antibiotic	3	24	12.5	0.0492385516413429	0.132422872195076	1	1	0.999998861753158	0.999998861753158	1
down	LDLR; SRC; CCNB1;	GO:0071398~cellular response to fatty acid	3	24	12.5	0.0492385516413429	0.132422872195076	1	1	0.999998861753158	0.999998861753158	1
down	HRH1; P2RY6; ANO1; ADRA1D; ADRA1B;	GO:0007200~phospholipase C-activating G protein-coupled receptor signaling pathway	5	60	8.33333333333333	0.0498870528723292	0.132422872195076	1	1	0.999998861753158	0.999998861753158	1
